PHARMACEUTICAL REFERENCE STANDARDS AND IMPURITES STANADARDS
PHARMACEUTICAL REFERENCE STANDARDS AND IMPURITES STANADARDS
Characterization data will be providing Pharmaceutical Impurity standards and reference standards like Certificate of analysis (COA) /Infrared spectrum/ Mass spectrum/1H NMR spectrum /13C NMR spectrum/TGA report /HPLC chromatogram.
At Bhavanish Life sciences we specialize in the custom synthesis of complex organic compounds for use as reference standards /Nitroso impurities/Impurities by the bio-medical and pharmaceutical industries around the world.
Bhavanish Life sciences currently offer over 8,000 certified reference standards from stock and we add approximately 500 new standards yearly. Our product line includes Active Pharmaceutical Ingredients (API), drug impurities and metabolite standards, as well as their stable isotope labelled analogues and Nitroso impurities / amino acid/peptide drug standards.
Sr.No | PROJECT | PRODUCT NAME | MONOGRAPH | CHEMICAL NAME | CAS Reg.No. |
1 | Abacavir sulfate | Abacavir sulfate | IH | (1S,4R)-4-[2-(Amino-6-(cyclopropylamino)-9H-purin-9-yl)-2-cyclopentane-1-methanol | 136470-78-5 |
2 | Abacavir sulfate | Abacavir Cyclopropyl Diamino Purine Impurity | IH | N6-Cyclopropyl-9H-purine-2,6-diamine | 120503-69-7 |
3 | Aceclofenac | Aceclofenac | EP | [[[2-[(2,6-Dichlorophenyl)amino]phenyl]acetyl]oxy]acetic acid | 89796-99-6 |
4 | Aceclofenac | Aceclofenac Impurity - A | EP | [2-[(2,6-dichlorophenyl)amino]phenyl]acetic acid(diclofenac) (Sodium salt) 15307-86-5 | 15307-79-6 |
5 | Aceclofenac | Aceclofenac Impurity - B | EP | methyl [2-[(2,6-dichlorophenyl)amino]phenyl]acetate (methyl ester of diclofenac) | 15307-78-5 |
6 | Aceclofenac | Aceclofenac Impurity - C | EP | ethyl [2-[(2,6-dichlorophenyl)amino]phenyl]acetate (ethyl ester of diclofenac) | 15307-77-4 |
7 | Aceclofenac | Aceclofenac Impurity - D | EP | methyl [[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (methyl ester of aceclofenac) | 139272-65-5 |
8 | Aceclofenac | Aceclofenac Impurity - E | EP | ethyl [[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (ethyl ester of aceclofenac) | 139272-67-6 |
9 | Aceclofenac | Aceclofenac Impurity - F | EP | benzyl [[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetate (benzyl ester of aceclofenac) | 100499-89-6 |
10 | Aceclofenac | Aceclofenac Impurity - G | EP | [[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetic acid (acetic aceclofenac) | 1215709-75-3 |
11 | Aceclofenac | Aceclofenac Impurity - H | EP | [[[[[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]acetyl]oxy]acetyl]oxy]acetic acid (diacetic aceclofenac) | 1216495-92-9 |
12 | Aceclofenac | Aceclofenac Impurity - I | EP | 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one | 15362-40-0 |
13 | Acemetacin | Acemetacin | EP | [[[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetyl]oxy]acetic acid | 53164-05-9 |
14 | Acemetacin | Acemetacin Impurity - A | EP | 4-chlorobenzoic acid | 74-11-3 |
15 | Acemetacin | Acemetacin Impurity - B | EP | [1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid(indomethacin) | 53-86-1 |
16 | Acesulfame Potassium | Acesulfame Potassium | EP | Potassium 6-methyl-1,2,3-oxathiazin-4-olate 2,2-dioxide | 55589-62-3 |
17 | Acesulfame Potassium | Acesulfame Impurity - A | EP | 3-oxobutanamide (acetylacetamide) | 5977-14-0 |
18 | Acesulfame Potassium | Acesulfame Impurity - B | EP | 5-chloro-6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide | 72827-08-8 |
19 | Acetazolamide | Acetazolamide | EP | N-(5-sulphamoyl-1,3,4-thiadiazol-2-yl) acetamide | 59-66-5 |
20 | Acetazolamide | Acetazolamide Impurity - A | EP | N-(5-chloro-1,3,4-thiadiazol-2-yl) acetamide | 60320-32-3 |
21 | Acetazolamide | Acetazolamide Impurity - B | EP | N-(1,3,4-thiadiazol-2-yl)acetamide | 5393-55-5 |
22 | Acetazolamide | Acetazolamide Impurity - C | EP | N-(5-sulphanyl-1,3,4-thiadiazol-2-yl)acetamide | 32873-56-6 |
23 | Acetazolamide | Acetazolamide Impurity - D | EP | 5-amino-1,3,4-thiadiazole-2-sulphonamide | 14949-00-9 |
24 | Acetazolamide | Acetazolamide Impurity - E | EP | 5-acetamido-1,3,4-thiadiazole-2-sulphonic acid | 827026-60-8 |
25 | Acetazolamide | Acetazolamide Impurity - F | EP | N-[5-[(5-acetamido-1,3,4-thiadiazol-2-yl)-sulphonyl]sulphamoyl-1,3,4-thiadiazol-2-yl]acetamide | 80495-47-2 |
26 | Acetazolamide | Acetazolamide Impurity - G | EP | 5-amino-1,3,4-thiadiazole-2-thiol | 2349-67-9 |
27 | Acetazolamide | Acetazolamide Related Compound D | USP | 5-amino-1,3,4-thiadiazole-2-sulphonamide | 14949-00-9 |
28 | Acetazolamide | Acetazolamide Related Compound E | USP | 5-Acetamido-1,3,4-thiadiazole-2-sulfonic acid potassium salt | Base is 827026-60-8 |
29 | Aciclovir | Aciclovir | EP | 2-amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one | 59277-89-3 |
30 | Aciclovir | Aciclovir Impurity - A | EP | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate | 102728-64-3 |
31 | Aciclovir | Aciclovir Impurity - B | EP | 2-amino-1,7-dihydro-6H-purin-6-one (guanine) | 73-40-5 |
32 | Aciclovir | Aciclovir Impurity - D | EP | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy] ethyl benzoate | 59277-91-7 |
33 | Aciclovir | Aciclovir Impurity - G | EP | 2-{[2-(acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate | 75128-73-3 |
34 | Aciclovir | Aciclovir Impurity F | EP | N-[9-[(2-hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H -purin-2-yl]acetamide | 110104-37-5 |
35 | Aciclovir | Aciclovir Impurity-L | EP | N-(9-acetyl-6-oxo-6,9-dihydro-1H -purin-2-yl)acetamide | 3056-33-5 |
36 | Aciclovir | Aciclovir Impurity P | EP | 2-amino-9-(2-hydroxyethyl)-1,9-dihydro-6H -purin-6-one | 23169-33-7 |
37 | Aciclovir | Aciclovir Related Compound - A | USP | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate | 102728-64-3 |
38 | Aciclovir | Aciclovir Related Compound - G | USP | 2-{[2-(acetylamino)-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy}ethyl acetate | 75128-73-3 |
39 | Agomelatine | Agomelatine | IH | N-[2-(7-methoxy-naphthalen-1-yl)ethyl]acetamide | 138112-76-2 |
40 | Agomelatine | Agomelatine Impurity | IH | N-[2-(3,4-Dihydro-7-methoxy-1-naphthyl)ethyl]acetamide | 1352139-51-5 |
41 | Agomelatine | Agomelatine Desacety impurity | IH | 2-(7-methoxynaphthalen-1-yl)ethanamine hydrochloride | 139525-77-2 |
42 | Agomelatine | Agomelatine impurity | IH | N-[2-(7-hydroxynaphthalen-1-yl)ethyl]acetamide | 152302-45-9 |
43 | Albendazole | Albendazole | EP | Methyl [5-(propylsulphanyl)-1H-benzimidazol-2-yl] carbamate | 54965-21-8 |
44 | Albendazole | Albendazole Impurity - A | EP | 5-(propylsulphanyl)-1H-benzimidazol-2-amine | 80983-36-4 |
45 | Albendazole | Albendazole Impurity - B | EP | Methyl [5-(propylsulfinyl)-1H-benzimidazol-2-yl]carbamate | 54029-12-8 |
46 | Albendazole | Albendazole Impurity - C | EP | Methyl [5-(propylsulphonyl)-1H-benzimidazol-2-yl] carbamate (Sulfone) | 75184-71-3 |
47 | Albendazole | Albendazole Impurity - D | EP | 5-(propylsulphonyl)-1Hbenzimidazol-2-amine (Desmethoxy carbonyl Albendazole sulfone) | 80983-34-2 |
48 | Albendazole | Albendazole Impurity - E | EP | Methyl (1H-benzimidazol-2-yl)carbamate | 10605-21-7 |
49 | Alendronate Sodium | Alendronate Sodium | EP | (4-amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt | 121268-17-5 |
50 | Alendronate Sodium | Alendronate Sodium Impurity - A | EP | 4-aminobutanoic acid | 56-12-2 |
51 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | EP | (2RS)-N-{3-[(4-Amino-6,7-dimethoxyquinazolin-2-yl)methylamino]propyl}tetrahydrofuran-2-carboxamide hydrochloride | 81403-68-1 |
52 | Alfuzosin Hydrochloride | Alfuzosin Impurity - A | EP | N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)methyl amino]propyl}furan-2-carboxamide | 98902-29-5 (HCl Salt) 98902-36-4 |
53 | Alfuzosin Hydrochloride | Alfuzosin Impurity - B | EP | 2-chloro-6,7-dimethoxyquinazolin-4-amine | 23680-84-4 |
54 | Alfuzosin Hydrochloride | Alfuzosin Impurity-C | EP | (2RS)-N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)amino]propyl}-N- methyltetrahydrofuran-2-carboxamide | 72104-34-8 |
55 | Alfuzosin Hydrochloride | Alfuzosin Impurity - D | EP | N-(4-amino-6,7-dimethoxyquinazolin-2-yl)-N- methylpropane-1,3-diamine | 76362-29-3 |
56 | Alfuzosin Hydrochloride | Alfuzosin Related compound-D | USP | N-(4-amino-6,7-dimethoxyquinazolin-2-yl)-N- methylpropane-1,3-diamine | 76362-29-3 |
57 | Alogliptin | Alogliptin Dimer impurity | IH | 2,2'-{(6-chloro-2,4-dioxypyrimidine-1,3(2H ,4H )-diyl)bis(methylene)}dibenzonitrile | 1618644-29-3 |
58 | Ambroxol Hydrochloride | Ambroxol Hydrochloride | EP | trans-4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride | 23828-92-4 |
59 | Ambroxol Hydrochloride | Ambroxol Impurity - A | EP | (2-amino-3,5-dibromophenyl) methanol | 50739-76-9 |
60 | Ambroxol Hydrochloride | Ambroxol Impurity - B | EP | trans-4-(6,8-dibromo-1,4-dihydroquinazolin-3(2H)-yl)cyclohexanol | 18683-95-9(free base) 15942-08-2 |
61 | Ambroxol Hydrochloride | Ambroxol Impurity - C | EP | trans-4-[(E)-2-amino-3,5-dibromo benzyliden)amino]cyclohexanol | 50910-53-7 |
62 | Ambroxol Hydrochloride | Ambroxol Impurity - D | EP | cis-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol (Cis-Isomer) | 107814-37-9 |
63 | Ambroxol Hydrochloride | Ambroxol Impurity - E | EP | 2-amino-3,5-dibromobenzaldehyde | 50910-55-9 |
64 | Amiodarone Hydrochloride | Amiodarone Hydrochloride | EP | (2-Butylbenzofuran-3-yl)[4-[2-(diethylamino) ethoxy]-3,5-diiodophenyl]methanone hydrochloride | 19774-82-4 |
65 | Amiodarone Hydrochloride | Amiodarone Impurity - A | EP | (2-butylbenzofuran-3-yl)[4-[2-(diethyl amino)ethoxy]phenyl]methanone | 23551-25-9 |
66 | Amiodarone Hydrochloride | Amiodarone Impurity - B | EP | (2-butylbenzofuran-3-yl)[4-[2-(ethylamino)ethoxy]-3,5-diiodophenyl] methanone | 96027-74-6 |
67 | Amiodarone Hydrochloride | Amiodarone Impurity - C | EP | (2-butylbenzofuran-3-yl)[4-[2- (diethyl amino)ethoxy]-3-iodophenyl] methanone | 85642-08-6 (HCl Salt) |
68 | Amiodarone Hydrochloride | Amiodarone Impurity - D | EP | (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone | 1951-26-4 |
69 | Amiodarone Hydrochloride | Amiodarone Impurity - E | EP | (2-butylbenzofuran-3-yl)(4-hydroxyphenyl) methanone | 52490-15-0 |
70 | Amiodarone Hydrochloride | Amiodarone Impurity - F | EP | (2-butylbenzofuran-3-yl)(4-hydroxy-3-iodo phenyl)methanone | 147030-50-0 |
71 | Amiodarone Hydrochloride | Amiodarone Impurity - H | EP | 2-chloro-N,N-diethylethanamine | 869-24-9(HCl Salt) 100-35-6(Free base) |
72 | Amiodarone Hydrochloride | Amiodarone Related Compound - D | USP | (2-butylbenzofuran-3-yl)(4-hydroxy-3,5-diiodophenyl)methanone | 1951-26-4 |
73 | Amiodarone Hydrochloride | Amiodarone Related Compound - E | USP | (2-butylbenzofuran-3-yl)(4-hydroxyphenyl) methanone | 52490-15-0 |
74 | Amiodarone Hydrochloride | Amiodarone Related Compound - H | USP | 2-chloro-N,N-diethylethanamine HCl | 869-24-9 |
75 | Amiodarone Hydrochloride | Amiodarone methoxy Impurity | IH | 2-n-butyl-3-(4-methoxy benzoyl) benzofuran | 83790-87-8 |
76 | Amiodarone Hydrochloride | Amiodarone Impurity | IH | 2-n-butylbenzofuran | 4265-27-4 |
77 | Amisulpride | Amisulpride | EP | 4-Amino-N-[[(2RS)-1-ethylpyrrolidin-2-yl]methyl]-5-(ethylsulfonyl)-2- methoxybenzamide | 71675-85-9 |
78 | Amisulpride | Amisulpride Impurity - A | EP | [(2RS)-1-ethylpyrrolidin-2-yl] methanamine | 26116-12-1 |
79 | Amisulpride | Amisulpride Impurity - B | EP | (4-amino-N-[[(2RS)-1-ethyl pyrrolidin-2-yl] methyl]-5-(ethylsulfonyl)-2-hydroxybenzamide | 148516-54-5 |
80 | Amlodipine Besilate | Amlodipine Besilate | EP | 3-Ethyl 5-methyl (4RS)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylatebenzenesulphonate | 111470-99-6 |
81 | Amlodipine Besilate | Amlodipine Impurity - A | EP | 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-2-[[2-(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)ethoxy]methyl]-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 88150-62-3 |
82 | Amlodipine Besilate | Amlodipine Impurity - B | EP | 3-ethyl 5-methyl (4RS)-4-(2-chlorophenyl)-6-methyl-2[[2-[[2-(methylcarbamoyl)benzoyl]amino] ethoxy]methyl]- 1,4-dihydropyridine-3,5- dicarboxylate, | 721958-72-1 |
83 | Amlodipine Besilate | Amlodipine Impurity - C | EP | ethyl methyl (4RS)-2-6-bis[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 721958-74-3 |
84 | Amlodipine Besilate | Amlodipine Impurity - D | EP | 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate | 113994-41-5 |
85 | Amlodipine Besilate | Amlodipine Impurity - E | EP | diethyl (4RS)-2-[(2-aminoethoxy)methyl]-4-(2- chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 140171-65-9 |
86 | Amlodipine Besilate | Amlodipine Impurity - F | EP | dimethyl (4RS)-2-[(2-aminoethoxy)methyl]-4-(2- chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate | 140171-66-0 |
87 | Amlodipine Besilate | Amlodipine Impurity - G | EP | dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, | 43067-01-2 |
88 | Amlodipine Besilate | Amlodipine Impurity - H | EP | 2-[[2-[(4RS)-4-(2-chlorophenyl)-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6- methyl-1,4-dihydropyridin-2-yl]methoxy]ethyl]carbamoyl]benzoic acid, | 318465-73-5 |
89 | Amlodipine Besilate | Amlodipine Related Compound - A | USP | (3-Ethyl 5-methyl [2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate fumarate) | 113994-41-5(base) 1216406-90-4 (Oxalate salt) |
90 | Amlodipine Besilate | Amlodipine Related Compound - C | USP | dimethyl 4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 43067-01-2 |
91 | Amlodipine Besilate | Amlodipine Related Compound - D | USP | (3-Ethyl 5-methyl-4-(2-chlorophenyl)-2-[2-(1,3-dioxoisoindolin-2-yl)ethoxy]ethyl-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate) | 88150-62-3 |
92 | Amlodipine Besilate | Amlodipine Di acid impurity | IH | 2-[2-aminoethoxy]methyl-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate acid | 1821498-25-2 |
93 | Amlodipine Besilate | Amlodipine Impurity-20 | IH | Diethyl-4-(2-chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 34148-67-9 |
94 | Amlodipine Besilate | Amlodipine Deschloro impurity | IH | 3-Ethyl 5-methyl-2-[2-Aminoethoxy]methyl-6-methyl-4-phenyl-1,4-dihydropyridine-3,5-dicarboxylate | 88150-62-1(free base) 103069-33-6(HCl Salt) |
95 | Amlodipine Besilate | Amlodipine impurity | IH | Ethyl-4-(2,1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethoxy]-3-oxobutanoate | 88150-75-8 |
96 | Amlodipine Besilate | Amlodipine Impurity - A | IH | 3-ethyl 5-methyl-2-[2-aminoethoxy]methyl-4-(2-chlorophenyl)-6-methylpyridine-3,5-dicarboxylate | 113964-41-5(base) 121640-60-4 (Oxalate salt) |
97 | Amoxicillin Trihydrate | Amoxicillin Trihydrate | EP | (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate | 61336-70-7 |
98 | Amoxicillin Trihydrate | Amoxicillin Impurity - A | EP | (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (6-aminopenicillanic acid) | 551-16-6 |
99 | Amoxicillin Trihydrate | Amoxicillin Impurity - B | EP | (2S,5R,6R)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (L-amoxicillin) | 26889-93-0 |
100 | Amoxicillin Trihydrate | Amoxicillin Impurity - C | EP | (4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid (amoxicillin diketopiperazines) | 94659-47-9 |
101 | Amoxicillin Trihydrate | Amoxicillin Impurity - D | EP | (4S)-2-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino-carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic acid (penicillic acids of amoxicillin) | 68728-47-2 (Sod salt) 42947-63-7 (Free base) |
102 | Amoxicillin Trihydrate | Amoxicillin Impurity - E | EP | (2S,4S)-2-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino-methyl]-5,5-dimethylthiazolidine-4-carboxylic acid (penicillic acids of amoxicillin) | 57414-05-8(base) 1356020-01-3 (Formate Salt) |
103 | Amoxicillin Trihydrate | Amoxicillin Impurity - F | EP | 3-(4-hydroxyphenyl)pyrazin-2-ol | 126247-63-0 |
104 | Amoxicillin Trihydrate | Amoxicillin Impurity - H | EP | (2R)-2-[2,2-dimethylpropanoyl]amino]-2-(4-hydroxyphenyl)acetic acid | 208828-86-4 |
105 | Amoxicillin Trihydrate | Amoxicillin Impurity - I | EP | (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid | 22818-40-2 |
106 | Amoxicillin Trihydrate | Amoxicillin Related Compound - A | USP | (2S,5R,6R)-6-amino-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (6-aminopenicillanic acid) | 551-16-6 |
107 | Amoxicillin Trihydrate | Amoxicillin Related Compound - B | USP | (2S,5R,6R)-6-[[(2S)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (L-amoxicillin) | 26889-93-0 |
108 | Amoxicillin Trihydrate | Amoxicillin Related Compound - C | USP | (4S)-2-[5-(4-hydroxyphenyl)-3,6-dioxopiperazin-2-yl]-5,5-dimethylthiazolidine-4-carboxylic acid (amoxicillin diketopiperazines) | 94659-47-9 |
109 | Amoxicillin Trihydrate | Amoxicillin Related Compound - D | USP | (4S)-2-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino-carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic acid monosodium salt (penicillic acids of amoxicillin) | 68728-47-2 (Sod salt) 42947-63-7 (Free base) |
110 | Amoxicillin Trihydrate | Amoxicillin Related Compound - F | USP | 3-(4-hydroxyphenyl)pyrazin-2-ol | 126247-63-0 |
111 | Amoxicillin Trihydrate | Amoxicillin Related Compound - H | USP | (2R)-2-(4-hydroxyphenyl)-2-pivalamidoacetic acid | 208828-86-4 |
112 | Amoxicillin Trihydrate | Amoxicillin Related Compound - I | USP | (2R)-2-amino-2-(4-hydroxyphenyl)acetic acid | 22818-40-2 |
113 | Amoxicillin Trihydrate | Amoxicillin Methyl Ester Impurity | IH | Methyl (2R)-amino-(4-hydroxyphenyl)ethanoate | 37763-23-8 |
114 | Aripiprazole | Aripiprazole | EP | 7-(4-[4-(2,3-Dichlorophenyl)piperazin-1-yl]butoxy)-3,4-dihydroquinolin-2(1H)-one | 129722-12-9 |
115 | Aripiprazole | Aripiprazole Impurity - A | EP | 7-(4-[(4,3-Dichlorophenyl)-2(1H)-one (Quinoline Impurity) | 22246-18-0 |
116 | Aripiprazole | Aripiprazole Impurity - B | EP | 1-(2,3-dichlorophenyl) piperazine Hydrochloride | 119532-26-2(HCl salt) 41202-77-1 (Base) |
117 | Aripiprazole | Aripiprazole Impurity - C | EP | 7-[4-[4-(2-Chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-81-7 |
118 | Aripiprazole | Aripiprazole Impurity - D | EP | 7-[4-[4-(3-Chlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-82-8 |
119 | Aripiprazole | Aripiprazole Impurity - E | EP | 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl] butoxy]-2(1H)-quinolinone | 129722-24-4 (Free Base) 1006531-60-9 (HCl Salt) |
120 | Aripiprazole | Aripiprazole Impurity - F | EP | 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl] butoxy]-3,4-dihydro-2(1H)-quinoline-N-oxide (N-Oxide Impurity) | 573691-09-5 |
121 | Aripiprazole | Aripiprazole Impurity-D (2-deschloro impurity) | IH | 7-[4-(4-(3-Chlorophenyl)-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-82-8 |
122 | Aripiprazole | Aripiprazole Impurity-C (3-deschloro impurity) | IH | 7-[4-(4-(2-Chlorophenyl)-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone | 203395-81-7 |
123 | Aripiprazole | aripiprazole Impurity - G | EP | Aripiprazole Dimer | 1797986-18-5 |
124 | Aripiprazole | Aripiprazole Related Compound B | USP | 7-(4-Hydroxybutoxy)-3,4-dihydroquinolin-2(1H)-one | 889443-20-3 |
125 | Aripiprazole | Aripiprazole Related Compound C | USP | 1-(2,3-dichlorophenyl) piperazine Hydrochloride | 119532-26-2 |
126 | Aripiprazole | Aripiprazole Related Compound F | USP | 4-(2,3-Dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazine 1-oxide | 573691-09-5 |
127 | Aripiprazole | Aripiprazole Related Compound G | USP | 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl] butoxy]-2(1H)-quinolinone | 129722-25-4 (Free Base) 1008531-60-9 (HCl Salt) |
128 | Aripiprazole | Aripiprazole Related Compound H | USP | 7-[4-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]butoxy]-3,4-dihydroquinolin-2(1H)-one | 1796928-63-6 |
129 | Aripiprazole | Aripiprazole BBDQ Impurity | IH | 7-(4-bromobutoxy)-3,4-dihydroquinilin-2-one | 129722-34-5 |
130 | Aripiprazole | Aripiprazole Impurity-3 | IH | 3,4-Di hydroxy-7-methoxy-quinazolin-2(1H)-one | 22246-17-9 |
131 | Aripiprazole | Aripiprazole Impurity-4 | IH | Diquinoline Butane Diol Imp | 882880-12-8 |
132 | Aripiprazole | Aripiprazole Impurity-6 | IH | 7-(4-Chlorobutoxy)-3,4-dihydroquinolin-2(1H)-one (chyloro butoxy quinoline impurity) | 120004-79-7 |
133 | Aripiprazole | Aripiprazole Impurity - B | IH | Aripiprazole hydoxy butyl impurity | 870765-38-1 (Free Base) 1797132-04-7 |
134 | Aspartame | Aspartame | EP | (3S)-3-Amino-4-[[(2S)-1-methoxy-1-oxo-3-phenylpropan-2-yl]amino]-4-oxobutanoic acid (methyl α-L-aspartyl-L- | 22839-47-0 |
135 | Aspartame | Aspartame Impurity - A | EP | 2-[(2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid | 5262-10-2 |
136 | Aspartame | Aspartame Impurity - B | EP | (3S)-3-amino-4-[[(1S)-1-carboxy-2-phenylethyl]amino]-4-oxobutanoic acid (α-L-aspartyl-L-phenylalanine) | 13433-09-5 |
137 | Aspartame | Aspartame Impurity - C | EP | (2S)-2-amino-3-phenylpropanoic acid (L-phenylalanine) | 63-91-2 |
138 | Aspartame | Aspartame Related Compound - A | USP | (2S,5S)-5-Benzyl-3,6-dioxopiperazin-2-yl]acetic acid | 5262-10-2 |
139 | Aspirin | Aspirin | EP | 2-(Acetyloxy)benzoic acid | 50-78-2 |
140 | Aspirin | Aspirin Impurity - A | EP | 4-hydroxybenzoic acid | 99-96-7 |
141 | Aspirin | Aspirin Impurity - B | EP | 4-hydroxybenzene-1,3-dicarboxylic acid (4-hydroxyisophthalic acid) | 636-46-4 |
142 | Aspirin | Aspirin Impurity - C | EP | 2-hydroxybenzencarboxylic acid (salicylic acid) | 69-72-7 |
143 | Aspirin | Aspirin Impurity - D | EP | 2-[(2-(acetyloxy)benzoyl)oxy]benzoic acid (acetylsalicylsalicylic acid) | 530-75-6 |
144 | Aspirin | Aspirin Impurity - E | EP | 2-[(2-hydroxybenzoyl)oxy]benzoic acid (salisalate, salicylsalicylic acid) | 552-94-3 |
145 | Aspirin | Aspirin Impurity - F | EP | 2-(acetyloxy)benzoic anhydride (acetylsalicylic anhydride) | 1466-82-6 |
146 | Atenolol | Atenolol | EP | 2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino]propoxy]phenyl]acetamide | 29122-68-7 |
147 | Atenolol | Atenolol Impurity - A | EP | 2-(4-hydroxyphenyl)acetamide | 17194-82-0 |
148 | Atenolol | Atenolol Impurity - B | EP | 2-[4-[(2RS)-2,3-dihydroxy propoxy] phenyl] acetamide | 61698-76-8 |
149 | Atenolol | Atenolol Impurity - D | EP | 2-[4-[(2RS)-3-chloro-2-hydroxy propoxy] phenyl]acetamide | 115538-83-5 |
150 | Atenolol | Atenolol Impurity - E | EP | 2,2'-[(2-hydroxypropane-1,3-diyl)bis(oxy-4,1-phenylene)]diacetamide | 141650-31-9 |
151 | Atenolol | Atenolol Impurity - F | EP | 2,2'-[(1-methylethyl)imino]bis[(2-hydroxypropane-3,1-diyl)oxy-4,1- phenylene]diacetamide | 87619-83-8 |
152 | Atenolol | Atenolol Impurity - G | EP | 2-[4-[(2RS)-2-hydroxy-3-[(1-methyl ethyl)amino]propoxy]phenyl]acetic acid | 56392-14-4 (Sod salt) |
153 | Atenolol | Atenolol Impurity - H | EP | 2-[4-[(2RS)-2-hydroxy-3-[(1-methylethyl) amino]propoxy]phenyl]acetonitrile | 29277-73-4 |
154 | Atenolol | Atenolol Impurity - I | EP | 2-[4-[(2RS)-3-(ethylamino)-2-hydroxy propoxy]-phenyl]acetamide | 1797116-92-7 |
155 | Atenolol | Atenolol Impurity - C | IH | 2-[4-[[(2RS)-oxiran-2-yl]methoxy] phenyl] acetamide | 29122-69-8 |
156 | Atorvastatin | Atorvastatin | EP | (3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid trihydrate | 134523-00-5 |
157 | Atorvastatin | Atorvastatin Impurity - H | EP | (4R,6R)-Cr2-(2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl]-4-hydroxytetrahydro-2H-pyran-2-one | 125995-03-1 |
158 | Atorvastatin | Atorvastatin Related Compound H | USP | 5-[4-Fluorophenyl)-1,2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-2-isopropyl-N,4-diphenyl-1H-pyrrole-3 carboxamide | 125995-03-1 |
159 | Atorvastatin | Atorvastatin Impurity | IH | (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxyheptanoic acid tert butylester | 134395-00-9 |
160 | Atorvastatin | Atorvastatin Impurity | IH | (5R)-6-cyano-5-hydroxy-3-oxo-hexanoic acid tert butyl ester | 125988-01-4 |
161 | Atorvastatin | Atorvastatin Impurity | IH | (4R,cis)-1,1-Dimethylethyl-6-Aminoethyl-2,2-dimethyl-1,3-dioxane-4-acetate | 125995-13-3 |
162 | Atorvastatin | Atorvastatin methyl ester impurity | IH | (3R,5R)-7-[3-(Phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid | 345891-62-5 |
163 | Atorvastatin | Atorvastatin impurity | IH | N-Phenyl isobutyrylacetamide | 124401-38-3 |
164 | Atracurium Besilate | Atracurium Besilate | EP | 2,2'-[pentane-1,5-diylbis[oxy-(3-oxopropane-1,3- diyl)]]bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] dibenzenesulfonate | 64228-81-5 |
165 | Atracurium Besilate | Atracurium Impurity - J | EP | methyl benzenesulphonate | 80-18-2 |
166 | Anagrelide | Anagrelide | USP | 6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2(3H)-one | 58579-51-4 |
167 | Anagrelide | Anagrelide Related Compound - A | USP | Ethyl-2-(6-amino-2,3-dichlorobenzylamino)acetate | 85325-12-8 |
168 | Anagrelide | Anagrelide Related Compound - C | USP | Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate hydrobromide | 70381-75-8 |
169 | Anagrelide | Anagrelide KSM | IH | Ethyl[(2,3-dichloro-6-nitrobenzyl)amino]acetate hydrochloride | 70380-50-6 85325-11-7 |
170 | Bendroflumethiazide | Bendroflumethiazide | EP | (3RS)-3-Benzyl-6-(trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulphonamide 1,1-dioxide | 73-48-3 |
171 | Bendroflumethiazide | Bendroflumethiazide Impurity - A | EP | 4-amino-6-(trifluoromethyl)benzene-1,3-disulfonamide | 654-62-6 |
172 | Benzothiadiazine | Benzothiadiazine | IH | 6-Chloro-1,1-dioxo-3-(phenylmethylsulfonylmethyl)-4H-benzo[e][1,2,4]thiadiazine-7-sulfonamide | NA |
173 | Benzothiadiazine | Benzothiadiazine Related Compound - A | USP | 4-Amino-6-chloro-1,3-benzene disulfonamide | 121-30-2 |
174 | Betahistine Dihydrochloride | Betahistine Dihydrochloride | EP | N-Methyl-2-(pyridin-2-yl)ethanamine dihydrochloride | 5579-84-0 |
175 | Betahistine Dihydrochloride | Betahistine Impurity - A | EP | 2-ethenylpyridine (2-vinylpyridine) | 100-69-6 |
176 | Betahistine Dihydrochloride | Betahistine Impurity - B | EP | 2-(pyridin-2-yl)ethanol | 103-74-2 |
177 | Betahistine Dihydrochloride | Betahistine Impurity - C | EP | N-methyl-2-(pyridin-2-yl)-N-[2-(pyridin-2-yl)ethyl]ethanamine | 5452-87-9 |
178 | Bisoprolol Fumarate | Bisoprolol Fumarate | EP | (2RS)-1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]propan-2-ol fumarate | 104344-23-2 |
179 | Bisoprolol Fumarate | Bisoprolol Impurity - A | EP | (2RS)-1-(4-hydroxymethyl-phenoxy)-3-isopropylaminopropan-2-ol | 62572-93-4 |
180 | Bisoprolol Fumarate | Bisoprolol Impurity - B | EP | (2RS)-1-isopropylarnino-3-(4-(2-propoxy-ethoxymethyl)phenoxy)propan-2-ol | 1447715-44-7 |
181 | Bisoprolol Fumarate | Bisoprolol Impurity - G | EP | (2RS)-1-(4-[[(2-isopropoxyethoxy)methoxy]methyl]phenoxy)-3-isopropylaminopropan-2-ol | 1215342-36-1 |
182 | Bisoprolol Fumarate | Bisoprolol Impurity - K | EP | 2-isopropoxyethyl 4-[[(2RS)-2-hydroxy-3-(isopropylamino) propyl]oxy]benzyl ether | 864544-37-6 |
183 | Bisoprolol Fumarate | Bisoprolol Impurity - L | EP | 4-[[(2RS)-2-hydroxy-3-(isopropylamino) propyl]oxy]-benzaldehyde | 29122-74-5(HCl salt) |
184 | Bisoprolol Fumarate | Bisoprolol Impurity - M | EP | 4-[(2-Isopropoxyethoxy)methyl]phenol | 177034-57-0 |
185 | Bisoprolol Fumarate | Bisoprolol Impurity - N | EP | (2RS)-1-(4-[(2-ethoxyethoxy)methyl]phenoxy)-3-isopropyl aminopropan-2-ol | 1346601-75-9 |
186 | Bisoprolol Fumarate | Bisoprolol Impurity - Q | EP | (2RS)-1-(isopropylamino)-3-[4-(2-methoxyethoxy) methyl) phenoxypropan-2-ol | 1346604-00-9 (Fumarate salt) |
187 | Bisoprolol Fumarate | Bisoprolol Impurity - R | EP | (2RS)-1-(isopropylamino)-3-(4-methylphenoxy) propan-2-ol | 5790-46-5 |
188 | Bisoprolol Fumarate | Bisoprolol Impurity - S | EP | 4-hydroxybenzaldehyde | 123-08-0 |
189 | Bisoprolol Fumarate | Bisoprolol Impurity - T | EP | 4-[(3-isopropyl-2-oxo-1,3-oxazolidin-5-yl)methoxy]-benzaldehyde | 1173203-26-3 |
190 | Bisoprolol Fumarate | Bisoprolol Impurity - U | EP | 5-[[4-(hydroxymethylphenoxy)methyl]-3-isopropyl-1,3-oxazolidin-2-one | 1071765-44-0 |
191 | Bisoprolol Fumarate | Bisoprolol Benzyl Alcohol | IH | 4-(2-hydroxy-3-[(propan-2-yl)amino]propoxy)benzoic acid | NA |
192 | Brimonidine | Brimonidine | IH | 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | 59803-98-4 |
193 | Brimonidine | Brimonidine Impurity - A (Impurity -II) | IH | N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine | 91147-43-2 |
194 | Bronoprol | Bronoprol | IH | 2-Bromo-2-nitro-1,3-propanediol | 52-51-7 |
195 | Bronoprol | Bronoprol Impurity | IH | 2-methyl-2-nitropropane-1,3-diol | 77-49-6 |
196 | Candesartan Cilexetil | Candesartan Cilexetil | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate | 145040-37-5 |
197 | Candesartan Cilexetil | Candesartan Impurity - A | EP | Ethyl 2-ethoxy-1-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylate | 139481-58-6 |
198 | Candesartan Cilexetil | Candesartan Impurity - B | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate | 869631-11-8 |
199 | Candesartan Cilexetil | Candesartan Impurity - C | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(1-ethyl-1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate | 1185255-99-5 |
200 | Candesartan Cilexetil | Candesartan Impurity - D | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(2-ethyl-2H-tetrazol-5- yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate | 118526-03-4 |
201 | Candesartan Cilexetil | Candesartan Impurity - E | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-ethyl-1H-tetrazol- 5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate | 914613-35-7 |
202 | Candesartan Cilexetil | Candesartan Impurity - F | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol- 5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate | 914613-36-8 |
203 | Candesartan Cilexetil | Candesartan Impurity - G | EP | 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylic acid (candesartan) | 139481-59-7 |
204 | Candesartan Cilexetil | Candesartan Impurity - H | EP | (1RS)-1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1-triphenylmethyl)- 1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (N- tritylcandesartan) | 170791-09-0 |
205 | Candesartan Cilexetil | Candesartan Impurity-I | EP | 2-Ethoxy-1-[[2-(1-triphenylmethyl)-1H-tetrazol-5-yl]-1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-Carboxylic acid methyl ester | 139481-69-9 |
206 | Candesartan Cilexetil | Candesartan Related Compound A | USP | Ethyl 2-ethoxy-1-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylate | 139481-58-6 |
207 | Candesartan Cilexetil | Candesartan Related Compound B | USP | 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-oxo-3-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-2,3-dihydro-1H-benzimidazole-4-carboxylate | 869631-11-8 |
208 | Candesartan Cilexetil | Candesartan Related Compound - D | USP | 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 3-[[2'-(2-ethyl-2H-tetrazol-5- yl)biphenyl-4-yl]methyl]-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate | 1185255-03-4 |
209 | Candesartan Cilexetil | Candesartan Related Compound - F | USP | 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(2-ethyl-2H-tetrazol- 5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate | 914613-36-8 |
210 | Candesartan Cilexetil | Candesartan Related Compound - G | USP | 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7- carboxylic acid (candesartan) | 139481-59-7 |
211 | Candesartan Cilexetil | Candesartan Impurity | IH | 1-Chloro ethyl N-Ethyl N-Phenyl carbamate | NA |
212 | Candesartan Cilexetil | Candesartan Impurity | IH | 5-(4'-(Hydroxymethyl)(1,1'-biphenyl)-2-yl)-trityl-1H-tetrazole | 154709-18-9 |
213 | Candesartan Cilexetil | Candesartan Impurity | IH | 1-Chloroethyl Cyclohexyl Carbonate | 99464-83-2 |
214 | Candesartan Cilexetil | Candesartan Impurity | IH | 2-Ethoxy-1-[[2'-(N-triphenyl methyl tetrazol-5-yl)biphenyl -4-yl]methyl] benzimidazole-7-carboilic acid | 139481-72-4 |
215 | Carbamazepine | Carbamazepine | EP | 5H-Dibenz[b,f]azepine-5-carboxamide | 298-46-4 |
216 | Carbamazepine | Carbamazepine Impurity - A | EP | 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide (10,11-dihydrocarbamazepine) | 3564-73-6 |
217 | Carbamazepine | Carbamazepine Impurity - B | EP | 9-methylacridine | 611-64-3 |
218 | Carbamazepine | Carbamazepine Impurity - D | EP | 5H-dibenzo[b,f]azepine (iminostilbene) | 256-96-2 |
219 | Carbamazepine | Carbamazepine Impurity - E | EP | 10,11-dihydro-5H-dibenzo[b,f]azepine(iminodibenzyl) | 494-19-9 |
220 | Carbamazepine | Carbamazepine Impurity - F | EP | 5H-dibenzo[b,f]azepine-5-carbonyl chloride (5-chlorocarbonyliminostilbene) | 33948-22-0 |
221 | Carbamazepine | Carbamazepine Impurity - G | EP | 10-bromo-5H-dibenzo[b,f]azepine-5-carboxamide (10-bromocarbamazepine) | 59690-97-0 |
222 | Carbamazepine | Carbamazepine Related Compound - A | USP | 10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide (10,11-dihydrocarbamazepine) | 3564-73-6 |
223 | Carbamazepine | Carbamazepine Related Compound - B | USP | 5H-dibenzo[b,f]azepine (iminostilbene) | 256-96-2 |
224 | Carbamazepine | Carbamazepine Related Compound - C | USP | 5H-dibenzo[b,f]azepin-5-ylcarbonyl)urea (N-carbamoylcarbamazepine) | 1219170-51-0 |
225 | Carbamazepine | Methoxy Carbamazepine | IH | 10-Methoxy-5H-dibenzo[b,f]azepine-5-carboxamide | 28721-09-7 |
226 | Carbamazepine | Carbamazepine Impurity | IH | Carbamazepine 10,11 epoxide | 36507-30-9 |
227 | Carbidopa | Carbidopa | EP | (2S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropanoic acid monohydrate | 38821-49-7 (monohydrate) 28860-95-9 |
228 | Carbidopa | Carbidopa Impurity (Methyldopa methyl Ester Imp) | IH | Methyl-2-amino-3-(3,4-dihydroxy phenyl)-2-methylpropanoate | 18181-08-3 |
229 | Carbocisteine | Carbocisteine | EP | (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid | 638-23-3 |
230 | Carbocisteine | Carbocisteine Lactam Impurity | IH | 5-oxothiomorpholine-3-carboxylic acid | 14226-97-2 |
231 | Carbocisteine | Carbocisteine Sulfoxide Impurity | IH | 3-[(carboxymethyl)sulfinyl]-L-alanine | 5439-87-2 |
232 | Carbocisteine | Carbocisteine Impurity | IH | Bis(β-amino-β-carboxyethyl) Disulfide (L - Cystine) | 56-89-3 |
233 | Captopril | Captopril | EP | (2S)-1-[(2S)-2-Methyl-3-sulphanylpropanoyl]pyrrolidine-2-carboxylic acid | 62571-86-2 |
234 | Captopril | Captopril Impurity - G | EP | (2RS)-3-(acetylsulfanyl)-2-methylpropanoic acid | 33325-40-5 |
235 | Carisoprodol | Carisoprodol | EP | (2RS)-2-[(Carbamoyloxy)methyl]-2-methylpentyl (1-methyl ethyl)carbamate | 78-44-4 |
236 | Carisoprodol | Carisoprodol Impurity - A | EP | (2RS)-2-(hydroxymethyl)-2-methylpentyl (1-methyl ethyl)carbamate | 25462-17-3 |
237 | Carisoprodol | Carisoprodol Impurity - B | EP | 3-methyl-5-propyl-1,3-dioxan-2-one (Dioxanone Impurity) | 7148-50-7 |
238 | Carisoprodol | Carisoprodol Impurity - C | EP | 2-methyl-2-propylpropane-1,3-diol | 78-26-2 |
239 | Carisoprodol | Carisoprodol Related Compound - A | USP | 2-hydroxymethyl-2-methylpentyl carbamate | 1471-56-3 |
240 | Carvedilol | Carvedilol | EP | (2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxy phenoxy)ethyl] amino]propan-2-ol | 72956-09-3 |
241 | Carvedilol | Carvedilol Impurity - A | EP | 1-[[9-(2-hydroxy-3-[[2-(2-methoxy phenoxy)ethyl]amino] propyl]-9H-carbazol-4-yl)oxy]-3-[[2-(2-methoxy phenoxy) ethyl]amino] propan-2-ol | 1198090-73-1 |
242 | Carvedilol | Carvedilol Impurity - B | EP | 1,1'-[[2-(2-methoxyphenoxy)ethyl]nitrilo]bis[3-(9H-carbazol-4-yloxy)propan-2-ol] | 918903-20-5 |
243 | Carvedilol | Carvedilol Impurity - C | EP | (2RS)-1-[benzyl-[(2-(2-methoxyphenoxy)ethyl)]amino]-3-(9H-carbazol-4-yl oxy)propan-2-ol | 72955-94-3 |
244 | Carvedilol | Carvedilol Related Compound - A | USP | 1-[(2-hydroxy-3-[(2-(2-methoxyphenoxy)ethyl)amino]propoxy)-9H-carbazol-9-yl]-3-[(2-(2-methoxyphenoxy)ethyl)amino] propan-2-ol | 1198090-73-1 |
245 | Carvedilol | Carvedilol Related Compound - B | USP | 3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol | 918903-20-5 |
246 | Carvedilol | Carvedilol Related Compound - C | USP | 1-(9H-Carbazol-4-yloxy)-3-(benzyl(2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol | 72955-94-3 |
247 | Carvedilol | Carvedilol Related Compound - D | USP | 4-(oxiran-2-yl)methoxy)-9H-carbazole | 51997-51-4 |
248 | Carvedilol | Carvedilol Related Compound - E | USP | (2-(2-methoxyphenoxy)ethylamine | 1836-62-0 |
249 | Carvedilol | Carvedilol Impurity IH | IH | 1-amino-3-(9H-carbazol-4-yloxy)-2-propanol | 72955-96-5 |
250 | Carvedilol | Carvedilol Impurity - I | IH | 1,2,3,9-Tetrahydro-4-H-carbazole-4-one | 15128-52-6 |
251 | Carvedilol | Carvedilol Impurity-II | IH | N-benzyl-2-(2-methoxy phenoxy)ethylamine | 3246-03-5 |
252 | Celecoxib | Celecoxib | USP | 4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | 169590-42-5 |
253 | Celecoxib | Celecoxib Impurity - A | EP | (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) [3-methyl Celecoxib] | 170570-01-1 |
254 | Celecoxib | Celecoxib Related Compound - A | USP | (4-[5-(3-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide) [3-methyl Celecoxib] | 170570-01-1 |
255 | Celecoxib | Celecoxib Impurity (4-SAPH) / (HBSH) | IH | 4-Sulfamoylphneylhydrazine Hydrochloride / 4-hydrazinobenzenesulfonamide hydrochloride | 17852-52-7 |
256 | Celecoxib | Celecoxib Diketone Impurity (CB0) | IH | 4,4,4-Trifluoro-1-p-tolyl-butane-1,3-dione | 720-94-5 |
257 | Celecoxib | Celecoxib Impurity (CB2) | IH | 4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide [2-methyl Celecoxib] | 170569-99-0 |
258 | Celecoxib | Celecoxib Des-methyl Impurity (CB3) | IH | 4-[5-phenyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | 170569-87-6 |
259 | Celecoxib | Celecoxib Hydrazine Impurity (CB4) | IH | 5-(p-tolyl)-3-(trifluoromethyl)pyrazole | 26974-15-2 |
260 | Celecoxib | Celecoxib impurity | IH | 4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | 170569-99-0 |
261 | Celecoxib | Celecoxib impurity | IH | 4,4,4-trifluoro-1-(3-methylphenyl)butane-1,2-dione | 53764-99-1 |
262 | Celecoxib | Celecoxib impurity | IH | 4,4,4-trifluoro-1-(2-methylphenyl)butane-1,2-dione | 163266-02-2 |
263 | Celecoxib | Celecoxib (MAP) Hydrazine impurity | IH | 4-{(2E)-2-[1-(4-methylphenyl)ethylidene]hydrazinyl}benzenesulfonamide | 1061214-06-9 |
264 | Cetirizine HCl | Cetirizine HCl | EP | (RS)-2-[2-[4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride | 83881-52-1 83881-51-0 (Free Base) |
265 | Cetirizine HCl | Cetirizine Impurity - A (CBHP Impurity) | EP | (RS)-1-[(4-chlorophenyl)phenylmethyl]piperazine | 303-26-4 |
266 | Cetirizine HCl | Cetirizine Impurity - B | EP | (RS)-2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]acetic acid | 113740-61-7 |
267 | Cetirizine HCl | Cetirizine Impurity - C | EP | (RS)-2-[2-[4-[(2-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid | 83881-59-8 |
268 | Cetirizine HCl | Cetirizine Impurity - D | EP | 1,4-bis[(4-chlorophenyl)phenylmethyl]piperazine | 346451-15-8 |
269 | Cetirizine HCl | Cetirizine Impurity - E | EP | (RS)-2-[2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]ethoxy]acetic acid (ethoxycetirizine) | 83881-56-5 |
270 | Cetirizine HCl | Cetirizine Impurity - F | EP | [2-[4-(diphenylmethyl)piperazin-1-yl]ethoxy]acetic acid | 83881-54-3 83881-53-2(free base) |
271 | Cetirizine HCl | Cetirizine Impurity - G | EP | 2-[4-[(RS)-(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol | 109806-71-5(Free base) 164726-80-1 (HCl Salt) |
272 | Cetirizine HCl | Cetirizine Related Compound - A | USP | ((RS)-2-[2-[4-[(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetic acid ethyl ester oxalate) | 246870-46-2 (Free Base) |
273 | Cetirizine HCl | Cetirizine Related Compound - B | USP | 2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride | 108983-83-1 |
274 | Cetirizine HCl | Cetirizine Related Compound - C | USP | (2-(2-{4-[(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetamide) | 83881-37-2 |
275 | Cetirizine HCl | Cetirizine Related Compound- G | USP | 2-[4-[(RS)-(4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethanol dihydrochloride | 109806-71-5(Free base) 164726-80-1 (HCl Salt) |
276 | Cetrizine HCl | Cetrizine 4-CBH impurity | USP | 4-Chlorobenzoylrol | 119-56-2 |
277 | Cetrizine HCl | Cetrizine Methyl Ester Impurity | USP | [2-[4-[4-Chlorophenyl)phenylmethyl]-1-giperazinyl]ethoxy]-acetic acid methyl ester | 83881-46-3 |
278 | Cetrizine HCl | Cetrizine 3-chloro impurity | USP | ([RS)-2-[2-[4-[3-Chlorophenyl)phenyl methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride | 1232460-29-5(HCl salt) |
279 | Cetrizine HCl | Cetrizine Impurity | HI | 4-Chlorobenzophenone | 134-85-0 |
280 | Cetrizine HCl | Cetrizine NOxide Impurity | HI | [2-[4-[4-Chlorophenyl)phenylmethyl]-1-oxido-1-piperazinyl]ethoxy]acetic acid | 1076199-80-8 |
281 | Cetrizine HCl | Levocetrizine Amide Impurity | HI | [R ]>[2-[4-[4-chlorophenyl)phenylmethyl]piperazin-1-yl]ethoxy]acetamide | 909779-33-5 |
282 | Cetrizine | Cetrizine s-isomer | HI | [S)-2-[2-[4-[4-chlorophenyl)phenyl methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride | 163837-48-7 |
283 | Chloramphenicol | Chloramphenicol | EP | 2,2-dichloro-N-[(1/3,2/3),2-hydroxy-1-hydroxymethyl)-2-(4-nitrophenyl)ethyl]acetamide | 56-75-7 |
284 | Chloramphenicol | Chloramphenicol AMPD Impurity | HI | 2-Amino-1-(4-nitrophenyl) propane-1,3-diol | 2964-48-9 |
285 | Chlordiazepoxide | Chlordiazepoxide | EP | 7-Chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4 oxide | 58-25-3 |
286 | Chlordiazepoxide | Chlordiazepoxide Impurity - C | EP | 2-amino-5-chlorophenyl)phenylmethanone (aminochlorobenzophenone) | 719-59-5 |
287 | Chlorphenamine Maleate | Chlorphenamine Maleate | EP | [3RS)-3-(4-Chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine hydrogen (Z)-butenedioate | 113-92-8 |
288 | Chlorphenamine Maleate | Chlorphenamine Impurity - A | EP | 2-(4-chlorophenyl)-4-(dimethylamino)-2-[2-(dimethylamino)ethyl]butanemithie | 1246816-57-8 |
289 | Chlorphenamine Maleate | Chlorphenamine Impurity - B | EP | N-(pyridin-2-yl)pyridin-2-amine (2,2'-dipyridylamine) | 1202-34-2 |
290 | Chlorphenamine Maleate | Chlorphenamine Impurity - C | EP | [3RS)-3-(4-chlorophenyl)-N-methyl-3-(pyridin-2-yl)propan-1-amine | 22630-25-7 20619-12-9(free base) |
291 | Chlorphenamine | Chlorphenamine Impurity-D | EP | [2RS)-2-(4-chlorophenyl)-4-(dimethylamino)-2-(pyridin-2-yl)butanemithie | 65676-21-3 |
292 | Chlorpromazine Hydrochloride | Chlorpromazine Hydrochloride | EP | 3-[2-Chloro-10H-phenothiazin-10-yl]-N,N-dimethyl propan-1-amine hydrochloride | 69-09-0 50-53-3(free base) |
293 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - A | EP | 3-[2-chloro-10H-phenothiazin-10-yl]-N,N-dimethylpropan-1-amine S-oxide (chlorpromazine sulfoxide) | 969-99-3 |
294 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - B | EP | N-[3-(2-chloro-10H-phenothiazin-10-yl)propyl]-N,N',N'-trimethylpropan-1,3- diamine | 19077-20-4 |
295 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - C | EP | 3-(10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine (promazine) | 53-60-1 (HCl salt) |
296 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - D | EP | 3-[2-chloro-10H-phenothiazin-10-yl]-N-methylpropan-1-amine (desmethylchlorpromazine) | 3953-65-9 |
297 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - E | EP | 2-chloro-10H-phenothiazine | 92-39-7 |
298 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity - F | EP | 3-(4-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine | 13094-24-1 |
299 | Chlorpromazine Hydrochloride | Bromopromazine Impurity | HI | 3-[2-bromo-10H-phenothiazine-10-yl]-N,N-dimethylpropan-1-amine | 15502-93-9(HCl salt) 1757-73-9(Free Base) |
300 | Chlorpromazine Hydrochloride | Chlorpromazine Impurity G | EP | 3-[2-Chloro-10H-phenothiazin-10-yl]-N-ethyl-N-methylpropan-1-amine | 1622313-77-2 |
301 | Chlorthalidone | Chlorthalidone | HI | 2-Chloro-5-(2,3-dihydro-1-hydroxy-3-oxo-1H-isolndol-1-yl)-benzoresulfonamide | 77-36-1 |
302 | Chlorthalidone | Chlorthalidone Impurity-J | HI | 3-(4-Chlorophenyl)-2,3-dihydro-3-hydroxy-1H-isolndol-1-one | 956-92-3 |
303 | Cinacalcet | Cinacalcet | HI | [R ]>[4-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl) phenyl]propan-1-amine hydrochloride | 364782-34-3 |
304 | Cinacalcet | Cinacalcet Related Compound - B | USP | [3-(3-(trifluoromethyl)phenyl)propan-1-amine | 1271930-15-4 |
305 | Cinacalcet | Cinacalcet Related Compound D (Cinacalcet S - isomer) | USP | N-[(1/3)-1-(naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride | 694495-47-1 (Free Base) 1217809-88-5 |
306 | Cinacalcet | Cinacalcet CH7 Impurity | HI | N-[(1/3)-1-(naphthalen-1-yl)ethyl]-3-phenyl propan-1-amine hydrochloride | 938177-81-2 |
307 | Cinacalcet | Cinacalcet CH5 Impurity | IH | 3-[3-(difluoromethyl)phenyl]-N-[(1R)-1-naphthalen-1-ylethyl] propan-1-amine hydrochloride | 1025064-41-8 (Base) |
308 | Cinacalcet | Cinacalcet Regio-Isomer | IH | N-[(1R)-1-naphthalen-2-ylethyl]-3-[3-(trifluoromethyl)phenyl] propan-3-amine hydrochloride | 364782-34-3 |
309 | Cinacalcet | Cinacalcet Impurity | IH | (1R)-1-(naphthalen-1-yl)ethanamine | 3886-70-2 (HCl) |
310 | Cinnarizine | Cinnarizine | EP | (E)-1-(Diphenylmethyl)-4-(3-phenylprop-2-enyl)piperazine | 298-57-7 |
311 | Cinnarizine | Cinnarizine Impurity - A | EP | 1-(diphenylmethyl)piperazine | 841-77-0 |
312 | Cinnarizine | Cinnarizine Impurity - E | EP | 1,4-bis(diphenylmethyl)piperazine | 216581-01-0 |
313 | Ciprofloxacin | Ciprofloxacin | EP | 1-Cyclopropyl-(6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 85721-33-1 |
314 | Ciprofloxacin | Ciprofloxacin Impurity - A | EP | 7-chloro-1-cyclopropyl-(6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) (fluoroquinolonic acid) (Q-acid) | 86393-33-1 |
315 | Ciprofloxacin | Ciprofloxacin Impurity - B | EP | 1-cyclopropyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid (Desfluoro compound) | 93107-11-0 (HCl Salt) |
316 | Ciprofloxacin | Ciprofloxacin Impurity - C | EP | 7-[(2-aminoethyl)amino]-1-cyclopropyl-6-fluoro -4-oxo-1,4-dihydroquinoline-3-carboxylic acid ( Ethylenediamine Compound) | 103222-12-4 or 528851-31-2 (HCl) |
317 | Ciprofloxacin | Ciprofloxacin Impurity - F | EP | 1-cyclopropyl-(6-hydroxy-4-oxo-7-(piperazin -1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 226903-07-7 |
318 | Ciprofloxacin | Ciprofloxacin Ethylenediamine Analog | USP | (1-Cyclopropyl-(6-fluoro-1, 4-dihydro-4-oxo-7-[(2-aminoethyl)-amino]-3-quinoline-carboxylic acid hydrochloride) | 103222-12-4 or 528851-31-2 (HCl) |
319 | Ciprofloxacin | Ciprofloxacin N-formyl Impurity | IH | 1-Cyclopropyl-(6-fluoro-4-oxo-7-(4-formyl-piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 93594-39-9 |
320 | Citalopram HBr | Citalopram HBr | USP | (1RS)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide | 59729-32-7 |
321 | Citalopram HBr | Citalopram Impurity - A | EP | (1RS)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carboxamide | 64372-56-1 |
322 | Citalopram HBr | Citalopram Impurity - B | EP | [1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihy droisobenzofuran-5-carbonitrile] | 411221-53-9 |
323 | Citalopram HBr | Citalopram Impurity - C | EP | (3RS)-6-cyano-3-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)isobenzofuran-1(3H)-one | 372941-54-3 (base) |
324 | Citalopram HBr | Citalopram Impurity - D | EP | (1RS)-1-(4-fluorophenyl)-1-[3-(methylamino)propyl]-1,3-dihydroisobenzofuran-5-carbonitrile | 62498-67-3 97743-99-2(HCl salt) |
325 | Citalopram HBr | Citalopram Related Compound - A | USP | [1-(3-(dimethylamino) propyl)-1-(4-fluorophenyl)-1, 3-dihydroisobenzofuran-5-carboxamide] | 64372-56-1 |
326 | Citalopram HBr | Citalopram Related Compound - B | USP | 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3-hydroxy-1,3-dihy droisobenzofuran-5-carbonitrile oxalate | 411221-53-9 (base) |
327 | Citalopram HBr | Citalopram Related Compound - C | USP | 3-(3-Dimethylaminopropyl)-3-(4-fluorophenyl)-6-cyano-1(3H)-isobenzofuranone oxalate | 372941-54-3 (base) |
328 | Citalopram HBr | Citalopram Related Compound - D | USP | 1-(4-fluorophenyl)-1/[3-(methylamino)propyl]-1,3-dihydro iso benzofuran-5-carbonitrile Hydrobromide | 62498-67-3 97743-99-2(HCl salt) |
329 | Citalopram HBr | Citalopram Related Compound - E | USP | 1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile-N-oxide hydrochloride | 63284-72-0 |
330 | Citalopram HBr | R-Citalopram Oxalate Impurity | USP | (R(-)-1-[3-(di-methylaminopropyl) -1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate) | 219861-53-7 |
331 | Citalopram HBr | Citalopram Impurity (Dimethyl amino butyryl Citalopram) | IH | 4-(dimethylamino)-2-[1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-yl]butan-1-one dioxalate | 1329742-98-3 (Free Base) |
332 | Citalopram HBr | Citalopram Impurity | IH | 5-bromo-2-benzofuran-1(3H)-one (5-bromophthalide) | 64169-34-2 |
333 | Citalopram HBr | Citlaopram Diol Impurity | IH | 4-(4-Dimethylamino)-1-4-fluoro phenyl)-1-hydroxy butyl-3-(hydroxymethyl)benzonitrile | 163145-25-4 (Free Base) 163146-26-5 |
334 | Citicoline Sodium | Citicoline Sodium | IH | (Cytidine 5'-(trihydrogen diphosphate), P'-[2-(trimethylammonio)ethyl] ester, inner salt, monosodium salt) | 33818-15-4 |
335 | Citicoline Sodium | Citicoline Impurity - B | IH | Cytidine 5'-monophosphate | 63-37-6 |
336 | Clomipramine Hydrochloride | Clomipramine Hydrochloride | EP | 3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride | 17321-77-6 |
337 | Clomipramine Hydrochloride | Clomipramine Impurity - A | EP | N-[3-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N,N',N'-trimethylpropane-1,3-diamine | NA |
338 | Clomipramine Hydrochloride | Clomipramine Impurity - F | EP | 3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine | 32943-25-2 |
339 | Clomipramine Hydrochloride | Clomipramine Impurity - G | EP | 3-chloro-5-(prop-2-enyl)-10,11-dihydro-5H-dibenzo[b,f]azepine | 1425793-87-8 |
340 | Clomipramine | Clomipramine impurity-C | EP | 3-(3-chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine | 2095-42-3 |
341 | Clomipramine | Clomipramine Impurity | IH | 5-Acetyl-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine | 25961-11-9 |
342 | Clomipramine | Clomipramine KSM impurity | IH | N-benzylacetamide | 10464-35-4 |
343 | Clomipramine Hydrochloride | clomipramine N-Desmethyl impurity | IH | 3-Chloro-10,11-dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride | 303-48-0(free base) 29854-14-6 |
344 | Clopidogrel bisulfate | Clopidogrel bisulfate | USP | Methyl (+)-(S)-α-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, sulfate (1:1) | 120202-66-6 |
345 | Clopidogrel bisulfate | Clopidogrel Related Compound - A | USP | (+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride) | 144750-42-5 |
346 | Clopidogrel bisulfate | Clopidogrel Related Compound - B | USP | (Methyl(+/-)-s-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride) | 144750-52-7 |
347 | Clopidogrel bisulfate | Clopidogrel Related Compound - C | USP | (methyl (+)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate) | 120202-71-3 |
348 | Clopidogrel bisulfate | Clopidogrel Bromo Ester impurity | IH | Alpha bromo -4-chloro phenyl acetic acid methyl ester | 24091-92-7 |
349 | Clopidogrel bisulfate | Clopidogrel Thienopyridine Impurity | IH | Thieno [3,2-c]- 4,5,6,7 - Tetrahydro pyridine hydrochloride | 28783-41-7 |
350 | Clopidogrel bisulfate | Clopidogrel Thienylethyl Impurity | IH | (S)-2-Chloro-alpha-[[2-(2-thienyl) ethyl] amino] benzene acetic acid methyl ester HCl | 141109-20-8 (base) 141109-19-5 (HCl salt) |
351 | Clotrimazole | Clotrimazole | EP | 1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole | 23593-75-1 |
352 | Clotrimazole | Clotrimazole Impurity - A | EP | (2-chlorophenyl)diphenylmethanol | 66774-02-5 |
353 | Clotrimazole | Clotrimazole Impurity - B | EP | 1-[(4-chlorophenyl)diphenylmethyl]-1H-imidazole | 23593-71-7 |
354 | Clotrimazole | Clotrimazole Impurity - C | EP | 1-chloro-2-(chlorodiphenylmethyl)-benzene | 42074-68-0 |
355 | Clotrimazole | Clotrimazole Impurity - D | EP | Imidazole | 288-32-4 |
356 | Clotrimazole | Clotrimazole Impurity - E | EP | (2-chlorophenyl)phenylmethanone (2-chlorobenzophenone) | 5162-03-8 |
357 | Clotrimazole | Clotrimazole Impurity - F | EP | 1-(triphenylmethyl)-1H-imidazole(deschloro clotrimazole) | 15469-97-3 |
358 | Clotrimazole | Clotrimazole Related Compound - A | USP | (o-chlorophenyl)diphenylmethanol | 66774-02-5 |
359 | Clinidipine | Clinidipine | IH | 3-O-(2-methoxyethyl)-5-O-((E)-3-phenylprop-2-enyl)2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 132203-70-4 |
360 | Clinidipine | Clinidipine Impurity - A | IH | Bis(2-methoxyethyl)2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 70172-96-2 |
361 | Cyamemazine | Cyamemazine | IH | 10-[3-(dimethylamino)-2-methylpropyl]phenothiazine-2-carbonitrile | 3546-03-0 |
362 | Cyamemazine | Cyamemazine Acid Impurity | IH | 10H-phenothiazine-2-carboxylic acid | 25234-50-8 |
363 | Cyamemazine | Cyamemazine Amide Impurity | IH | 10-H-phenothiazine-2-carboxamide | 1778-82-1 |
364 | Cyamemazine | Cyamemazine Impurity | IH | 2-chloro-10H-phenothiazine | 92-39-7 |
365 | Cyamemazine | Cyamemazine Impurity-III | IH | N,N,2-trimethyl-3-(10H phenothiazin-10-yl)propan-1-amine maleate | NA |
366 | Cyamemazine | Cyamemazine Impurity-IV | IH | 3-(2-chloro-10H phenothiazin-10-yl)-N ,N ,2-trimethylpropan-1-amine maleate | NA |
367 | Cyamemazine | Cyamemazine impurity-2 | IH | 10-[3-(dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carboxylic acid | NA |
368 | Cycloserine | Cycloserine | IH | (4R)-4-Amino-3-isoxazolidinone | 68-41-7 |
369 | Cycloserine | Cycloserine Dimer Impurity | IH | (3R,6R)-3,6-bis[(aminooxy)methyl] piperazine-2,5-dione | 16337-02-3 |
370 | Cyclobenzaprine Hydrochloride | Cyclobenzaprine Hydrochloride | IH | 3-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine Hydrochloride | 6202-23-9 |
371 | Cyclobenzaprine Hydrochloride | Norcyclobenzaprine Impurity | IH | 3-(5H-dibenzo(a,d)(7) annulen-5-ylidene-N-methylpropan-1-amine | 303-50-4 |
372 | Dabigatran Etexil | Dabigatran Etexil | IH | Ethyl3-[(2-{[(4-{N-hexyloxycarbonyl carbaminidoyl} phenyl)amino]methyl}-1-methyl}-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl-amino propanate | 872728-81-9 (as Mesylate) |
373 | Dabigatran Etexil | Dabigatran N-Oxide Impurity | IH | N-[[2-[[[4-[[[(Hexyloxy)carbonyl] amino] iminomethyl] phenyl] amino] methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(1-oxido-2-pyridinyl)-β-Alanine Ethyl Ester | 1381757-44-3 |
374 | Dabigatran Etexil | Dabigatran Impurity-I | IH | Ethyl-3-(2-((4-amidino phenyl amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate hydrochloride | 211914-50-0(HCl salt) 429658-95-7 (Base) |
375 | Darifenacin | Darifenacin | IH | (S)-2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl] pyrrolidin-3-yl] -2,2-diphenyl-acetamide | 133099-07-7 (HBr salt) |
376 | Darifenacin | Darifenacin Impurity KSM - I A | IH | 5-acetyl-2,3-dihydro-1-benzofuran | 90843-31-5 |
377 | Darifenacin | Darifenacin Impurity KSM-II B | IH | 1-Tosyl-(3S)-hydroxy pyrrolidine | 943587-25-5 |
378 | Darifenacin | Darifenacin Impurity KSM-II C | IH | 1-Tosyl-(3S)-tosyloxy pyrrolidine | 133034-01-2 |
379 | Darifenacin | Darifenacin Impurity KSM - II D | IH | 3-(1-cyano-1,1-diphenyl)methyl-1,1-tosylpyrrolidine | 133099-09-9 |
380 | Darifenacin | Darifenacin Impurity KSM-II E | IH | (Diphenyl[(3S)pyrrolidine -3-yl] acetonitrile oxalate salt | 133099-11-3 (Free Base) 194602-27-2 |
381 | Darifenacin | Darifenacin Impurity KSM- 1 OXIDE | IH | Benzofuran-5-yl-acetic acid | 142935-60-2 |
382 | Darifenacin | Darifenacin Quarternary Salt | IH | 3(S)-3-(1-carbomyl-1,1-diphenyl methyl)-1,1-di[2-(2,3-dihydro benzofuran-5yl) ethyl]pyrolidinium | 1396968-57-2 |
383 | Darifenacin | Darifenacin R-Isomer | IH | (R )-2-[1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl]-2,2-diphenyl acetamide hydrobromide | 1092800-15-1 |
384 | Darifenacin | Darifenacin Morpholine Amide Impurity | IH | 2,3-dihydro-1-benzofuran-5-yl-carbonyl)sulfanyl morpholine | 97483-11-9 |
385 | Darifenacin | Darifenacin HBr Stage - I Impurity | IH | 2-(2,3-dihydro-1-benzofuran-5-yl) ethyl methane sulfonate | NA |
386 | Darifenacin | Darifenacin Regio Acetyl Impurity | IH | 7-Acetyl-2,3-dihydrobenzofuran | 170730-06-0 |
387 | Darifenacin | Darifenacin Regio Morpholin amide Impurity | IH | 2-(2,3-dihydrobenzofuran-7-yl)-1-morpholinoethanethione | 97483-11-9 |
388 | Darifenacin | Darifenacin Tosyl Impurity | IH | 1-Tosyl-3-ethoxybenzylfuran pyrrolidine | NA |
389 | Darifenacin | Darifenacin Regio acid Impurity | IH | (2,3-dihydro-1-benzofuran-7-yl)acetic acid | 152149-94-5 |
390 | Darifenacin | Darifenacin N-oxide impurity | IH | (3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide | 1391080-40-2 |
391 | Darifenacin | Darifenacin Impurity | IH | 2,3-Dihydrobenzofuran-5-acetic Acid | 69999-16-2 |
392 | Darifenacin | Darifenacin Dehydro impurity | IH | 2,3-Dehydro Darifenacin Hydrobromide | 943034-52-4 |
393 | Darifenacin | Darifenacin Impurity | IH | (S)-2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetonitrile | 252317-48-9 |
394 | Desvenlafaxine Succinate | Desvenlafaxine Succinate | IH | 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenol succinate | 386750-22-7 |
395 | Desvenlafaxine Succinate | Desvenlafaxine N-oxide Impurity | IH | [4-(2-(N,N-Dimethylamino-N-oxide)-1-(1-Hydroxycyclohexyl)ethyl]phenol] | 1021933-95-8 |
396 | Desvenlafaxine Succinate | Desvenlafaxine Impurity - A | IH | 2-(4-methoxyphenyl)ethanamine | 55-81-2 |
397 | Desvenlafaxine Succinate | Desvenlafaxine Anhydro Impurity | IH | 2-cyclohexenyl-2-(4-hydroxyphenyl)-N,N-dimetylethanamine | 1346600-38-1 |
398 | Desvenlafaxine Succinate | Desvenlafaxine N,N-Didesmethyl impurity | IH | 1-[2-amino-1-(4-hydroxyphenyl)ethyl]cyclohexanol | 149289-29-2 |
399 | Desvenlafaxine Succinate | Desvenlafaxine N-Desmethyl impurity | IH | 4-[2-(methylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol | 135308-74-6 |
400 | Desvenlafaxine Succinate | Desvenlafaxine Hordenine Impurity | IH | 4-[2-(dimethylamino)ethyl]phenol | 539-15-1 |
401 | Desvenlafaxine Succinate | Desvenlafaxine Benzyl ether | IH | 1-[2-(Dimethylamino)-1-(4-(phenylmethoxy)phenyl)ethyl]cyclohexanol | 93413-61-7 |
402 | Dextromethorphan HBr | Dextromethorphan HBr | EP | ent-3-Methoxy-17-methylmorphinan hydrobromidemonohydrate | 6700-34-1 |
403 | Dextromethorphan HBr | Dextromethorphan Impurity - A | EP | ent-3-methoxymorphinan | 1087-69-0 (HCl) |
404 | Dextromethorphan HBr | Dextromethorphan Impurity - B | EP | ent-17-methylmorphinan-3-ol | 1021868-94-9(Tartrate) |
405 | Dextromethorphan HBr | Dextromethorphan Impurity - C | EP | ent-3-methoxy-17-methylmorphinan-10-one | 57969-05-8 |
406 | Dexibuprofen | Dexibuprofen | IH | (2S)-2-(4-(2-methylpropyl)phenyl)propanoic acid | 51146-56-6 |
407 | Dexibuprofen | Dexibuprofen Methyl Ester Impurity | IH | Methyl(2S)-2-(4-(2-methylpropyl) phenyl)propanoate | 81576-55-8 |
408 | Diazepam | Diazepam | EP | 7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 439-14-5 |
409 | Diazepam | Diazepam Impurity - A | EP | 7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzo diazepin-2-one (Nordazepam) | 1088-11-5 |
410 | Diazepam | Diazepam Impurity - B | EP | 2-chloro-N-(4-chloro-2-benzoylphenyl)-N-methylacetamido | 6021-21-2 |
411 | Diazepam | Diazepam Impurity - D | EP | (5-chloro-2-(methylamino) phenyl)phenyl methanone | 1022-13-5 |
412 | Diazepam | Diazepam Related Compound - A | USP | (2-methylamino-5-chlorobenzophenone) | 1022-13-5 |
413 | Diclofenac Sodium | Diclofenac Sodium | EP | Sodium 2-[(2,6-dichlorophenyl)amino]phenylacetate | 15307-79-6 |
414 | Diclofenac Sodium | Diclofenac Impurity - A | EP | 1-(2,6-dichlorophenyl)-1,3-dihydro-2H-indol-2-one | 15362-40-0 |
415 | Diclofenac Sodium | Diclofenac Impurity - B | EP | 2-[(2,6-dichlorophenyl)amino]-benzaldehyde | 22121-58-0 |
416 | Diclofenac Sodium | Diclofenac Impurity - C | EP | [2-[(2,6-dichlorophenyl)amino]-phenyl]methanol | 27204-57-5 |
417 | Diclofenac Sodium | Diclofenac Impurity - D | EP | 2-[2-[(2-bromo-6-chlorophenyl)amino]phenyl]aceti cacid | 127792-45-4 (Sodium Salt) 127792-23-8 |
418 | Diclofenac Sodium | Diclofenac Impurity - E | EP | 1,3-dihydro-2H-indol-2-one | 59-48-3 |
419 | Diclofenac Sodium | Diclofenac Impurity - F | EP | 2,6-Dichloro-N-(4-chlorophenyl)-benzeneacetamide | 560075-65-2 |
420 | Diclofenac Sodium | Diclofenac Related Compound - A | USP | N-(2,6-Dichlorophenyl)indolin-2-one) | 15362-40-0 |
421 | Diclofenac Sodium | Diclofenac Related Compound - B | USP | 2-[(2,6-dichlorophenyl)amino]-benzaldehyde | 22121-58-0 |
422 | Diclofenac Sodium | Diclofenac Related Compound - C | USP | [2-[(2,6-dichlorophenyl)amino]-phenyl]methanol | 27204-57-5 |
423 | Diclofenac Sodium | Diclofenac Related Compound - E | USP | 1,3-dihydro-2H-indol-2-one | 59-48-3 |
424 | Dimethyl Fumarate | Dimethyl Fumarate | IH | Dimethyl(E)-butenedioate | 23055-10-9 |
425 | Dimethyl Fumarate | Dimethyl Fumarate Impurity - A | IH | trans-butenedioic acid | 26877-81-6 |
426 | Dimethyl Fumarate | Dimethyl Fumarate Impurity - B | IH | Methyl hydrogen Fumarate | 2756-87-8 |
427 | Dimethyl Fumarate | Dimethyl Fumarate Impurity - C | IH | Dimethyl Maleate | 624-48-6 |
428 | Diltiazem Hydrochloride | Diltiazem Hydrochloride | EP | (2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride | 33286-22-5 |
429 | Diltiazem Hydrochloride | Diltiazem Impurity - A | EP | (2R,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | 103532-27-0 |
430 | Diltiazem Hydrochloride | Diltiazem Impurity - B | EP | (2S,3S)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | 87447-47-0 |
431 | Diltiazem Hydrochloride | Diltiazem Impurity - C | EP | (2S,3S)-3-(Acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-hydroxyphenyl)-1,5-benzothiazepin-4(5H)-one | 142926-07-6(HCl salt) |
432 | Diltiazem Hydrochloride | Diltiazem Impurity - D | EP | (2S,3S)-2-(4-methoxyphenyl)-5-[2-(methylamino)ethyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate | 130606-60-9(HCl salt) |
433 | Diltiazem Hydrochloride | Diltiazem Impurity - E | EP | (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | 42399-49-5 |
434 | Diltiazem Hydrochloride | Diltiazem Impurity - F | EP | (2S,3S)-5-[2-(dimethylamino)ethyl]-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | 23515-45-9(HCl salt) |
435 | Diltiazem Hydrochloride | Diltiazem Related Compound - A | USP | (2R,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate hydrochloride | 103532-27-0 |
436 | Diltiazem Hydrochloride | Diltiazem Related Compound - G | USP | (2S,3S)-3-hydroxy-2-(3-methoxyphenyl)-5-(2-(methylamino)ethyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one | 86408-44-8 |
437 | Diltiazem Hydrochloride | Diltiazem Related Compound - H | USP | (3S)-5-(2-aminoethyl)-3-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | 115992-91-1 |
438 | Diltiazem Hydrochloride | Diltiazem Impurity - G | IH | (2S,3S)-3-hydroxy-2-(3-methoxyphenyl)-5-(2-(methylamino)ethyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one hydrochloride | 86408-44-8 (Free base) |
439 | Diltiazem Hydrochloride | Diltiazem Impurity - H | IH | (3S)-5-(2-aminoethyl)-3-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one | 115992-91-1 |
440 | Diphenhydramine Hydrochloride | Diphenhydramine Hydrochloride | EP | 2-(Diphenylmethoxy)-N,N-Dimethylethanamine hydrochloride | 147-24-0 |
441 | Diphenhydramine Hydrochloride | Diphenhydramine Impurity - A | EP | 2-(diphenylmethoxy)-N-methylethanamine | 17471-10-2 |
442 | Diphenhydramine Hydrochloride | Diphenhydramine Impurity - B | EP | 2-[(RS)-(4-methylphenyl)phenylmethoxy]-N,N-dimethylethanamine | 19804-27-4 |
443 | Diphenhydramine Hydrochloride | Diphenhydramine Impurity - C | EP | 2-[(RS)-(4-bromophenyl)phenylmethoxy]-N,N-dimethylethanamine | 1808-12-4 |
444 | Diphenhydramine Hydrochloride | Diphenhydramine Impurity - D | EP | diphenylmethanol (Benzhydrol) | 91-01-0 |
445 | Diphenhydramine Hydrochloride | Diphenhydramine Impurity - E | EP | diphenylmethanone (Benzophenone) | 119-61-9 |
446 | Diphenhydramine Hydrochloride | Diphenhydramine Related Compound - A | USP | (2-(Diphenylmethoxy)-N-methylethanamine hydrochloride) | 53499-40-4 17471-10-2(free base) |
447 | Donepezil Hydrochloride | Donepezil Related Compound - A | USP | (E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one | 145546-80-1 |
448 | Donepezil Hydrochloride | Donepezil Hydrochloride | IH | (RS)-2-[(1-benzyl-4-piperidinyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one hydrochloride | 120011-70-3 |
449 | Donepezil Hydrochloride | Donepezil Hydroxy Impurity | IH | 2-[(1-Benzylpiperidin-4-yl)(hydroxy)methyl]-5,6-dimethoxyindan-1-one | 197010-20-1 |
450 | Donepezil Hydrochloride | Donepezil Dehydro impurity | IH | (E)-2-[(1-Benzylpiperidin-4-yl)methylene]-5,6-dimethoxyindan-1-one | 145546-80-1 |
451 | Donepezil Hydrochloride | Donepezil Benzylchloride Impurity | IH | 1,1-Dibenzyl-4-[(5,6-dimethoxy-1-oxo-2,3-dihydro-1H-2-yl)methyl]piperidinium chloride | 937362-16-8 |
452 | Donepezil Hydrochloride | Donepezil N-Oxide Impurity | IH | (RS)-2-[(1-Benzyl-4-piperidyl)methyl]-5,6-dimethoxy-1-indanone N-oxide | 120013-84-5 |
453 | Donepezil Hydrochloride | Donepezil Pyridine Analog | IH | 5,6-Dimethoxy-2-(pyridine-4-yl]-2,3-dihydro-1H-inden-1-onemethyl)indan-1-one | 4803-57-0 |
454 | Donepezil | Donepezil Dehydro deoxy impurity | IH | 4-[(5,6-Dimethoxy-1H-inden-2-yl)methyl]-1-(phenylmethyl)piperidine | 120013-45-8 |
455 | Doxazosin Mesilate | Doxazosin Mesilate | EP | 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[(2RS)-2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl]piperazine methanesulphonate | 77883-43-3 |
456 | Doxazosin Mesilate | Doxazosin Impurity - A | EP | (2RS)-2,3-dihydro-1,4-benzodioxine-2-carboxylic acid | 3663-80-7 |
457 | Doxazosin Mesilate | Doxazosin Impurity - B | EP | 1-[(2RS)-2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl]piperazine | 70918-74-0 (HCl salt) 70918-00-2 |
458 | Doxazosin Mesilate | Doxazosin Impurity - C | EP | 1,4-bis(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazine | 617677-53-9 |
459 | Doxazosin Mesilate | Doxazosin Impurity - D | EP | 6,7-dimethoxyquinazoline-2,4(1H,3H)-dione | 28888-44-0 |
460 | Doxazosin Mesilate | Doxazosin Impurity - E | EP | 2,4-dichloro-6,7-dimethoxyquinazoline | 27631-29-4 |
461 | Doxazosin Mesilate | Doxazosin Impurity - F | EP | 2-chloro-6,7-dimethoxyquinazolin-4-amine | 23680-84-4 |
462 | Doxazosin Mesilate | Doxazosin Impurity - G | EP | 6,7-dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine | 60547-97-9 |
463 | Doxazosin Mesilate | Doxazosin Impurity - H | EP | 2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) | 102839-00-9 |
464 | Doxazosin Mesilate | Doxazosin Related Compound - A | USP | N-(1,4-benzodioxane-2-carbonyl)piperazine hydrochloride | 70918-74-0 |
465 | Doxazosin Mesilate | Doxazosin Related Compound - B | USP | 6,7-dimethoxyquinazoline-2,4-dione | 28888-44-0 |
466 | Doxazosin Mesilate | Doxazosin Related Compound - C | USP | 2-Chloro-4-amino-6,7-dimethoxyquinazoline | 23680-84-4 |
467 | Doxazosin Mesilate | Doxazosin Related Compound - D | USP | 1,4benzodioxane-2-carboxylic acid | 3663-80-7 |
468 | Doxazosin Mesilate | Doxazosin Related Compound - E | USP | 2,4-dichloro-6,7-dimethoxyquinazoline | 27631-29-4 |
469 | Doxazosin Mesilate | Doxazosin Related Compound - F | USP | N,N'-bis(1,4-benzodioxane-2-carbonyl)piperazine | 617677-53-9 |
470 | Doxepin | Doxepin N-oxide | IH | (3E)-3-(dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine N-oxide | 22684-91-9 |
471 | Doxycycline Monohydrate | Doxycycline Monohydrate | EP | (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-1,4,4a,5,5a,6,11, 12a-octahydrotetracene-2-carboxamide monohydrate | 17086-28-1 |
472 | Doxycycline Monohydrate | Doxycycline Impurity - B | EP | (4S,4aR,5S,5aR,12aS)-4-(dimethyl amino)-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-1,4,4a,5,5a,6,11, 12a-octahydrotetracene-2-carboxamide | 914-00-1 (Free Base) 2963-95-9 |
473 | Doxylamine Succinate | Doxylamine Succinate | EP | N,N-dimethyl-2-[(1RS)-1-phenyl-1-(pyridin-2-yl) ethoxy]ethanamine hydrogen butanedioate | 562-10-7 |
474 | Doxylamine Succinate | Doxylamine Impurity - D | EP | phenyl(pyridin-2-yl)methanone (2- benzoyl pyridine) | 91-02-1 |
475 | Doxylamine Succinate | Doxylamine Impurity-A | IH | N,N-Dimethyl-2-[1-phenyl-1-(4-pyridinyl)ethoxy]ethanamine(orDoxylamine 4-pyridinyl isomer | 873407-01-3 |
476 | Doxylamine Succinate | Doxylamine Impurity-B | IH | α-Methyl-α-phenyl-2-pyridinemethanol hydrochloride | 19490-92-7(freebase) 879671-67-7(HCl salt) |
477 | Doxylamine Succinate | Doxylamine Impurity-C | IH | Desmethyl Doxylamine(or) N,N-Dimethyl-2-(phenyl-2-pyridinylmethoxy)ethanamine | 1221-70-1 |
478 | Duloxetine Hydrochloride | Duloxetine Hydrochloride | USP | (+)-(S)-N-methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine Hydrochloride | 136434-34-9 |
479 | Duloxetine Hydrochloride | Duloxetine Related Compound - A | USP | (R)-N-Methyl-3-(naphthalene-1-yl oxy)-3-(thiophen-2-yl)propan-1-amine Hydrochloride | 910138-96-4 |
480 | Duloxetine Hydrochloride | Duloxetine Impurity (R - Isomer of Stage - I) | IH | R-(-)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine oxalate | NA |
481 | Duloxetine Hydrochloride | R-Isomer of Duloxetine Impurity | IH | (R)-N-Methyl-3-(naphthalene-1-yl oxy)-3-(thiophen-2-yl)propan-1-amine | 910138-96-4(HCl salt) |
482 | Duloxetine Hydrochloride | R- Isomer of Duloxetine KSM | IH | R-(+)-N,N-Dimethyl-3-hydroxy-3- (2-thienyl)propanamine | 132335-49-0 |
483 | Duloxetine Hydrochloride | Duloxetine impurity-A | IH | N-Methyl-N-[(3S)-3-(1-naphthalenyloxy)-3-(2-thienyl)propyl]carbamic Acid Phenyl Ester | 947686-08-1 |
484 | Duloxetine Hydrochloride | Duloxetine Related Compound-D | IH | N-methyl-3-[(naphthalene-1-yl)oxy]-3-thiophen-3-yl)propan-1-amine oxalate salt | 116817-28-8 |
485 | Duloxetine Hydrochloride | Duloxetine N-Methyl Oxalate impurity | IH | (S)-N,N-Dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine Ethanedioate | 132335-47-8 |
486 | Duloxetine Hydrochloride | Duloxetine Hydroxy Impurity | IH | 3-(Dimethylamino)-1-(thiophen-2-yl)propan-1-ol | 13636-02-7 |
487 | Duloxetine Hydrochloride | Duloxetine Impurity - F | IH | (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine oxalate | 116817-27-7(Free base) 1104890-90-5(HCl salt) |
488 | Duloxetine Hydrochloride | Duloxetine Related Compound - H | USP | (S)-4-Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino]-4-oxobutanoic acid | 199191-66-7 |
489 | Duloxetine Hydrochloride | Duloxetine Impurity - C | IH | 4-[(1RS)-3-(Methylamino)-1-(thiophen-2-yl)propyl]naphthalen-1-ol | 940096-01-9(HBr salt) |
490 | Dalfampridine | Dalfampridine | IH | 4-Aminopyridine | 504-24-5 |
491 | Dalfampridine | Dalfampridine Impurity | IH | N-(4-Aminopyridin-3-yl)acetamide hydrochloride | 676464-96-3 |
492 | Dalfampridine | Dalfampridine N-Oxide Impurity | IH | 4-Aminopyridine N-Oxide | 3535-75-9 |
493 | Dalfampridine | Dalfampridine Methane diamine Impurity | IH | N,N'-Di-4-pyridinyl-methanediamine | 4589-32-6 |
494 | Dalfampridine | Dalfampridine Impurity | IH | 4-Aminopyridin-3-ol hydrochloride | 52334-53-9 |
495 | Ebastine | Ebastine | EP | 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenyl methoxy)piperidin-1-yl] butan-1-one | 90729-43-4 |
496 | Ebastine | Ebastine Impurity - A | EP | Diphenylmethanol | 91-01-0 |
497 | Ebastine | Ebastine Impurity - B | EP | 1-[4-(1,1-dimethylethyl)phenyl]ethanone | 943-27-1 |
498 | Ebastine | Ebastine Impurity - C | EP | 4-(diphenylmethoxy)piperidine | 58258-01-8 |
499 | Ebastine | Ebastine Impurity - D | EP | 1-[4-(1,1-dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl)butan-1-one | 97928-18-2 |
500 | Ebastine | Ebastine Impurity - E | EP | 1-[4-(1,1-dimethylpropyl)phenyl]-4-[4-(diphenylmethoxy)piperidin-1-yl] butan-1-one | 1312211-93-0 |
501 | Ebastine | Ebastine Impurity-F | EP | 1-[4-(1,1-dimethylethyl)phenyl]-4-[cis-4-(diphenylmethoxy)-1-oxidopiperidin-1- yl]butan-1-one, | 1256285-71-8 |
502 | Ebastine | Ebastine Related Compound - B | USP | 1-[4-(dimethylethyl)phenyl]ethanone | 943-27-1 |
503 | Ebastine | Ebastine Related Compound - C | USP | 4-(diphenylmethoxy)piperidine hydrochloride | 58258-01-8 (Free Base) |
504 | Ebastine | Ebastine Related Compound - D | USP | 1-[4-(1,1-Dimethylethyl)phenyl]-4-(4-hydroxypiperidin-1-yl) butan-1-one | 97928-18-2 |
505 | Ebastine | Ebastine N-Oxide Impurity | IH | 1-[4-(1,1-Dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-oxido-1-piperidinyl]-1-butanone) | 1256285-71-8 |
506 | Ebastine | Ebastine Impurity | IH | 1-(4-tert-butylphenyl)-4-chlorobutan-1-one | 43076-61-5 |
507 | Ebastine | Ebastine Impurity - H | IH | 1,1',1'',1'''-(oxydinethanetetryl) tetrabenzene | 574-42-5 |
508 | Eletriptan | Eletriptan | IH | (R )-3-[(1-methylpyrrolidin-2-yl) methyl]-5(2-phenyl sulfonylethyl)-1H-indole | 143322-58-1 |
509 | Eletriptan | Eletriptan Related Compound - B | USP | 5-bromo-3-((R )-1-methyl pyrrolidin-2-yl)methyl)-1H-indole | 143322-57-0 |
510 | Eletriptan | Eletriptan S-Enantiomer | USP | (S )-3-[(1-methylpyrrolidin-2-yl) methyl]-5(2-phenylsulfony lethyl)-1H-indole monohydrobromide | 1252673-29-2 |
511 | Eletriptan | Eletriptan Impurity - A | IH | 3-((R )-1-methyl pyrrolidin-2-yl) methyl)-1H-indole | 143322-55-8 |
512 | Eletriptan | Eletriptan Impurity - B | IH | 5-bromo-3-((R )-1-methyl pyrrolidin-2-yl)methyl)-1H-indole | 143322-57-0 |
513 | Eletriptan | Eletriptan Impurity - C | IH | 3-((R )-1-methyl pyrrolidin-2-yl) methyl)-5-((E )-2-(Phenyl sulfonyl)vinyl)-1H-indole | 188113-72-6 |
514 | Eletriptan | Eletriptan Impurity - D | IH | 5-(2-phenyl sulfonyl ethyl)-1H-indole | 1225327-16-1 |
515 | Eletriptan | Eletriptan S-Isomer Impurity | IH | (S )-3-[(1-methylpyrrolidin-2-yl) methyl]-5(2-phenylsulfony lethyl)-1H-indole | 1252673-29-2 |
516 | Emtricitabine | Emtricitabine | IH | 4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one | 143491-57-0 |
517 | Emtricitabine | Emtricitabine Enantiomer | IH | 5-fluoro-1-[(2S,5R)-2-(hydroxy methyl)-1,3-oxathiolan-5-yl] cytosine | 134379-77-4 |
518 | Enalapril Maleate | Enalapril Maleate | EP | (2S)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid (Z)-butenedioate (1:1)(isomer) | 76095-16-4 |
519 | Enalapril Maleate | Enalapril Impurity - A | EP | (2S)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid (ECDPA Impurity ) | 76420-74-1 |
520 | Enalapril Maleate | Enalapril Impurity - B | EP | (2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoic acid (Diacid) | 82717-96-2 |
521 | Enalapril Maleate | Enalapril Impurity - F | EP | (2S)-1-[(2S)-2-[[(1S)-1-(butoxycarbonyl)-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid (Butyl Ester Analog) | 76391-34-9 |
522 | Enalapril Maleate | Enalapril Impurity - H | EP | (2S)-1-[(2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino] propanoyl]pyrrolidine-2-carboxylic acid (Cyclohexyl analog) | 2055735-10-7 |
523 | Enalapril Maleate | Enalapril Impurity - I | EP | 1H-imidazole | 288-32-4 |
524 | Enalapril Maleate | Enalapril Impurity - D | EP | (2R)-(2S,3aS,7aS)-1-[(2S)-2-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]octahydro-1H-indole-2-carboxylic acid | 115729-52-7 |
525 | Enalapril Maleate | Enalapril Impurity - C | EP | (2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid | 84680-54-6 |
526 | Enalapril Maleate | Enalapril Impurity - G | EP | (2S)-2-[[(1S)-3-cyclohexyl-1-(ethoxycarbonyl)propyl]amino]propanoic acid | 460720-14-3 |
527 | Entacapone | Entacapone | EP | (2E)-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-N,N-diethylprop-2-enamide | 130929-57-6 |
528 | Entacapone | Entacapone Impurity - C | EP | 3,4-dihydroxy-5-nitro benzaldehyde | 116313-85-0 |
529 | Ethambutol Hydrochloride | Ethambutol Hydrochloride | EP | (2S,2'S)-2,2'-(ethylenediimino)dibutan-1-ol dihydrochloride | 1070-11-7 |
530 | Ethambutol Hydrochloride | Ethambutol Impurity - A | EP | 2-aminobutan-1-ol | 96-20-8 |
531 | Ethambutol Hydrochloride | Ethambutol Impurity - D | EP | 1,2-dichloroethane (ethylene chloride) | 107-06-2 |
532 | Erdosteine | Erdosteine | IH | [(2-oxo-2-[(2-oxotetrahydrothiophen-3-yl)amino] ethyl]sulfanyl]acetic Acid | 84611-23-4 |
533 | Erdosteine | Erdosteine Impurity ( Metabolite - 1) | IH | N-[(carboxymethyl)thioacetyl]homocysteine | 121213-21-6 |
534 | Erdosteine | Erdosteine Impurity ( EP21506 ) | IH | Bis-N-(2-Oxo-3-tetrahydrothienyl) thiodiglycylamide | NA |
535 | Erdosteine | Erdosteine RV201 | IH | S-[2-[N-3-(2-oxotetrahydrothienyl) acetamido]-N-(carboxymethyl thioetyl) homocysteine | NA |
536 | Escitalopram | Escitalopram | IH | (S)-1-[3-(dimethylaminopropyl)-1-(4-fluoro phenyl)-1,3-dihydroisobenzofuran-5-carbonitrile | 219861-08-2 |
537 | Escitalopram | Escitalopram Oxo Impurity | IH | (±S)-1-[3-(dimethylaminopropyl)-1-(4-fluorophenyl)-3-oxo-1,3-dihydro-2-benzofuran-5-carbonitrile oxalate | 372941-54-3 (Free Base) |
538 | Escitalopram | Escitalopram Impurity - C | IH | (1-(3-(dimethylamino)propyl)-1,3-dihydro-1-phenylisibenzofuran-5-carbonitrile) oxalate(Desfluoro Escitalopram) | 1093072-86-6 |
539 | Escitalopram | Escitalopram Acid impurity | IH | (S)-1-[3-(dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-Carboxylic acid | 1133881-04-5 |
540 | Escitalopram | Di-Demethyl Impurity | IH | (±s)-1-(3-aminopropyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile | 166037-78-1 |
541 | Escitalopram | Escitalopram amide impurity | IH | 4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzamide | NA |
542 | Esomeprazole Magnesium Trihydrate | Esomeprazole Magnesium Trihydrate | EP | Magnesium bis[5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl pyridin-2-yl) methyl]sulphinyl]-1H-benzimidazol-1-ide] trihydrate | 217087-09-7 |
543 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - A | EP | 5-methoxy-1H-benzimidazole-2-thiol | 37052-78-1 |
544 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - C | EP | 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl) methyl]sulphanyl]-1H-benzimidazole (Lifrazole) | 73590-85-9 |
545 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - D | EP | 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl) methyl]sulphonyl]-1H-benzimidazole (Omeprazole Sulfone) | 88546-55-8 |
546 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - E | EP | 4-methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl) sulphinyl]methyl]-3,5-dimethylpyridine 1-oxide | 176219-04-8 |
547 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - B | EP | 2-[[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole | 110374-16-8 |
548 | Esomeprazole Magnesium Trihydrate | Esomeprazole Related Compound - A | USP | 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2yl) methyl]sulphonyl]-1H-benzimidazole (Omeprazole Sulfone) | 88546-55-8 |
549 | Esomeprazole Magnesium Trihydrate | Esomeprazole Related compound - E | USP | 4-methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl) sulphinyl]methyl]-3,5-dimethylpyridine 1-oxide | 176219-04-8 |
550 | Esomeprazole Magnesium Trihydrate | Esomeprazole Related Compound - I | USP | 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulphonyl]-1H-benzimidazole N-oxide | 158812-85-2 |
551 | Esomeprazole Magnesium Trihydrate | Esomeprazole Impurity - I | IH | 5-Methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole N-oxide | 158812-85-2 |
552 | Esomeprazole Magnesium Trihydrate | Esomeprazole R-isomer | IH | 5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl]sulfinyl]-1H-benzimidazole potassium salt | 161796-77-6 (Sodium Salt) |
553 | Ethyl Hydroxybenzoate | Ethyl Hydroxybenzoate | EP | Ethyl 4-hydroxybenzoate | 120-47-8 |
554 | Ethyl Hydroxybenzoate | Ethyl Hydroxybenzoate Impurity - A | EP | 4-hydroxybenzoicacid | 99-96-7 |
555 | Ethyl Hydroxybenzoate | Ethyl Hydroxybenzoate Impurity - B | EP | methyl 4-hydroxybenzoate(Methyl parahydroxybenzoate) | 99-76-3 |
556 | Ethyl Hydroxybenzoate | Ethyl Hydroxybenzoate Impurity - C | EP | propyl 4-hydroxybenzoate(Propyl parahydroxybenzoate) | 94-13-3 |
557 | Ethyl Hydroxybenzoate | Ethyl Hydroxybenzoate Impurity - D | EP | butyl 4-hydroxybenzoate(Butyl parahydroxybenzoate) | 94-26-8 |
558 | Etoricoxib | CDPTH Impurity | IH | 1-[(2E)-2-chloro-3-(piperidin-1-yl)prop-2-en-1-ylidene]piperidin-1-ium | NA |
559 | Etodolac | Etodolac | EP | 2-[(1RS)-1,8-Diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid | 41340-25-4 |
560 | Etodolac | Etodolac Impurity - B | EP | 2-[(1RS)-1-ethyl-8-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid (8-methyl etodolac) | 41340-19-6 |
561 | Etodolac | Etodolac Impurity - C | EP | 2-[(1RS)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid (1-methyl etodolac) | 109518-50-5 109518-47-0 (Mixture +/-) |
562 | Etodolac | Etodolac Impurity - H | EP | 2-(7-ethyl-1H-indol-3-yl)ethanol | 41340-36-7 |
563 | Etodolac | Etodolac Impurity - K | EP | methyl 2-[(1RS)-1,8-diethyl-1,3,4,9-tetrahydro pyrano[3,4-b]indol-1-yl acetate ( etodolac methyl ester) | 122188-02-7 |
564 | Etodolac | Etodolac Related Compound - A | USP | 2-[(1RS)-8-ethyl-1-methyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid (1-methyl etodolac) | 109518-50-5 109518-47-0 (Mixture +/-) |
565 | Epinephrine | Epinephrine | EP | 4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | 51-43-4 |
566 | Epinephrine | Epinephrine Impurity - F | EP | (1R)-1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanesulfonic acid | 78995-75-2 |
567 | Epinephrine | Epinephrine Sulfonic acid impurity | IH | 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethanesulfonic acid | 26405-77-8 |
568 | Epinephrine | Epinephrine Methoxy Impurity | IH | 4-[1-methoxy-2-(methylamino)ethyl]benzene-1,2-diol hydrochloride | 74571-90-7 |
569 | Epinephrine | Epinephrine S-Epinephrine Impurity | IH | 4-[(1S)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol | 150-05-0 |
570 | Epinephrine | Epinephrine Methyl benzyl ethanone Impurity | IH | 2-[benzyl(methyl)amino]-1-(3,4-dihydrophenyl)ethane-1-one hydrochloride | 317351-39-6 |
571 | Epinephrine | Epinephrine Methyl benzyl ethanol Impurity | IH | 4-[2-[benzyl(methyl)amino]-1-hydroxyethyl]benzene-1,2-diol | 1095714-91-2 |
572 | Epinephrine | Epinephrine Deoxy Impurity | IH | 4-[2-(methylamino)ethyl]benzene-1,2-diol hydrochloride | 501-15-5(Free base) 62-32-8(HCl salt) |
573 | Enrofloxacin | Enrofloxacin | EP | 1-Cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 93106-60-6 |
574 | Enrofloxacin | Enrofloxacin Impurity - C | EP | 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 138892-82-7 |
575 | Enrofloxacin | Enrofloxacin Impurity - E | EP | 6-chloro-1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 1369495-59-9 |
576 | Enrofloxacin | Enrofloxacin Impurity - F | EP | 1-cyclopropyl-7-(4-ethylpiperazin-1-yl)-6-fluoroquinolin-4(1H)-one | 131775-99-0 |
577 | Felodipine | Felodipine | EP | Ethyl methyl (4RS)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 72509-76-3 |
578 | Felodipine | Felodipine Impurity - A | EP | Ethyl methyl -4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | 96382-71-7 |
579 | Felodipine | Felodipine Impurity - B | EP | Dimethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 91189-59-2 |
580 | Felodipine | Felodipine Impurity - C | EP | Diethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | 79925-38-5 |
581 | Felodipine | Felodipine Related Compound - A | USP | Ethyl methyl -4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate | 96382-71-7 |
582 | Fenofibrate | Fenofibrate | EP | 1-Methylethyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | 49562-28-9 |
583 | Fenofibrate | Fenofibrate Impurity - A | EP | (4-chlorophenyl)(4-hydroxyphenyl) methanone | 42019-78-3 |
584 | Fenofibrate | Fenofibrate Impurity - B | EP | 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid (fenofibric acid) | 42017-89-0 |
585 | Fenofibrate | Fenofibrate Impurity - C | EP | (3RS)-3-[4-(4-chlorobenzoyl)phenoxy]butan-2-one | 217636-47-0 |
586 | Fenofibrate | Fenofibrate Impurity - D | EP | methyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | 42019-07-8 |
587 | Fenofibrate | Fenofibrate Impurity - E | EP | ethyl 2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | 42019-08-9 |
588 | Fenofibrate | Fenofibrate Impurity - F | EP | (4-chlorophenyl)[4-(1-methylethoxy-)phenyl] methanone | 154356-96-4 |
589 | Fenofibrate | Fenofibrate Impurity - G | EP | 1-methylethyl 2-[[2-[4-(4-chlorobenzoyl phenoxy)-2-methyl propanoyl]oxy]-2-methyl propanoate | 217636-48-1 |
590 | Fenofibrate | Fenofibrate Related Compound - A | USP | (4-chlorophenyl)(4-hydroxyphenyl)methanone) | 42019-78-3 |
591 | Fenofibrate | Fenofibrate Related Compound - B | USP | (2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl propanoic acid) | 42017-89-0 |
592 | Fenofibrate | Fenofibrate Related Compound - C | USP | (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoyl]oxy]-2-methylpropanoate) | 217636-48-1 |
593 | Fenofibrate | Fenofibrate choline impurity | IH | 2-Hydroxy-N,N,N,-trimetyl ethanaminium,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoate | 856676-23-8 |
594 | Flecainide Acetate | Flecainide Acetate | EP | N-[(RS)-(Piperidin-2-ylmethyl)]-2,5-bis(2,2,2-trifluoroethoxy)benzamide acetate | 54143-56-5 |
595 | Flecainide Acetate | Flecainide Impurity - B | EP | (RS)-piperidin-2-ylmethanamine | 22990-77-8 |
596 | Flecainide Acetate | Flecainide Impurity - C | EP | (RS)-4-hydroxy-N-(piperidin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide | 15217-1-74-9 |
597 | Flecainide Acetate | Flecainide Impurity - D | EP | 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid | 35480-52-5 |
598 | Flecainide Acetate | Flecainide Impurity - E | EP | N-(pyridin-2-ylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide | 57415-36-8 |
599 | Fingolimod Hydrochloride | Fingolimod Hydrochloride | IH | 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol hydrochloride | 162359-56-0 |
600 | Fingolimod Hydrochloride | Fingolimod Impurity - 1 | IH | N-(1,1-bis(hydroxymethyl)-3-(4-octylphenyl)propyl)acetamide | 249289-10-9 |
601 | Fingolimod Hydrochloride | Fingolimode Impurity | IH | 2-chloro-1-(4-octylphenyl)ethanone | 51326-38-6 |
602 | Fingolimod Hydrochloride | Fingolimod Nitro Impurity | IH | 2-Nitro-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol | 374077-88-0 |
603 | Fluconazole | Fluconazole | EP | 2-(2,4-Difluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl) propan-2-ol | 86386-73-4 |
604 | Fluconazole | Fluconazole impurity-D | EP | 2-(4-fluorophenyl)-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | 81886-51-3 |
605 | Fluconazole | Fluconazole Related compound-A | USP | 2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-ol | 871550-15-1 |
606 | Fluconazole | Fluconazole Related compound-B | USP | 2-Desfluoro fluconazole | 81886-51-3 |
607 | Fluconazole | Fluconazole Impurity | IH | 1-[[2-(2,4-difluorophenyl)oxiran-2-yl]methyl]-1H-1,2,4-triazole | 86386-77-8 (Sulfonate salt) |
608 | Fluconazole | Fluconazole Impurity | IH | 1,3-bis(1H-1,2,4-triazol-1-yl)propan-2-one | 98414-56-3 |
609 | Fluconazole | Fluconazole Impurity-C | IH | 1,1'-(1,3-phenylene)bis(1H-1,2,4-triazole) | 514222-44-7 |
610 | Fluoxetine Hydrochloride | Fluoxetine Hydrochloride | EP | (3RS)-N-Methyl-3-phenyl-3-(4-trifluoromethylphenoxy)propan-1-amine hydrochloride | 59333-67-4 |
611 | Fluoxetine Hydrochloride | Fluoxetine Impurity - A | EP | (1RS)-3-(methylamino)-1-phenylpropan-1-ol | 42142-52-9 |
612 | Fluoxetine Hydrochloride | Fluoxetine Impurity - B | EP | N-methyl-3-phenylpropan-1-amine, | 23580-89-4 |
613 | Fluoxetine Hydrochloride | Fluoxetine Impurity - C | EP | (3RS)-N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenoxy]propan-1-amine | 79088-29-2 (HCl Salt) 56161-72-9 |
614 | Fluoxetine Hydrochloride | Fluoxetine Related Compound - A | USP | (N-Methyl-3-phenyl-3-[alpha,alpha,alpha-(trifluoro-m-tolyl)oxy] propylamine Hydrochloride | 79088-29-2 |
615 | Fluoxetine Hydrochloride | Fluoxetine Related Compound - B | USP | N-methyl 3-phenylpropylamine | 23580-89-4 |
616 | Fluoxetine Hydrochloride | Fluoxetine impurity | IH | 3-(dimethylamino)-1-phenylpropan-1-ol | 5554-64-3 |
617 | Fluoxetine Hydrochloride | Fluoxetine Dimethyl amine impurity | IH | N,N-dimethyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine | 56225-81-1 |
618 | Fluvoxamine Maleate | Fluvoxamine Maleate | EP | 2-{[(E)-5-Methoxy-1-(4-trifluoromethyl phenyl) pentan-1-ylidene] aminooxy}ethanamine (Z)-butenedioate | 61718-82-9 |
619 | Fluvoxamine Maleate | Fluvoxamine impurity-I | EP | (±Z)-N-hydroxy-5-methoxy-1-(4-trifluoromethylphenyl)pentan-1-imine | 88699984-7 |
620 | Fluvoxamine Maleate | Fluvoxamine Impurity - VIII | IH | 5'-Methoxy-4-trifluoromethyl valerophenone | 61718-80-7 |
621 | Folic acid | Folic acid | EP | (2S)-2-[[4-[[2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino] benzo]amino]pentanedioic acid | 59-30-3 |
622 | Folic acid | Folic acid Impurity - A | EP | (2S)-2-[(4-aminobenzoyl)amino]pentanedioic acid (N-(4-aminobenzoyl)-L-glutamic acid) | 4271-30-1 |
623 | Folic acid | Folic acid Impurity - D | EP | 4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino] benzoic acid (pteroic acid) | 119-24-4 |
624 | Furosemide | Furosemide | EP | 4-Chloro-2-(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid | 54-31-9 |
625 | Furosemide | Furosemide Impurity - A | EP | 2-chloro-4-[(furan-2-ylmethylamino)-5-sulfamoylbenzoic acid | 4818-59-1 |
626 | Furosemide | Furosemide Impurity - B | EP | 2,4-dichloro-5-sulfamoylbenzoic acid, | 2736-23-4 |
627 | Furosemide | Furosemide Impurity - C | EP | 2-amino-4-chloro-5-sulfamoylbenzoic acid | 3086-91-7 |
628 | Furosemide | Furosemide Impurity - E | EP | 2,4-dichlorobenzoic acid | 50-84-0 |
629 | Furosemide | Furosemide Related Compound - A | USP | 2-Chloro-4-N-furfurylamino-5-sulfomylbenzoic acid | 4818-59-1 |
630 | Furosemide | Furosemide Related Compound - B | USP | 4-Chloro-5-sulfonylanthranilic acid | 3086-91-7 |
631 | Febuxostat | Febuxostat | IH | 2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methyl-5-thiazolecarboxylic Acid | 144060-53-7 |
632 | Febuxostat | Febuxostat Descyano hydroxy ethyl ester Impurity | IH | 2-(4-Hydroxyphenyl)-4-methylthiazole-5-carboxylic acid ethyl ester | 161797-99-5 |
633 | Febuxostat | Febuxostat Descyano ethyl ester Impurity | IH | 2-(4-Isobutoxyphenyl)-4-methylthiazole-5-Carboxylic acid ethyl ester | 144060-97-9 |
634 | Febuxostat | RSM of Febuxostat | IH | Ethyl 2-(3-formyl-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate | 161798-01-2 |
635 | Febuxostat | Febuxostat Des Stage-1 | IH | Ethyl 2-(3-formyl-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylate | 161798-03-4 |
636 | Febuxostat | Febuxostat Ethyl ester | IH | Ethyl 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate | 160844-75-7 |
637 | Febuxostat | Febuxostat Sec-butoxy Stage-2 | IH | Ethyl 2-(4-(butan-2-yloxy)-3-cyanophenyl)-4-methyl-1,3-thiazole-5-carboxylate | NA |
638 | Febuxostat | Febuxostat Di acid & Amide impurities | IH | 2-(3-carboxy-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid | 1239233-87-4 |
639 | Febuxostat | Febuxostat Impurity | IH | 2-(3-cyano-4-propoxyphenyl)-4-methyl-1,3-thiazole-5-carboxylic acid | 1657014-33-9 |
640 | Febuxostat | Febuxostat Impurity | IH | 2-(3-formyl-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid | 161798-03-4 |
641 | Gabapentin | Gabapentin | EP | [1-(aminomethyl)cyclohexyl]acetic acid | 60142-96-3 |
642 | Gabapentin | Gabapentin Related Compound - A | USP | 2-Azaspiro[4,5]decan-3-one | 64744-50-9 |
643 | Gatifloxacin | Gatifloxacin | IH | 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid | 112811-59-3 |
644 | Gatifloxacin | 8-Hydroxy Gatifloxacin | IH | 1-cyclopropyl-6-fluoro-8-hydroxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 616205-76-6 |
645 | Gatifloxacin | Difluoro Hydroxy Gatifloxacin | IH | 1-cyclopropyl-6,7-difluoro-8-hydroxy-4-oxo-1,4-dihydro quinoline-3-carboxylic acid | 154093-72-8 |
646 | Gatifloxacin | Difluoro Methoxy Gatifloxacin | IH | 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro quinoline-3-carboxylic acid | NA |
647 | Gatifloxacin | Iso Gatifloxacin Impurity | IH | 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(2-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic Acid | 1029364-65-5 |
648 | Gatifloxacin | Gatifloxacin Desmethyl Impurity | IH | 1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 112811-57-1 |
649 | Gatifloxacin | Gatifloxacin Impurity - I | IH | 7-[(2-aminopropyl)amino]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydro quinoline-3-carboxylic acid | 172426-86-7 |
650 | Gatifloxacin | Gatifloxacin Impurity - II | IH | 7-[(2-aminopropyl)amino]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid(Gatifloxacin Desethylene impurity) | 172426-87-8 |
651 | Glimepiride | Glimepiride | EP | 1-[[4-(2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)-ethylphenyl)sulfonyl]-3-trans-(4-methylcyclohexyl)urea | 93479-97-1 |
652 | Glimepiride | Glimepiride Impurity - B | EP | 3-ethyl-4-methyl-2-oxo-N-[2-(4-sulfamoyl phenyl)ethyl]-2,3-dihydro-1H-pyrrole-1-carboxamide, | 119018-29-0 |
653 | Glimepiride | Glimepiride Impurity - C | EP | methyl [[4-[2-[[(3-ethyl-4-methyl-2-oxo-2,3-dihydro-1H-pyrrol-1-yl)carbonyl] amino] ethyl]phenyl] sulphonyl]carbamate | 119018-30-3 |
654 | Glimepiride | Glimepiride Related Compond - B | USP | Glimepiride sulfonamide | 119018-29-0 |
655 | Glimepiride | Glimepiride Related Compond - C | USP | Glimepiride urethane | 119018-30-3 |
656 | Glimepiride | Glimepiride Ethyl Urethane Impurity | IH | 1-[[4-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl] phenylsulfonyl]-ethoxy carbamate | 318515-70-7 |
657 | Glipizide | Glipizide | EP | 1-Cyclohexyl-3-[[4-[2-[(5-methylpyrazin-2- yl)carbonyl]amino] ethyl]phenyl] sulfonyl]urea | 29094-61-9 |
658 | Glipizide | Glipizide Impurity - B | EP | cyclohexanamine | 108-91-8 |
659 | Glipizide | Glipizide Impurity - F | EP | Ethyl [2-(4-sulfamoylphenyl) ethyl] carbamate | 192118-08-4 |
660 | Guaifenesin | Guaifenesin | EP | (2RS)-3-(2-Methoxyphenoxy)propane-1,2-diol | 93-14-1 |
661 | Guaifenesin | Guaifenesin Impurity A | EP | 2-methoxyphenol (guaiacol) | 90-05-1 |
662 | Guaifenesin | Guaifenesin Impurity -B | EP | 2-(2-methoxyphenoxy)propane-1,3-diol (B-isomer) | 14007-09-1 |
663 | Guaifenesin | Guaifenesin Impurity -C | EP | 1,1'-oxybis[3-(2-methoxyphenoxy)propan-2-ol] (bisether) | 1797132-23-0 |
664 | Guaifenesin | Guaifenesin Impurity -D | EP | 1,3-bis(2-methoxyphenoxy)propan-2-ol | 16929-60-5 |
665 | Guaifenesin | Guaifenesin Impurity | IH | 4-[(2-methoxyphenoxy)methyl]-1,3-dioxolan-2-one | 2049-21-0 |
666 | Gliclazide | Gliclazide | EP | 1-(Hexahydrocyclopenta[C]pyrrol-2(1H)-yl)-3-[(4-methylphenyl)sulfonyl]urea | 21187-98-4 |
667 | Gliclazide | Gliclazide Impurity - C | IH | Ethyl(P-Toluenesulfonyl)carbamate | 5577-13-9 |
668 | Haloperidol | Haloperidol | EP | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidln-1-yl]-1-(4-fluorophenyl)butan-1-one | 52-86-8 |
669 | Haloperidol | Haloperidol Impurity - D | EP | 4-[4-(4-chlorophenyl)-4-hydroxypiperidln -1-yl]-1-[4-(4,4-chlorophenyl)-4-hydroxy piperidin-1-yl]phenylbutan-1-one | 67987-08-0 |
670 | Haloperidol | Haloperidol Related Compound - A | USP | (4,4'-Bis[4-(p-chlorophenyl)-4-hydroxy-piperidino]-butyrophenone) | 67987-08-0 |
671 | Hydrochlorothiazide | Hydrochlorothiazide | EP | 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | 58-93-5 |
672 | Hydrochlorothiazide | Hydrochlorothiazide Impurity - A | EP | 6-Chloro-2H-1,2,4-benzothiadiazine-7-Sulfonamide 1,1-dioxide(chlorothiazide) | 58-94-6 |
673 | Hydrochlorothiazide | Hydrochlorothiazide Impurity - B | EP | 4-amino-6-chlorobenzene-1,3-disulfonamide (salamide) | 121-30-2 |
674 | Hydrochlorothiazide | Hydrochlorothiazide Impurity - C | EP | 6-chloro-N-[(6-chloro-7-sulfamoyl-2,3-dihydro-4H-1,2,4-benzothiadiazin-4-yl) 1,1-dioxide)methyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide | 402824-96-8 |
675 | Hydrochlorothiazide | 5-Chloro Hydrochlorothiazide Impurity | IH | 5,6-dichloro-3,4-dihydro-2H-1,2,4-benzthiadiazine-7-sulfonamide 1,1-dioxide | 5233-42-1 |
676 | Isoniazid | Isoniazid | EP | Pyridine-4-Carbohydrazide | 54-85-3 |
677 | Isoniazid | Isoniazid Impurity | IH | 3,5-di(pyridin-4-yl)-4H-1,2,4-triazol-4-amine | 38634-05-8 |
678 | Ibuprofen | Ibuprofen | BP/EP | (2RS)-2-[4-(2-Methylpropyl)phenyl]propanoic acid | 15687-27-1 |
679 | Ibuprofen | Ibuprofen Impurity - B | BP/EP | (2RS)-2-(4-butylphenyl)propanoic acid | 3585-49-7 |
680 | Ibuprofen | Ibuprofen Impurity - C (Amide Imp) | BP/EP | (2RS)-2-[4-(2-methylpropyl)phenyl]propanamide | 59512-17-3 |
681 | Ibuprofen | Ibuprofen Impurity - N | EP | (2RS)-2-(4-ethylphenyl)propanoic acid | 3585-52-2 |
682 | Ibuprofen | Ibuprofen impurity-D | EP | 2-(p-Tolyl)propionic Acid | 938-94-3 |
683 | Ibuprofen | Ibuprofen impurity-E | EP | 4'-Isobutylacetophenone | 38861-78-8 |
684 | Ibuprofen | Ibuprofen impurity-A | EP | (2RS)-2-[3-(2-methylpropyl)phenyl]propanoic acid, | 66622-47-7 |
685 | Ibuprofen | Ibuprofen methyl ester | IH | (±)-Ibuprofen Methyl Ester | 61566-34-5 |
686 | Ibuprofen | Ibuprofen isopropyl ester | IH | Ibuprofen Isopropyl Ester | 64622-17-9 |
687 | Ibuprofen | S(+)ibuprofen ethyl ester | IH | Ethyl(2S)-2-[4-(2-methylpropyl)phenyl]propanoate | 272458-63-6 |
688 | Iloperidone | Iloperidone | IH | 1-[4-[3-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)propoxy]-3-methoxyphenyl]ethanone | 133454-47-4 |
689 | Iloperidone | Iloperidone Impurity - A | IH | 1-[4-(3-chloropropoxy)-3-methoxyphenyl]ethanone | 58113-30-7 |
690 | Iloperidone | Iloperidone Impurity - B | IH | 1-[{3-(4-acetyl -2-methoxyphenoxy) propoxy}-3-ethoxyphenyl]ethanone | NA |
691 | Iloperidone | Iloperidone Impurity - C | IH | 6-Fluoro-3-(piperidin-4-yl)-1,2-benzisoxazole hydrochloride | 84163-13-3 |
692 | Iloperidone | Iloperidone Dimer Impurity (Methyl Dimer Impurity) | IH | 1-[4-[3-(4-acetyl-2-methoxy) propyl]-3-methoxyphenyl]ethanone | NA |
693 | Irbesartan | Irbesartan impurity-A | EP | 1-[(1-Oxopentyl)amino]-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-cyclopentanecarboxamide | 748812-53-5 |
694 | Irbesartan | Irbesartan impurity A | USP | 1-Pentanylamino-cyclopentanecarboxylic acid [2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amide | 748812-53-5 |
695 | Irbesartan | Irbesartan Hydroxy N2-Trityl Impurity | IH | 5-[4'-Hydroxymethyl-(1,1'-biphenyl)-2-yl]-2-triphenylmethyltetrazole | 154709-18-9 |
696 | Irbesartan | Irbesartan | IH | 2-butyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4,4]non-1-en-4-one | 138402-11-6 |
697 | Irbesartan | Irbesartan Impurity-I | IH | 2 –butyl-3-[[2'cyano (1, 1'-biphenyl)-4-yl] methyl]-1, 3-diazaspiro[4, 4] non-1-en-4-one | 138401-24-8 |
698 | Irbesartan | Irbesartan Impurity | IH | 2-propyl-1,3-diazaspiro[4,4]non-1-en-4-one | 148236-54-8 |
699 | Irbesartan | Irbesartan Propyl Analog Impurity | IH | 2-n-propyl-3-[[2'-(1H-tetrazol-5-yl) [1,1'-biphenyl]-4-yl] methyl]-1,3-diazaspiro[4,4] non-1-en-4-one | 158778-58-6 |
700 | Irbesartan | Irbesartan Impurity | IH | 4'-(Bromomethyl)-2-cyanobiphenyl | 114772-54-2 |
701 | Ivabradine Hydrochloride | Ivabradine | IH | 3-[3-[[(7S)-3,4-Dimethoxybicyclo[4,2,0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one Hydrochloride | 148849-67-6 |
702 | Ivabradine Hydrochloride | Ivabradine ITHAC Impurity | IH | 3-(3-Chloropropyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepine-2-one | 85175-65-1 |
703 | Itraconazole | Itraconazole Impurity-A | EP | 4-[4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl]-2-[(1RS)-1-methylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one | 252964-68-4 |
704 | Ketoprofen | Ketoprofen | EP | (2RS)-2-(3-Benzoylphenyl)propanoic acid | 22071-15-4 |
705 | Ketoprofen | Ketoprofen Impurity - A | EP | 1-(3-benzoylphenyl)ethanone | 66067-44-5 |
706 | Ketoprofen | Ketoprofen Impurity - B | EP | (3-benzoylphenyl)acetic acid | 22071-22-3 |
707 | Ketoprofen | Ketoprofen Impurity - C | EP | 3-[(1RS)-1-carboxyethyl]benzoic acid | 68432-95-1 |
708 | Ketoprofen | Ketoprofen Impurity - D | EP | (2RS)-2-[3-(4-methylbenzoyl)phenyl] propanoic acid | 107257-20-5 |
709 | Ketoprofen | Ketoprofen Impurity - E | EP | (2RS)-2-(3-benzoylphenyl)propanamide | 59512-16-2 |
710 | Ketoprofen | Ketoprofen Impurity - F | EP | (2RS)-2-(3-benzoylphenyl) propanenitrile | 42872-30-0 |
711 | Ketoprofen | Ketoprofen Impurity - H | EP | 3-(cyanomethyl)benzoic acid | 5689-33-8 |
712 | Ketoprofen | Ketoprofen Impurity - I | EP | (3-benzoylphenyl)ethanenitrile | 21288-34-6 |
713 | Ketoprofen | Ketoprofen Related Compound - D | USP | 3-acetylbenzophenone | 66067-44-5 |
714 | Ketoprofen | Ketoprofen Related compound - C | USP | 3-[(1RS)-1-carboxyethyl]benzoic acid | 68432-95-1 |
715 | Ketoprofen | Ketoprofen Related Compound - A | USP | (2RS)-2-[3-(4-methylbenzoyl) phenyl] propanoic acid | 107257-20-5 |
716 | Ketoprofen | Ketoprofen Related Compound - F | USP | (2RS)-2-(3-benzoylphenyl) propanenitrile | 42872-30-0 |
717 | Lacosamide | Lacosamide | IH | (2R)-2-(acetylamino)-N-benzyl-3-methoxypropamide | 175481-36-4 |
718 | Lacosamide | Lacosamide S - Isomer Impurity | IH | (S)-2-acetamino-N-benzyl-3-methoxypropamide | 175481-37-5 |
719 | Lacosamide | Lacosamide Impurity - B (Desacetyl Impurity) | IH | (R)-2-Amino-N-benzyl-3-methoxy propanamide | 196601-69-1 |
720 | Lacosamide | Lacosamide LAC2 NMBA Impurity | IH | (R)-2-acetamido-N-benzyl-3-methoxy-N-methylpropanamide | 388619-64-5 |
721 | Lacosamide | Lacosamide Impurity - F (Propionic Impurity) | IH | 2(R)-Propionylamino-N-benzyl-3-methoxypropionamide | 1318777-56-8 |
722 | Lacosamide | Locasamide N-Benzyl Acetamide | IH | (R)-2-Amino-N-benzyl-3-methoxypropionamide | 175481-38-6 |
723 | Lacosamide | Lacosamide Urea Impurity | IH | 1,3-Diisoproplylurea | 4128-37-4 |
724 | Lacosamide | Lacosamide Desmethyl impurity | IH | 2(R)-Acetamido-N-benzyl-3-hydroxypropionamide | 175481-38-6 |
725 | Lacosamide | O-Acetyl Lacosamide | IH | 2(R)-(Acetylamino)-3-(benzylamino)-3-oxopropyl acetate | 1318777-54-6 |
726 | Lacosamide | Lacosamide Stage II S-Isomer | IH | tert-butyl [(2S)-1-(benzylamino)-3-hydroxy-1-oxopropan-2-yl] carbamate | NA |
727 | Lacosamide | Lacosamide Stage III S-Isomer | IH | tert-butyl [(2S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl] carbamate | NA |
728 | Lamivudine | Lamivudine | EP | 4-Amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one | 134678-17-4 |
729 | Lamivudine | Lamivudine Impurity - A | EP | (2RS,5SR)-5-(4-amino-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid | NA |
730 | Lamivudine | Lamivudine Impurity | IH | Isopropyl para toluenesulfonate | 2307-69-9 |
731 | Lamivudine | Lamivudine Impurity | IH | Ethyl Methanesulfonate | 62-50-0 |
732 | Lamivudine | Lamivudine Impurity | IH | Methyl Methanesulfonate | 66-27-3 |
733 | Lamivudine | Lamivudine Impurity | IH | Ethyl Para Toluenesulfonate | 80-40-0 |
734 | Lamivudine | Lamivudine Impurity | IH | Isopropyl Methanesulfonate | 926-06-7 |
735 | Lamotrigine | Lamotrigine | EP | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine | 84057-84-1 |
736 | Lamotrigine | Lamotrigine Impurity - A | EP | 3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one | 252186-78-0 |
737 | Lamotrigine | Lamotrigine Impurity - B | EP | (2E)-[2-(diaminomethylidene)diazanylidene](2,3-dichlorophenyl)acetonitrile | NA |
738 | Lamotrigine | Lamotrigine Impurity - E | EP | 2,3-dichlorobenzoic acid | 50-45-3 |
739 | Lamotrigine | Lamotrigine Impurity - F | EP | N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide | 252186-79-1 |
740 | Lamotrigine | Lamotrigine Impurity - G | EP | 6-(2,4-dichlorophenyl)-1,2,4-triazine-3,5-diamine | 38943-76-9 |
741 | Lamotrigine | Lamotrigine Related Compound -B | USP | 2,3-dichlorobenzoic acid | 50-45-3 |
742 | Lamotrigine | Lamotrigine Related Compound -C | USP | 3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one | 252186-78-0 |
743 | Lamotrigine | Lamotrigine Related Compound -D | USP | N-[5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl]-2,3-dichlorobenzamide | 252186-78-0 |
744 | Lamotrigine | Lamotrigine Impurity | IH | 2,3-Dichloro benzoyl nitrile | 77668-42-9 |
745 | Lamotrigine | Lamotrigine Impurity | IH | 2,4-Dichlorobenzoyl nitrile | 35022-43-6 |
746 | Lamotrigine | Lamotrigine Impurity | IH | 3,4-Dichlorobenzoyl nitrile | 35022-44-7 |
747 | Lamotrigine | Lamotrigine Impurity | IH | 2,5-Dichlorobenzoyl nitrile | 64985-85-9 |
748 | Lamotrigine | Lamotrigine Impurity | IH | 2,3-Dichlorobenzoic anhydride | 51417-52-8 |
749 | Lansoprazole | Lansoprazole | EP | 2-{(RS)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfinyl}-1H-benzimidazole | 103577-45-3 |
750 | Lansoprazole | Lansoprazole Impurity - A | EP | 2-{(RS)-[[3-methyl-1-oxido-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl] sulfinyl}-1H-benzimidazole | 213476-12-1 |
751 | Lansoprazole | Lansoprazole Impurity - B | EP | 2-{[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl] sulphonyl}-1H-benzimidazole (Lansoprazole Sulfone) | 131926-99-3 |
752 | Lansoprazole | Lansoprazole Impurity - C | EP | 2-{[[3-methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methyl] sulfonyl}-1H-benzimidazole (Lansoprazole Sulfide) | 103577-40-8 |
753 | Lansoprazole | Lansoprazole Impurity - D | EP | 1H-benzimidazol-2-ol | 615-16-7 |
754 | Lansoprazole | Lansoprazole Impurity - E | EP | 1H-benzimidazole-2-thiol | 583-39-1 |
755 | Lansoprazole | Lansoprazole Related Compound - A | USP | 2-{[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]- methylsulfonyl] benzimidazole | 131926-99-3 |
756 | Lansoprazole | Lansoprazole Related Compound - B | USP | 2-{[[3-methyl-4-(2,2,2-trifluoroethoxy)-pyridin-2-yl]methylsulfanyl]-1H-benzimidazole monohydrate) | 1288338-69-1 |
757 | Leflunomide | Leflunomide | EP | 5-Methyl-N-(4-trifluoromethylphenyl)isoxazole-4-carboxamide | 75706-12-6 |
758 | Leflunomide | Leflunomide Impurity - A | EP | 4-(trifluoromethyl)aniline | 455-14-1 |
759 | Leflunomide | Leflunomide Impurity - B | EP | (2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide | 163451-81-8 108605-62-5(E/Z mixture) |
760 | Leflunomide | Leflunomide Impurity - C | EP | 5-methyl-N-[3-(trifluoromethylphenyl)]isoxazole-4-carboxamide | 61643-23-0 |
761 | Leflunomide | Leflunomide Impurity - D | EP | 5-methylisoxazole-4-carboxylic acid | 42831-50-5 |
762 | Leflunomide | Leflunomide Impurity - E | EP | 3-methyl-N-[4-(trifluoromethylphenyl)] isoxazole-4-carboxamide | 208401-20-1 |
763 | Leflunomide | Leflunomide Impurity - F | EP | 5-methyl-N-[2-(trifluoromethylphenyl)]isoxazole-4-carboxamide | 1403564-06-6 |
764 | Leflunomide | Leflunomide Impurity - G | EP | 5-methyl-N-(4-methylphenyl) isoxazole-4-carboxamide | 724429-16-7 |
765 | Leflunomide | Leflunomide Impurity - H | EP | 2-cyano-N-(4-(trifluoromethyl)phenyl)-acetamide | 24522-30-3 |
766 | Leflunomide | Leflunomide Related Compound - A | USP | 4-(trifluoromethyl)aniline | 455-14-1 |
767 | Leflunomide | Leflunomide Related Compound - B | USP | (2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl)crotone amide | 108605-62-5 |
768 | Leflunomide | Leflunomide Related Compound - C | USP | N-(3-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide | 61643-23-0 |
769 | Lercanidipine HCl | Lercanidipine HCl | IH | 2(3,3-diphenylpropylmethylamino)-1,1-dimethylethylmethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride | 225785-54-6 100427-26-7(free base) |
770 | Lercanidipine HCl | Lercanidipine Impurity - A | IH | Methyl propyl-2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydro pyridine-3,5-dicarboxylate | 225785-54-6 |
771 | Lercanidipine HCl | Lercanidipine Impurity - B | IH | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylate | 77888-05-2 |
772 | Lercanidipine HCl | Lercanidipine Impurity - C | IH | 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic Acid-2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl Prop) Ester Hydrochloride | 1797124-83-4 (free base) |
773 | Lercanidipine HCl | Lercanidipine Impurity - D | IH | 2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine dicarboxylic acid-3-[2-(3,3-diphenyl propyl)methylamino]-1,1-dimethylethyl ester,5-methylester | 887769-34-8 |
774 | Lercanidipine HCl | Lercanidipine Impurity - 1 | IH | 2-N- Dimethyl-N-(3,3-diphenylpropyl)-1-amino-2-propanol | 100442-33-9 |
775 | Lercanidipine HCl | Lercanidipine Impurity - 2 | IH | 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)-1,4-dihydro pyridine-3-carboxylic acid | 74936-72-4 |
776 | Lercanidipine HCl | Lercanidipine Impurity - 3 | IH | 2,6-Dimethyl-5-(methoxycarbonyl)-4-(3-nitrophenyl)-1-[2-[(3,3-diphenylpropyl)amino-1,1-dimethyl]ethyl]-1,4-dihydropyridine-3-carboxylic acid | NA |
777 | Lercanidipine HCl | Lercanidipine Impurity - 4 | IH | Dimethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 21881-77-6 |
778 | Lercanidipine HCl | Lercanidipine Impurity | IH | N- methyl-3,3-diphenylpropylamine | 28075-29-8 |
779 | Lercanidipine HCl | Lercanidipine Chloro Impurity | IH | 2- Chloro-N-(3,3-diphenylpropyl)-N,2-dimethylpropan-1-amine | 936491-32-6 |
780 | Lercanidipine HCl | Lercanidipine Impurity | IH | Dimethyl 2,6-dimethyl-4-(3-nitrophenyl) pyridine-3,5-dicarboxylate | 21829-28-7 |
781 | Lercanidipine HCl | Lercanidipine Impurity | IH | 5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3-carboxylic acid | 74936-72-4 |
782 | Lercanidipine HCl | Lercanidipine Impurity | IH | Ethyl methyl 2,6-dimethyl-4-(3-nitro phenyl)-1,4-dihydropyridine-3,5-dicarboxylate | 39562-70-4 |
783 | Lercanidipine HCl | Lercanidipine HCl Impurity | IH | 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid-3-[2-(3,3-diphenylpropyl)methyl amino]-1,1-dimethylethyl ethyl 1,5-ethyl ester(Lercanidipine Ethyl Ester | 786625-22-7 |
784 | Levetiracetam | Levetiracetam | EP | (2S)-2-(2-oxopyrrolidin-1-yl)butanamide | 102767-28-2 |
785 | Levetiracetam | Levetiracetam Impurity - A | EP | (2RS)-2-(2-oxopyrrolidin-1-yl)butanoic acid | 67118-31-4 |
786 | Levetiracetam | Levetiracetam Impurity - B | EP | (2Z)-2-(2-oxopyrrolidin-1-yl)but-2- enamide | 358629-47-7 |
787 | Levetiracetam | Levetiracetam Impurity - C | EP | Pyridin-2-ol | 142-08-5 |
788 | Levetiracetam | Levetiracetam Impurity - D | EP | (2R)-2-(2-Oxopyrrolidin-1-yl) butanamide(R)-etiracetam) | 103765-01-1 |
789 | Levetiracetam | Levetiracetam Related Compound - A | USP | (S)-N-(1-amino-1-oxobutan-2-yl)-4-chlorobutanamide | 102767-31-7 |
790 | Levetiracetam | Levetiracetam Related Compound - B | USP | (S)-2-aminobutanamide hydrochloride | 7682-20-4 |
791 | Levetiracetam | Levetiracetam Racemic Mixture | USP | (+/-alpha-ethyl-2-oxo-1-pyrrolidine acetamide) | 33996-58-6 |
792 | Levetiracetam | Levetiracetam Racemic Mixture | IH | (+/-alpha-ethyl-2-oxo-1-pyrrolidine acetamide) 2-(2-oxopyrrolidin-1-yl) butamide | 33996-58-6 |
793 | Levetiracetam | Levetiracetam Impurity | IH | (S)-alpha-ethyl-2-oxo-1-pyrrolidine acetic acid | 102849-48-0 |
794 | Levetiracetam | Levetiracetam Acid | IH | (2R)-2-(2-oxopyrrolidin-1-yl)butanoic acid & R,n-ethyl-2-oxpyrrolidine | 103833-72-3 |
795 | Levodopa | Levodopa | EP | (2S)-2-Amino-3-(3,4-dihydroxy phenyl)propanoic acid | 59-92-7 |
796 | Levodopa | Levodopa Impurity - B | EP | (2S)-2-amino-3-(4-hydroxy phenyl) propanoic acid(L-tyrosine) | 60-18-4 |
797 | Levodopa | Levodopa Impurity - C | EP | (2RS)-2-amino-3-(4-hydroxy-3-methoxy phenyl)propanoic acid(3-methoxy-DL-tyrosine) | 7636-26-2 |
798 | Levodopa | Levodopa Impurity - D | EP | (2R)-2-amino-3-(3,4-dihydroxyphenyl) propanoic acid(D-dopa) | 5796-17-8 |
799 | Levodopa | Levodopa Related Compound - B | USP | (3-methoxytyrosine) | 7636-26-2 |
800 | Levofloxacin | Levofloxacin | USP | (-)-(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4- benzoxazine-6-carboxylic acid hemihydrate | 138199-71-0 |
801 | Levofloxacin | Levofloxacin Related Compound - A (Piperazine Impurity) | USP | (S)-9-fluoro-3-methyl-10-(piperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid | 117707-40-1 |
802 | Levofloxacin | Levofloxacin Related Compound - B (Q-Acid) | USP | (S)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de] [1,4]benzoxazine-6-carboxylic acid | 100986-89-8 |
803 | Levofloxacin | Levofloxacin Related Compound - C | USP | (5)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate | 17747230-9 |
804 | Levofloxacin | Levofloxacin Related Compound - E (Diamine) | USP | (5)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid hydrochloride | 1346603-62-0 |
805 | Levofloxacin | Levofloxacin Related Compound - F (9-Desfluoro Imp) | USP | (5)-2,3-Dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 11762085-6 |
806 | Levofloxacin | Levofloxacin Impurity (Levo acid) | IH | (5)-9,10-Difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 10098689-8 |
807 | Levofloxacin | Levofloxacin Desmethyl Impurity | IH | (5)-9-fluoro-2,3-dihydro-3-methyl-10-(piperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 11770740-1 |
808 | Levofloxacin | Levofloxacin Impurity N-Oxide Impurity | IH | (5)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid N-oxide | 11767837-2 |
809 | Levofloxacin | Levofloxacin Impurity - B (Des Carboxy) | IH | (5)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 17896452-9 |
810 | Levofloxacin | Levofloxacin D-isomer Impurity | IH | (R)-(+)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 10098686-5 |
811 | Lisinopril Dihydrate | Lisinopril Dihydrate | EP | (2S)-1-[(2S)-6-Amino-2-[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid dihydrate | 83915857-7 |
812 | Lisinopril Dihydrate | Lisinopril Impurity - A | EP | (2RS)-2-amino-4-phenylbutanoic acid | 1012051-1 |
813 | Lisinopril Dihydrate | Lisinopril Impurity - B | EP | 4-methylbenzenesulfonic acid | 6192625 (monohydrate) |
814 | Loratadine | Loratadine | EP | Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate | 79794-75-5 |
815 | Loratadine | Loratadine Impurity - A | EP | ethyl 4-[(11RS)-8-chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate | 13328474-9 |
816 | Loratadine | Loratadine Impurity - B | EP | 8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one | 31251-41-9 |
817 | Loratadine | Loratadine Impurity - D | EP | 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 10064371-8 |
818 | Loratadine | Loratadine Impurity - G | EP | 8-chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 3809299-6 |
819 | Loratadine | Loratadine Related Compound - F | EPA | ethyl 4-[(11RS)-8-chloro-11-hydroxy-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidine-1-carboxylate | 13328474-9 |
820 | Loratadine | Loratadine Related Compound - C | USP | 8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one | 31251-41-9 |
821 | Loratadine | Loratadine Related Compound - A | USP | 8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 10064371-8 |
822 | Loratadine | Loratadine Related Compound - B | USP | 8-chloro-11-(1-methylpiperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 3809299-6 |
823 | Loratadine | Loratadine N-Formyl Impurity | IH | 8-Chloro-6,11-dihydro-11-(N-formyl-4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine | 11781061-4 |
824 | Losartan Potassium | Losartan potassium | EP | Potassium 5-[4'-[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-ide | 12475099-8 |
825 | Losartan Potassium | Losartan Impurity - A | EP | 2-butyl-4-chloro-1H-imidazole-5-methanol | 79047419 |
826 | Losartan Potassium | Losartan Impurity - B | EP | 2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methanol | 16051413-6 |
827 | Losartan Potassium | Losartan Impurity - C (iso losartan) | EP | 2-butyl-5-chloro-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl-1H-imidazol-4-yl]methanol | 11479933-2 (free base) 86084428-6 |
828 | Losartan Potassium | Losartan Impurity - D | EP | 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | 83857969 |
829 | Losartan Potassium | Losartan Impurity - E | EP | 5-(4'-methylbiphenyl-2-yl)-1H-tetrazole | 12056811-8 |
830 | Losartan Potassium | Losartan Impurity - G | EP | triphenylmethanol | 76846 |
831 | Losartan Potassium | Losartan Related Compound - A | USP | 2-butyl-4-chloro-1H-imidazole-5-carbaldehyde | 83857969 |
832 | Losartan Potassium | Losartan Impurity - A | IH | 4'-[2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl]methyl-1,1'-biphenyl-2-carbonitrile | 12475067-0 |
833 | Losartan Potassium | Losartan Impurity - B | IH | 4'-[2-butyl-4-chloro-5-formyl-1H-imidazol-1-yl]methylbiphenyl-2-carbonitrile | 11477255-3 |
834 | Losartan Potassium | Losartan Impurity | IH | 2'-(1H-tetrazol-5-yl)-biphenyl-4-carbaldehyde | 151052-40-3 |
835 | Losartan Potassium | Losartan Impurity | IH | 2-Cyano-4-bromomethyl biphenyl | 114772-54-2 |
836 | Lovastatin | Lovastatin | EP | [1S,3R,7S,8S,8aR]-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate | 75330-75-5 |
837 | Lovastatin | Lovastatin Impurity - A | EP | [1S,7S,8S,8aR]-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2- | 73573-88-3 |
838 | Lumefantrine | Lumefantrine | IH | 2-(dibutylamino)-1-[(2R)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol | 82186-77-4 |
839 | Lumefantrine | Lumefantrine DBA Impurity | IH | 1-(2,7-dichloro-9H-fluoren-4yl)-2-(Dibutylamino)-ethanol | NA |
840 | Levosulpiride | Levosulpiride | IH | N-[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide | NA |
841 | Levosulpiride | Levosulpiride Impurity - D | IH | 2-Methoxy-5-sulfamoyl benzoic acid | 22117-85-7 |
842 | Levosulpiride | Levosulpiride Impurity - C | IH | Ethyl 2-methoxy-5-sulfamoyl benzoate | 33045-53-3 |
843 | Lidocaine | Lidocaine | EP | 2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide | 137-58-6 |
844 | Lidocaine | Lidocaine Glycinexylidide.HCl impurity | IH | 2-Amino-N-(2,6-dimethylphenyl)acetamide hydrochloride | 35891-83-9(HCl salt) 18865-38-8 |
845 | Mannitol | Mannitol | EP | D-Mannitol | 69-65-8 |
846 | Mannitol | Mannitol Impurity - A | EP | D-Sorbitol(D-glucitol) | 50-70-4 |
847 | Mannitol | Mannitol Impurity - B | EP | 4-O-α-D-glucopyranosyl-D-glucitol(D-Maltitol) | 585-88-6 |
848 | Mannitol | Mannitol Impurity - C | EP | Mixture of 6-O-α-D-glucopyranosyl-D-glucitol and 1-O-α-D-glucopyranosyl-D-mannitol(isomalt) | NA |
849 | Moxifloxacin | Marbofloxacin | BP/EP | 9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido [3,2,1-ij][4, 1,2]benzoxadiazine-6-carboxylic acid | 115550-35-1 |
850 | Moxifloxacin | Marbofloxacin Impurity - A | BP/EP | 6,7-difluoro-8-hydroxy-1-(methylamino)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 115551-40-1 |
851 | Moxifloxacin | Marbofloxacin Impurity - B | BP/EP | 9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-[1,3,4]oxadiazino[6,5,4]quinoline-6-carboxylic acid | 115551-41-2 |
852 | Mebendazole | Mebendazole | EP | Methyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate | 31431-39-7 |
853 | Mebendazole | Mebendazole Impurity - A | EP | (2-amino-1H-benzimidazol-5-yl)phenylmethanone | 52329-60-9 |
854 | Mebendazole | Mebendazole Impurity - B | EP | (2-hydroxy-1H-benzimidazol-5-yl)phenylmethanone | 21472-33-3 |
855 | Mebendazole | Mebendazole Impurity - C | EP | (2-amino-1-methyl-1H-benzimidazol-5-yl)phenylmethanone | 66066-76-0 |
856 | Mebendazole | Mebendazole Impurity - D | EP | Methyl (5-benzoyl-1-methyl-1H-benzimidazol-2-yl)carbamate | 132119-11-0 |
857 | Mebendazole | Mebendazole Impurity - E | EP | Ethyl (5-benzoyl-1H-benzimidazol-2-yl)carbamate | 31430-19-0 |
858 | Mebendazole | Mebendazole Impurity - F | EP | Methyl [5-(4-methylbenzoyl)-1H-benzimidazol-2-yl]carbamate | 31545-31-0 |
859 | Mebendazole | Mebendazole Impurity - G | EP | N,N'-bis(5-benzoyl-1H-benzimidazol-2-yl)urea | 129165-82-8 |
860 | Mebendazole | Mebendazole Related Compound - A | USP | 2-amino-5-benzoylbenzimidazole | 52329-60-9 |
861 | Mebendazole | Mebendazole Related Compound - B | USP | 5-benzoyl-1H-benzo[d]imidazole-2(3H)-one | 21472-33-3 |
862 | Mebendazole | Mebendazole Related Compound - C | USP | 2-Amino-5-benzoyl-1-methylbenzimidazole | 66066-76-0 |
863 | Mebendazole | Mebendazole Related Compound - D | USP | Methyl 5-benzoyl-1-methylbenzimidazol-2-ylcarbamate | 132119-11-0 |
864 | Mebendazole | Mebendazole Related Compound - E | USP | (Ethyl)-5-benzoyl-1H-benzimidazol-2-ylcarbamate | 31430-19-0 |
865 | Mebendazole | Mebendazole Related Compound - F | USP | Methyl 5-(4-toluxyl)-1H-benzimidazol-2-ylcarbamate | 31545-31-0 |
866 | Mebeverine Hydrochloride | Mebeverine Hydrochloride | EP | [RS]-4-{ethyl[1-(4-methoxyphenyl)propan-2-yl]amino}butyl 3,4-dimethoxy benzoate Hydrochloride | 2753-45-9 |
867 | Mebeverine Hydrochloride | Mebeverine Impurity - A | EP | 4-methoxyphenylacetone | 122-84-9 |
868 | Mebeverine Hydrochloride | Mebeverine Impurity - B | BP | (N-[(RS)-1-(4-methoxyphenyl) methyl]ethyl)ethanamine | 14367-46-5 |
869 | Mebeverine Hydrochloride | Mebeverine Impurity - C | BP | (N-[(1RS)-ethyl]-[2-(4-methoxy phenyl)-1-methylethyl]amino]butan-1-ol | 14367-47-6 |
870 | Mebeverine Hydrochloride | Mebeverine Impurity - D | BP | 3,4-dimethoxybenzoric acid | 93-07-2 |
871 | Mebeverine Hydrochloride | Mebeverine Impurity - E | BP | 4-Chlorobutyl 3,4-dimethoxybenzoate | 69788-75-6 |
872 | Mebeverine Hydrochloride | Mebeverine Impurity - F | BP | 4-iodobutyl 3,4-dimethoxybenzoate | 69788-70-1 |
873 | Mefenamic Acid | Mefenamic Acid | EP | 2-[(2,3-dimethylphenyl)amino]benzoic acid | 61-68-7 |
874 | Mefenamic Acid | Mefenamic Acid Impurity - A | EP | 2,3-dimethylaniline | 87-59-2(Free base) 5417-45-8(HCl salt) |
875 | Mefenamic Acid | Mefenamic acid Impurity - B | EP | N-(2,3-dimethylphenyl)-2-[(2,3-dimethylphenyl)amino]benzamide | 21122-68-9 |
876 | Mefenamic Acid | Mefenamic acid Impurity - C | EP | 2-Chlorobenzoic Acid | 118-91-2 |
877 | Mefenamic Acid | Mefenamic acid Impurity - D | EP | Benzoic Acid | 65-85-0 |
878 | Mefenamic Acid | Mefenamic acid Impurity - E | EP | N-(2,3-dimethylphenyl)aniline | 4869-11-8 |
879 | Meloxicam | Meloxicam | EP | 4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2-H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | 71125-38-7 |
880 | Meloxicam | Meloxicam Impurity - E | EP | methyl 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | 35511-15-0 |
881 | Meloxicam | Meloxicam Impurity - F | EP | isopropyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | 118854-48-1 |
882 | Meloxicam | Meloxicam Related Compound - C | USP | isopropyl 4-Hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxylate 1,1-dioxide | 118854-48-1 |
883 | Memantine | Memantine Hydrochloride | USP | 3,5-dimethyltricyclo[3.3.1.13,7]decan-1-amine hydrochloride | 41100-52-1 |
884 | Memantine | Memantine Related compound - A | USP | 1,3-Dimethyladamantane | 702-37-9 |
885 | Memantine | Memantine Related compound - B | USP | 3,5-Dimethyladamantane-1-ol | 707-37-9 |
886 | Memantine | Memantine Related compound - C | USP | 1-Chloro-3,5-dimethyladamantane | 707-36-8 |
887 | Memantine | Memantine Related compound - D | USP | 1-Bromo-3,5-dimethyladamantane | 941-37-7 |
888 | Memantine | Memantine Related compound - D | IH | 3-methyltricyclo[3.3.1.13,7]decan-1-amine | 78056-28-7 |
889 | Memantine | Memantine Acetamido Impurity | IH | 1-acetamido-3,5dimethyl adamantane | 19982-07-1 |
890 | Memantine | Memantine Impurity | IH | 1-Acetamido-adamantane | 880-52-4 |
891 | Mesalazine | Mesalazine | BP/EP | 5-Amino-2-hydroxybenzoic acid | 89-57-6 |
892 | Mesalazine | Mesalazine Impurity - A | BP/EP | 4-aminophenol | 123-30-8 |
893 | Mesalazine | Mesalazine Impurity - B | BP/EP | 3-aminophenol | 591-27-5 |
894 | Mesalazine | Mesalazine Impurity - C | BP/EP | 2-aminophenol | 95-55-6 |
895 | Mesalazine | Mesalazine Impurity - D | BP/EP | 3-aminobenzoic acid | 99-05-8 |
896 | Mesalazine | Mesalazine Impurity - E | BP/EP | 4-amino-2-hydroxybenzoic acid (4-aminosalicylic acid) | 65-49-6 |
897 | Mesalazine | Mesalazine Impurity - F | BP/EP | 3-amino-2-hydroxybenzoic acid (3-aminosalicylic acid) | 570-23-0 |
898 | Mesalazine | Mesalazine Impurity - G | BP/EP | 2,5-dihydroxybenzoic acid | 490-79-9 |
899 | Mesalazine | Mesalazine Impurity - H | BP/EP | 2-hydroxybenzoic acid (salicylic acid) | 69-72-7 |
900 | Mesalazine | Mesalazine Impurity - J | BP/EP | 3,5-diamino-2-hydroxybenzoic acid (diaminosalicylicacid) | 112725-89-0 |
901 | Mesalazine | Mesalazine Impurity - K | BP/EP | Aniline | 62-53-3 |
902 | Mesalazine | Mesalazine Impurity - L | BP/EP | 2-chlorobenzoic acid | 118-91-2 |
903 | Mesalazine | Mesalazine Impurity - M | BP/EP | 2-chloro-5-nitrobenzoic acid | 2516-96-3 |
904 | Mesalazine | Mesalazine Impurity - N | BP/EP | 2-hydroxy-5-nitrobenzoic acid (5-nitrosalicylic acid) | 96-97-9 |
905 | Metamizole Sodium Monohydrate | Metamizole Sodium | EP | Sodium [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methylamino] methane-sulphonate monohydrate | 5907-38-0 |
906 | Metamizole Sodium Monohydrate | Metamizole Impurity - A | EP | 4-(formylamino)-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one | 1672-58-8 |
907 | Metamizole Sodium Monohydrate | Metamizole Impurity - B | EP | 4-imino-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one | 83-07-8 |
908 | Metamizole Sodium Monohydrate | Metamizole Impurity - C | EP | 4-methylamino-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one | 856307-27-2 (HCl salt) |
909 | Metamizole Sodium Monohydrate | Metamizole Impurity - D | EP | 4-dimethylamino-1,5-dimethyl-2-phenyl-2,3-dihydro-1H-pyrazol-3-one | 58-15-1 |
910 | Metamizole Sodium Monohydrate | Metamizole Impurity - E | EP | [(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)amino] methanesulfonic acid | 129-89-5 (Sodium salt) |
911 | Metformin Hydrochloride | Metformin Hydrochloride | EP | 1,1-Dimethylbiguanide hydrochloride | 1115-70-4 |
912 | Metformin Hydrochloride | Metformin Impurity - A | EP | cyanoguanidine | 461-58-5 |
913 | Metformin Hydrochloride | Metformin Impurity - B | EP | (4,6-diamino-1,3,5-triazin-2-yl)guanidine | 4405-08-7 (Free base) 2959-04-8 |
914 | Metformin Hydrochloride | Metformin Impurity - C | EP | N,N-dimethyl-[1,3,5]-triazine-2,4,6-triamine | 1985-46-2 |
915 | Metformin Hydrochloride | Metformin Impurity - D | EP | 1,3,5-triazine-2,4,6-triamine (melamine) | 107-78-1 |
916 | Metformin Hydrochloride | Metformin Impurity - E | EP | 1-methylbiguanide | 1609-00-3 (Free base) 1674-62-0 |
917 | Metformin Hydrochloride | Metformin Impurity - F | EP | N-methylmethanamine | 506-59-2 (HCl salt) |
918 | Metformin Hydrochloride | Metformin Related Compound - A | USP | cyanoguanidine | 461-58-5 |
919 | Metformin Hydrochloride | Metformin Related Compound - B | USP | 1-Methylbiguanide Hydrochloride | 1674-62-0 |
920 | Metformin Hydrochloride | Metformin Related Compound - C | USP | Dimethyl-[1,3,5]triazine-2,4,6-triamine | 1985-46-2 |
921 | Methyl Nicotinate | Methyl Nicotinate | EP | Methyl pyridine-3-carboxylate | 93-60-7 |
922 | Methyl Nicotinate | Methyl Nicotinate Impurity - A | EP | pyridine-3-carboxylic acid (nicotinic acid) | 56-67-6 |
923 | Metoprolol Tartrate | Metoprolol Tartrate | EP | Bis[(2RS)-1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol] (2R,3R)-2,3-dihydroxybutanedioate | 56392-17-7 |
924 | Metoprolol Tartrate | Metoprolol Impurity - A | EP | (2RS)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | 109632-08-8 |
925 | Metoprolol Tartrate | Metoprolol Impurity - B | EP | 4-(2-methoxyethyl)phenol | 56718-71-9 |
926 | Metoprolol Tartrate | Metoprolol Impurity - C | EP | 4-[(2RS)-2-hydroxy-3-[(1-methylethyl)amino]propoxy]benzaldehyde | 29122-74-5 |
927 | Metoprolol Tartrate | Metoprolol Impurity - D | EP | (2RS)-3-[4-(2-methoxyethyl)phenoxy]propane-1,2-diol | 62572-90-1 |
928 | Metoprolol Tartrate | Metoprolol Impurity - E | EP | (2RS)-1-[2-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol | 163685-38-9 |
929 | Metoprolol Tartrate | Metoprolol Impurity - F | EP | (2RS)-1-[(1-methylethyl)amino]-3-phenoxypropan-2-ol, | 7695-63-8 |
930 | Metoprolol Tartrate | Metoprolol Impurity - G | EP | 2-(4-hydroxyphenyl)ethanol | 501-94-0 |
931 | Metoprolol Tartrate | Metoprolol Impurity - H | EP | (2RS)-1-[4-(2-hydroxyethyl)phenoxy]-3-[(1-methylethyl)amino]propan-2-ol | 62572-04-5 |
932 | Metoprolol Tartrate | Metoprolol Impurity - J | EP | 1-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | 163685-37-8 |
933 | Metoprolol Tartrate | Metoprolol Impurity - M | EP | 1,3-bis(1-methylethyl)amino]propan-2-ol | 343785-33-1 (Free base) 73313-36-7 |
934 | Metoprolol Tartrate | Metoprolol Impurity - N | EP | (2RS)-3-[(1-methylethyl)amino]propane-1,2-diol | 64522-57-9 |
935 | Metoprolol Tartrate | Metoprolol Impurity - O | EP | 1,1'-[(1-methylethyl)imino]bis[3-[4-(2-methoxyethyl)phenoxy]propan-2-ol] | 154784-36-8 |
936 | Metoprolol Tartrate | Metoprolol Related Compound - A | USP | [(±)-1-(ethylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol | 109632-08-8 |
937 | Metoprolol Tartrate | Metoprolol Related Compound - B | USP | [(±)-1-chloro-2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propane) | 56718-76-4 |
938 | Metoprolol Tartrate | Metoprolol Related Compound - C | USP | 4-[2-hydroxy-3-(isopropylamino)propoxy]benzaldehyde hydrochloride | 29122-74-5 (Free Base) |
939 | Metoprolol Tartrate | Metoprolol Related Compound - D | USP | [(±)N,N-bis[2-hydroxy-3-[4-(2-methoxyethyl) phenoxy]propyl]-1-methylethylamine hydrochloride | 1486464-40-7 |
940 | Metoprolol Tartrate | Metoprolol Impurity- MPE | IH | 3-[4-(2-Methoxyethyl)phenoxy]1,2-epoxy propane | 56718-70-8 |
941 | Metoprolol Tartrate | Metoprolol Impurity- BPP | IH | 1,3-bis-(4-(2-methoxyethyl)phenoxy)propane-2-ol | 230975-30-1 |
942 | Mirtazapine | Mirtazapine | EP | (14bRS)-2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine | 61337-67-5 |
943 | Mirtazapine | Mirtazapine Impurity- A | EP | (14bRS)-2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide | 155172-12-6 |
944 | Mirtazapine | Mirtazapine Impurity- B | EP | [2-[(2RS)-4-methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol, | 61337-89-1 |
945 | Mirtazapine | Mirtazapine Impurity- D | EP | (14bRS)-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2] benzazepine | 61337-68-6 |
946 | Mirtazapine | Mirtazapine Impurity- E | EP | (2RS)-4-methyl-1-(3-methylpyridin-2-yl)-2-phenylpiperazine | 191546-94-8 |
947 | Mirtazapine | Mirtazapine Impurity- F | EP | (14bRS)-2-methyl-1,3,4,14b-tetrahydropyrazino[2,1-a]pyrido[2,3-c] [2]benzazepin-10(2H)-one | 191546-97-1 |
948 | Mirtazapine | Mirtazapine Related Compound- A | USP | 1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine | 61337-68-6 |
949 | Mirtazapine | Mirtazapine Related Compound- B | USP | (1,2,3,4,10,14b-Hexahydro-2-methylpyrazino [2,1-a]pyrido[2,3-c][2]benzazepine 2-oxide monohydrate) | 155172-12-6 (Anhydrous) |
950 | Mirtazapine | Mirtazapine Related Compound- D | USP | 2-Methyl-1,2,3,4-tetrahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepin-10(14bH)-one) | 191546-97-1 |
951 | Mirtazapine | Mirtazapine Cyano Oxalate Impurity | IH | 1-(3-Cyano-2-pyridyl)-4-methyl-2-phenylpiperazine Oxalate | 61337-88-0 (Free base) |
952 | Modafinil | Modafinil | BP | 2-[(RS)-(Diphenylmethyl)sulphinyl]acetamide | 68693-11-8 |
953 | Modafinil | Modafinil Impurity- A | BP | [(RS)-(diphenylmethyl)sulfinyl]acetic acid | 63547-24-0 |
954 | Modafinil | Modafinil Impurity- B | BP | 2-[(diphenylmethyl)sulfonyl]acetamide | 118779-53-6 |
955 | Modafinil | Modafinil Impurity- C | BP | methyl[(RS)-(diphenylmethyl)sulfinyl]acetate | 63547-25-1 |
956 | Modafinil | Modafinil Related Compound- A | USP | 2-[(diphenylmethyl)sulfinyl]acetic acid) | 63547-24-0 |
957 | Modafinil | Modafinil Related Compound- B | USP | 2-[(diphenylmethyl)sulfonyl]acetamide) | 118779-53-6 |
958 | Modafinil | Modafinil Related Compound - C | USP | (2-(diphenylmethylsulfenyl)acetamide) | 68524-30-1 |
959 | Modafinil | Modafinil Ester Impurity | IH | methyl(RS)-(diphenylmethylsulfenyl)acetate | 63547-25-1 |
960 | Molsidomine | Molsidomine | EP | N-(Ethoxycarbonyl)-3-(morpholin-4-yl)sydnonimine | 25717-80-0 |
961 | Molsidomine | Molsidomine Impurity - A | EP | 3-(morpholin-4-yl)sydnonimine(Linsidomine) | 744953-71-7 & 1614-27-1 |
962 | Montelukast Sodium | Montelukast Sodium | EP | Sodium [1-[[[(1R)-1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetate | 151767-02-1 |
963 | Montelukast Sodium | Montelukast Racemic Mixture Of Diol | IH | 2-[2-[3-[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl]-3-hydroxy propyl] phenyl-2-propanol | NA |
964 | Montelukast Sodium | Montelukast Keto Impurity Of Diol | IH | 2-[3-[3-[3-[2-(7-Chloroquinoline -2-yl)ethenyl]phenyl]-3-hydroxypropyl]phenyl]methyl ketone | 184764-13-4 |
965 | Montelukast Sodium | Montelukast Impurity - C | EP | [1-[[1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetic acid | 909849-96-3 |
966 | Montelukast Sodium | Montelukast Impurity - B | EP | [1-[[1-[3-[(E)-2-(7-chloroquinolin-2- yl)ethenyl]phenyl]-3-(2-(1-methyletheny) phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetic acid | 918972-54-0 |
967 | Montelukast Sodium | Montelukast Related Compound - A | USP | [1-[[1-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetic acid | 909849-96-3 |
968 | Montelukast Sodium | Montelukast Related Compound - F | USP | [1-[[1-[3-[(E)-2-(7-chloroquinolin-2- yl)ethenyl]phenyl]-3-(2-(1-methyletheny) phenyl]propyl]sulfinyl]methyl]cyclopropyl]acetic acid | 918972-54-0 |
969 | Moxonidine | Moxonidine | EP | 4-Chloro-N-(imidazolidin-2-ylidene)-6-methoxy-2-methylpyrimidin-5-amine | 75438-57-2 |
970 | Moxonidine | Moxonidine Impurity - A | EP | 4,6-dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine (6-chloromoxonidine) | 352457-35-3 |
971 | Moxonidine | Moxonidine Impurity - B | EP | N-(imidazolidin-2-ylidene)-4,6-dimethoxy-2-methylpyrimidin-5-amine (4-methoxymoxonidine) | 75439-01-9 |
972 | Moxonidine | Moxonidine Impurity - C | EP | 5-[(imidazolidin-2-ylidene)amino]-5-methoxy-2-methylpyrimidin-4-ol(4-hydroxymoxonidine) | 352457-34-2 |
973 | Moxonidine | Moxonidine Impurity - D | EP | 6-chloro-5-[(imidazolidin-2-ylidene)amino]-2-methylpyrimidin-4-ol (6-desethylmoxonidine) | 352457-33-1 |
974 | Moxifloxacin Hydrochloride | Moxifloxacin Hydrochloride | EP | 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride | 186826-86-8 |
975 | Moxifloxacin Hydrochloride | Moxifloxacin Impurity - A | EP | 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Difluoro Analog) | 151213-15-9 |
976 | Moxifloxacin Hydrochloride | Moxifloxacin Impurity - B | EP | 1-cyclopropyl-6,8-dimethoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Dimethox Analog) | 1029364-73-5 |
977 | Moxifloxacin Hydrochloride | Moxifloxacin Impurity - C | EP | 1-cyclopropyl-8-ethoxy-6-fluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Ethyl Analog) | 1029364-75-7 |
978 | Moxifloxacin Hydrochloride | Moxifloxacin Impurity - E | EP | 1-cyclopropyl-6-fluoro-8-hydroxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Desmethyl Analog) | 1292904-74-5 |
979 | Moxifloxacin Hydrochloride | Moxifloxacin Related Compound - A | USP | 1-cyclopropyl-6,8-difluoro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (Difluoro Analog) | 151213-15-9 |
980 | Moxifloxacin Hydrochloride | Moxifloxacin Related Compound - B | USP | 1-Cyclopropyl-6,8-dimethoxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate | 1029364-73-5 (Free Base) |
981 | Moxifloxacin Hydrochloride | Moxifloxacin Related Compound - C | USP | 1-Cyclopropyl-8-ethoxy-6-fluoro-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride monohydrate (Ethyl | 1029364-75-7 (Free Base) |
982 | Moxifloxacin Hydrochloride | Moxifloxacin Related Compound - E | USP | [1-Cyclopropyl-6-fluoro-8-hydroxy-1,4-dihydro-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid hydrochloride (Des Methyl) | 1292904-74-5 (HBr Salt) |
983 | Moxifloxacin Hydrochloride | moxifloxacin Related Compound - F | USP | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-4-methyl-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid | 1179992-99-4 |
984 | Moxifloxacin Hydrochloride | N-Methyl Moxifloxacin Impurity | IH | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-4-methyl-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid | 1179992-99-4 |
985 | Moxifloxacin Hydrochloride | Moxifloxacin Methyl Ester | IH | Methyl 7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclo propyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate | 721970-35-0 |
986 | Moxifloxacin Hydrochloride | Moxifloxacin Quinilicethyl Ester | IH | Ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate | 112811-71-9 |
987 | Milinacipran Hydrochloride | Milinacipran | IH | (1R,2S)-rel-2(Aminomethyl)-N,N-diethyl-1-phenyl-cyclopropanecarboxamide, monohydrochloride | 101152-94-7 |
988 | Milinacipran Hydrochloride | Milinacipran MC-9 | IH | N,N'-dimethylbenzene-1,2-dicarboxamide | 1952-98-0 |
989 | Mirabegron | Mirabegron | IH | 2-Amino-N-(4-{2-[(2R)-2-hydroxy-2-phenylethylamino)ethyl]phenyl}-4-thiazoleacetamide | 223673-61-8 |
990 | Mirabegron | Mirabegron (S)-Isomer | IH | (S)-2-(2-Aminothiazol-4-yl)N-(4-(2-(2-hydroxy-2-phenylethylamino)ethyl)phenyl) acetamide | 1796931-48-0 |
991 | Mirabegron | Mirabegron Impurity - C | IH | (1R)-2-[[2-(4-Aminophenyl)ethyl]amino]-1-phenylethan-1-ol | 391901-45-4 |
992 | Naproxen | Naproxen | EP | (2S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid | 22204-53-1 |
993 | Naproxen | Naproxen Impurity - A | EP | (2S)-2-(6-hydroxynaphthalen-2-yl)propanoic acid | 52079-10-4 |
994 | Naproxen | Naproxen Impurity - E | EP | methyl (2S)-2-(6-methoxynaphthalen-2-yl)propanoate | 26159-35-3 |
995 | Naproxen | Naproxen Impurity - F | EP | ethyl (2S)-2-(6-methoxynaphthalen-2-yl) propanoate | 31220-35-6 |
996 | Naproxen | Naproxen Impurity - K | EP | (1RS)-1-(6-methoxynaphthalen-2-yl)ethanol | 77301-42-9 |
997 | Naproxen | Naproxen Impurity - L | EP | 1-(6-methoxynaphthalen-2-yl)ethanone | 3900-45-6 |
998 | Naproxen | Naproxen Impurity - M | EP | 2-methoxynaphthalene (neroline) | 93-04-9 |
999 | Naproxen | Naproxen Impurity - N | EP | 2-bromo-6-methoxynaphthalene | 5111-65-9 |
1000 | Naproxen | Naproxen Impurity - O | EP | Isopropyl-2-hydroxy-2-(6-methoxy naphthalen-2-yl)acetate | NA |
1001 | Naproxen | Naproxen Impurity - Q | IH | 6-methoxy-2-naphthoic acid | 2471-70-7 |
1002 | Naproxen | Naproxen Impurity - I | IH | (6-methoxynaphthalene-2-yl)acetic acid | 23981-47-7 |
1003 | Naproxen | Naproxen Related Compound - A | USP | (6-methoxy-2-naphthoic acid) | 2471-70-7 |
1004 | Naproxen | Naproxen Related Compound - L | USP | (1-(6-methoxynaphthalen-2-yl)ethanone) | 3900-45-6 |
1005 | Naproxen | Naproxen Related Compound - K | USP | (1RS)-1-(6-methoxynaphthalen-2-yl)ethanol | 77301-42-9 |
1006 | Nevirapine | Nevirapine | EP | 11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-one | 129618-40-2 |
1007 | Nevirapine | Nevirapine Impurity - A | EP | 11-ethyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one | 133627-17-5 |
1008 | Nevirapine | Nevirapine Related Compound - A | USP | (5-11-dihydro-6H-11-ethyl-4-methyl-dipyrido[3,2-b:2',3'-e] [1,4]diazepin-6-one) | 133627-17-5 |
1009 | Niacin | Niacin | IH | Pyridine-3-carboxylic acid | 59-67-6 |
1010 | Niacin | Niacin Impurity | IH | 6-methylnicotinic acid | 3222-47-7 |
1011 | Niacin | Niacin Impurity | IH | 2,2'-Bipyridine-5,5'-dicarboxylic acid | 1802-30-8 |
1012 | Niacin | Niacin Impurity | IH | 3-cyanopyridine | 100-54-9 |
1013 | Niacin | Niacin Impurity | IH | 3-nitropyridine | 2530-26-9 |
1014 | Niacin | Niacin Impurity | IH | 3-ethylpyridine | 536-78-7 |
1015 | Niacin | Niacin Impurity | IH | 5-ethyl-2-methylpyridine | 104-90-5 |
1016 | Niacin | Niacin Impurity | IH | pyridine-3-carboxamide | 98-92-0 |
1017 | Niacin | Niacin Impurity | IH | 2,5-Pyridinedicarboxylic Acid | 100-26-5 |
1018 | Niacin | Niacin Impurity | IH | 2-cyanopyridine | 100-70-9 |
1019 | Nicorandil | Nicorandil | EP | N-[2-(Nitro-oxy)ethyl]nicotinamide | 65141-46-0 |
1020 | Nicorandil | Nicorandil Amide Impurity | IH | N-(2-hydroxyethyl)pyridine-3-carboxamide N-(2-hydroxyethyl)nicotinamide | 6265-73-2 |
1021 | Nicorandil | Nicorandil nitrate Impurity | IH | 2-Aminoethyl nicotinate nitrate | 46053-56-9 (Free base) 88596-33-6(nitrate) |
1022 | Nicorandil | Nicorandil Impurity | EP | N-(2-hydroxyethyl)isonicotinamide | 6265-73-2 |
1023 | Nicorandil | Nicorandil Oxazoline Impurity | IH | 3-(4,5-Dihydro-1,3-oxazole-2-yl)pyridine | 40055-37-6 |
1024 | Nicorandil | Nicorandil 4- Dinitrate Impurity | IH | 2-[(Pyridin-3-carbonyl)-2-(pyridine-3ylcarbonyl)ethylamino]ethyl Nitrate | 1798026-96-6 (Free Base) |
1025 | Nicotine | Nicotine | EP | 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine | 54-11-5 |
1026 | Nicotine | Nicotine Impurity - B | EP | 3-(1-methyl-1H-pyrrol-2-yl)pyridine(β-nicotyrine) | 487-19-4 |
1027 | Nicotine | Nicotine Impurity - C | EP | (5S)-1-methyl-5-(pyridin-3-yl) pyrrolidin-2-one(Cotinine) | 486-56-6 |
1028 | Nicotine | Nicotine Impurity - D | EP | 3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine (myosmine) | 532-12-7 |
1029 | Nicotine | Nicotine Impurity - F | EP | 3-[(2S)-pyrrolidin-2-yl]pyridine (nornicotine) | 5746-86-1(Racemic) |
1030 | Nicotine | Nicotine Related Compound - B | USP | 3-(1-methyl-1H-pyrrol-2-yl)pyridine(β-nicotyrine) | 487-19-4 |
1031 | Nicotine | Nicotine Related compound - D | USP | 3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine (Fumerate) | 532-12-7 (Free base) |
1032 | Nimesulide | Nimesulide | EP | N-(4-nitro-2-phenoxyphenyl)methanesulfonamide | 51803-78-2 |
1033 | Nimesulide | Nimesulide Impurity - C | EP | 2-phenoxyaniline | 2688-84-8 |
1034 | Nimesulide | Nimesulide Impurity - D | EP | 4-Nitro-2-phenoxyaniline | 5422-92-4 |
1035 | Nitrofurantoin | Nitrofurantoin | EP | 1-[(5-Nitro-2-furanyl)methylene]amino]-2,4-imidazolidinedione | 67-20-9 |
1036 | Nitrofurantoin | Nitrofurantoin Impurity | IH | 2-[(5-Nitro-2-furanyl)methylene] hydrazinecarboxamide | NA |
1037 | Nitrofurantoin | Nitrofurantoin Impurity | IH | 2-(Diacetoxymethyl)-5-nitrofuran | NA |
1038 | Nitrofurantoin | Nitrofurantoin Impurity | IH | 5-Nitro -2-furaldehyde | 698-63-5 |
1039 | Norfloxacin | Norfloxacin | EP | 1-Ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 70458-96-7 |
1040 | Norfloxacin | Norfloxacin Impurity - A | EP | 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 68077-26-9 |
1041 | Norfloxacin | Norfloxacin Impurity - H | EP | 7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 105440-01-5 |
1042 | Norfloxacin | Norfloxacin Related Compound - A | USP | 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 68077-26-9 |
1043 | Norfloxacin | Norfloxacin Related Compound - H | USP | 7-[4-(ethoxycarbonyl)piperazin-1-yl]-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | 105440-01-5 |
1044 | Norfloxacin | Norfloxacin Related compound - K | USP | 6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 704593-07-3 (Free base) & 74011-48-6 |
1045 | Norfloxacin | Norfloxacin Impurity - K | IH | 6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid | 704593-07-3 (Free base) & 74011-48-6 |
1046 | Nefopam Hydrochloride | Nefopam Hydrochloride | IH | 3,4,5,6-tetrahydro-5-methyl-1-phenyl-1H-2,5-benzoxazocine hydrochloride | 23327-57-3 |
1047 | Nefopam Hydrochloride | Nefamide | IH | 2-Benzoyl-N-(2-hydroxyethyl)-N-methylbenzamide | 24833-47-4 |
1048 | Nefopam Hydrochloride | Nefodiol | IH | 2-((2-Hydroxyphenyl)methyl)benzyl)(methyl)aminoethanol | 60725-36-2 |
1049 | Ofloxacin | Ofloxacin | EP | (RS)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid | 82419-36-1 |
1050 | Ofloxacin | Ofloxacin Impurity - A | EP | (RS)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3-de]-1,4- benzoxazine-6-carboxylic acid (FPA) | 82419-35-0 |
1051 | Ofloxacin | Ofloxacin Impurity - E | EP | (RS) 9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[2,3-d][1,4]benzoxazine-6-carboxylic acid (N-Desacetyl, Desmethyl) | 82419-52-1 |
1052 | Ofloxacin | Ofloxacin Impurity - F | EP | 4-((3RS)-6-carboxy-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[2,3-d][1,4]benzoxazine-10-yl)-1-methylpiperazine-1-oxide (N-Oxide) | 104721-52-0 (01) 121651-73-7 |
1053 | Ofloxacin | Ofloxacin Related Compound - A | USP | (RS) 9-fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[2,3-d][1,4]benzoxazine-6-carboxylic acid (N-Desacetyl, Desmethyl Ofloxacin) | 82419-52-1 |
1054 | Ofloxacin | R-Ofloxacin | USP | (3R) 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-1,4-benzoxazine-2,3,4-de-quinoline-6-carboxylic acid | 100868-86-5 |
1055 | Ofloxacin | Dextro Ofloxacin Impurity | IH | (3R) 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-1,4-benzoxazine-2,3,4-de-quinoline-6-carboxylic acid | 100868-86-5 |
1056 | Olanzapine | Olanzapine | EP | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | 132539-06-1 |
1057 | Olanzapine | Olanzapine Related Compound - A | USP | (5-methyl-2-(2-nitrophenyl)amino...3-thiophenecarbonitrile | 138564-59-7 |
1058 | Olanzapine | Olanzapine Related Compound - B | USP | 2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-[5H]-one | 221176-49-4 |
1059 | Olanzapine | Olanzapine Related Compound - C | USP | 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4-N-oxide | 174794-02-6 |
1060 | Olanzapine | Olanzapine Desmethyl Impurity | IH | 2-methyl-4-(piperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | 161696-76-0 |
1061 | Olanzapine | Olanzapine Impurity - C (N-Chloromethyl)Olanzapine | IH | 1-(Chloromethyl)-1-methyl-4-(2-methyl-10H-thieno[2,3-b][1,5]benzodiazepin-4-yl)piperazin-1-ium chloride | 713900-59-1 |
1062 | Olanzapine | Olanzapine Impurity (Amino) | IH | 4-Amino-2-methyl-10H-thieno[2,3-b][1,5]benzodiazepine hydrochloride | 138564-60-0 |
1063 | Olopatadine Hydrochloride | Olopatadine Hydrochloride | USP | (11Z)-11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-acetic acid hydrochloride | 140462-76-6 |
1064 | Olopatadine Hydrochloride | Olopatadine Related Compound - B | USP | (Z)-3-(2-carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine oxide (N-Oxide) | 173174-07-7 |
1065 | Olopatadine Hydrochloride | Olopatadine Related Compound - C | USP | (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid | 55453-87-7 |
1066 | Olopatadine Hydrochloride | Olopatadine Carbaldehyde Impurity | IH | (11Z)-11-(3-(Dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-ethanol | 137661-97-2 |
1067 | Olopatadine Hydrochloride | Olopatadine HCl Impurity - III | IH | Isopropyl (11Z)-11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo[b,e]oxepin-2-yl acetate | NA |
1068 | Olopatadine Hydrochloride | Olopatadine N-Desmethyl Impurity | IH | (11Z)-6,11-Dihydro-11-(3-(methylamino)propylidene)-dibenzo[b,e]oxepin-2-acetic acid | 113835-92-0 |
1069 | Olmesartan Medoxomil | Olmesartan Medoxomil | IH | (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl-4-(1-hydroxy-1-methylethyl)-2-propyl-1-[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-1H-imidazole-5-carboxylate | 144689-63-4 |
1070 | Olmesartan Medoxomil | Olmesartan Related Compound - A | USP | 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[2'-(3H-tetrazole-5-yl)(1,1'-biphenyl)4-yl]methyl-4H-furo[3,4-d]imidazole-4-one | 849206-43-5 |
1071 | Olmesartan Medoxomil | Olmesartan Impurity | IH | Triphenylmethanol | 76-84-6 |
1072 | Olmesartan Medoxomil | Olmesartan Impurity - A | IH | 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-1H-imidazole-5-carboxylic acid | 144689-24-7 |
1073 | Olmesartan Medoxomil | Olmesartan TIBB Impurity (Dibromo) | IH | 1-triphenylmethyl-5-[4'-(dibromomethyl)-1,1'-biphenyl)-2-yl-1H-tetrazole | 358685-13-9 |
1074 | Olmesartan Medoxomil | Olmesartan TNMB Impurity | IH | 1-triphenylmethyl-5-[4'-(methyl)-1,1'-biphenyl)-2-yl-1H-tetrazole | 124750-53-4 |
1075 | Olmesartan Medoxomil | Olmesartan Impurity RNH6373 (Olefinic Impurity) | IH | (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl-4-isopropenyl-2-propyl-1-[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-1H-imidazole-5-carboxylate | 879562-26-2 |
1076 | Olmesartan Medoxomil | Trityl Olmesartan Acid | IH | 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[4'-[2-(trityltetrazole-5-yl)phenyl)]phenyl methylimidazole-5-carboxylic acid | 752179-89-8 |
1077 | Olmesartan Medoxomil | Olmesartan Dimer Impurity (RNH 8276) | IH | 4-[1-[4-(1-hydroxy-1-methylethyl)-2-propyl-1-[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methylimidazole-5-yl]carbonyloxy-1-methylethyl)-2-propyl-1-[2'-(1H-tetrazole-5-yl) | 1040250-19-8 |
1078 | Olmesartan Medoxomil | Olmesartan Impurity RNH6363 (Ethylene Imp) | IH | 4-isopropenyl-2-propyl-1-[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-1H-imidazole-5-carboxylic acid | 172875-98-8 |
1079 | Olmesartan Medoxomil | KSM-I of Olmesartan Medoxomil | IH | 4-(1-hydroxy-1-methylethyl)-2-propyl-1H-imidazole-5-carboxylic acid ethyl ester | 144689-93-0 |
1080 | Olmesartan Medoxomil | Olmesartan N-Alkyl Impurity (Trityl Olmesartan Medoxomil) | IH | 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[2'-(2-(tritylphenyl)methyl-1H-tetrazole-5-yl)(1,1'-biphenyl)-4-yl]methyl-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxol-4-yl) | NA |
1081 | Olmesartan Medoxomil | Olmesartan Impurity - B | EP | 6,6-dimethyl-2-propyl-3-[2'-(2H-tetrazole-5-yl)(1,1'-biphenyl-4-yl]methyl-3,6-dihydro-4H-furo[3,4-d]imidazole-4-one | 849206-43-5 |
1082 | Olmesartan Medoxomil | Olmesartan Diethyl Ester Impurity | IH | Diethyl 2-propyl-1H-imidazole-4,5-dicarboxylate | 144689-94-1 |
1083 | Olmesartan Medoxomil | Olmesartan Medoxomil Stage - I (Ethyl ester Impurity) | IH | Ethyl-4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(trityl tetrazol-5yl)-phenyl]phenyl}methyl imidazole-5-carboxylate | 144690-33-5 |
1084 | Olmesartan Medoxomil | Olmesartan Impurity | IH | 5-(4'-(Bromomethyl)(1,1'-Biphenyl)-2-yl)-1-Trityl-1H-tetrazole | 124750-51-2 & 133051-88-4 |
1085 | Olmesartan Medoxomil | Olmesartan Impurity - G | IH | 4-(1-Hydroxy-1-methylpropyl)-2-propyl-1-[[2’-(2H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid (5-methyl-2-oxo-1,3-dioxo-4-yl)methyl Ester | 1378863-74-1 |
1086 | Olmesartan Medoxomil | Olmesartan Diacid Impurity | IH | 2-propyl-1H-imidazole-4,5-di carboxylic acid | 58954-23-7 |
1087 | Olmesartan Medoxomil | KSM-II of Olmesartan Medoxomil | IH | 1-Triphenylmethyl-5-[4-(bromomethyl){1,1-biphenyl}-4-yl]-1H-tetrazole | NA |
1088 | Omeprazole | Omeprazole | EP | 5-Methoxy-2-[(RS)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl] sulfinyl]-1H-benzimidazole | 73590-58-6 |
1089 | Omeprazole | Omeprazole Impurity - A | EP | 5-methoxy-1H-benzimidazole-2-thiol | 37052-78-1 |
1090 | Omeprazole | Omeprazole Impurity - C | EP | 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfanyl]-1H-benzimidazole (Ufiprazole) | 73590-85-9 |
1091 | Omeprazole | Omeprazole Impurity - D | EP | 5-methoxy-2-[[(4-methoxy-3,5-dimethyl pyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole (Omeprazole Sulfone) | 88546-55-8 |
1092 | Omeprazole | Omeprazole Impurity - E | EP | 4-methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide | 76219-04-8 |
1093 | Omeprazole | Omeprazole Impurity - F | USP | 5-methoxy-2-[(R) –[(4-methoxy-3,5-dimethylpyridine-2-yl)methyl] sulfinyl]-1H-benzimidazole | 119141-89-8 |
1094 | Omeprazole | Omeprazole Impurity - B | IH/EP | 2-[(RS)-[(3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole | 110374-16-8 |
1095 | Omeprazole | Omeprazole Impurity - I | EP | 4-methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide | 158812-85-2 |
1096 | Omeprazole | Omeprazole Related Compound - A | USP | 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfonyl]-1H-benzimidazole | 88546-55-8 |
1097 | Omeprazole | Omeprazole Related Compound - B | USP | 5-Methoxy-1H-benzimidazol-2-thiol | 37052-78-1 |
1098 | Omeprazole | Omeprazole Related Compound - E | USP | 4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethyl pyridine 1-oxide | 176219-04-8 |
1099 | Ondansetron Hydrochloride Dihydrate | Ondansetron Hydrochloride Dihydrate | EP | (3RS)-9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate | 153139-56-1 (Free base) 119812-29-2 |
1100 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - A | EP | (3RS)-3-[(dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | 27387-31-1 |
1101 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - C | EP | 9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one | 99614-64-9 |
1102 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - D | EP | 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one | 288-32-4 |
1103 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - E | EP | 1H-imidazole | 693-98-1 |
1104 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - F | EP | 2-methyl-1H-imidazole | 99614-03-6 |
1105 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - G | EP | (3RS)-3-[(1H-imidazol-1-yl)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one (C-desmethyl ondansetron) | 99614-14-9 |
1106 | Ondansetron Hydrochloride Dihydrate | Ondansetron Impurity - H | EP | (3RS)-3-[(2-methyl-1H-imidazol-1-yl)methyl] -1,2,3,9-tetrahydro-4H-carbazol-4-one(N-Desmethyl ondansetron) | 119812-29-2 |
1107 | Ondansetron Hydrochloride Dihydrate | Ondansetron Related Compound - A | USP | (3RS)-3-[(dimethylamino)methyl]-1,2,3,9-tetrahydro-9-methyl-4H- carbazol-4-one hydrochloride | 27387-31-1 |
1108 | Ondansetron Hydrochloride Dihydrate | Ondansetron Related Compound - C | USP | (1,2,3,9-tetrahydro-9-methyl-4H-carbazol-4-one) | 27387-31-1 |
1109 | Ondansetron Hydrochloride Dihydrate | Ondansetron Related Compound - D | USP | (1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one | 99614964-9 |
1110 | Ornidazole | Ornidazole | IH | 1-chloro-3-(2-methyl-5-nitro-1H-imidazol-1-yl)propan-2-ol | 16773-42-5 |
1111 | Ornidazole | Ornidazole epoxy Impurity | IH | 1-(2,3-epoxypropyl)-2-methyl-5-nitro imidazole | 16773-52-7 |
1112 | Ornidazole | Ornidazole - 4 - isomer Impurity | IH | 1-(3-chloro-2-hydroxypropyl)-2-methyl-4-nitroimidazole | 14419-11-5 |
1113 | Ornidazole | Ornidazole diol Impurity | IH | 1-(2,3-dihydroxy propyl)-2-methyl-5-nitro imidazole | 62580-80-7 |
1114 | Oxcarbazepine | Oxcarbazepine | USP | 10,11-dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide | 28721-07-5 |
1115 | Oxcarbazepine | Oxcarbazepine Related Compound - C | USP | Acridin-9(10H)-one | 578-95-0 |
1116 | Oxcarbazepine | Oxcarbazepine Related Compound - E | USP | (10(11H)-Oxo-5H-dibenz(b,f)azepine) | 21737-58-6 |
1117 | Oxcarbazepine | Oxcarbazepine Impurity - I | IH | 10-oxo-10,11-dihydro-5H-dibenzo(b,f)azepine-5-carboxamide | 298-46-4 |
1118 | Oxcarbazepine | Oxcarbazepine Impurity - II | IH | 10-methoxy-5H-dibenzo(b,f)azepine | 4698-11-7 |
1119 | Oxcarbazepine | Oxcarbazepine Impurity - III | IH | 10-methoxy-5H-dibenzo(b,f)azepine-5-carboxamide | 28721-09-7 |
1120 | Paliperidone | Paliperidone | USP | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | 144598-75-4 |
1121 | Paliperidone | Paliperidone Related Compond - A (Des-Chloro Imp) | USP | (3-Ethyl-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | 849903-79-3 |
1122 | Paliperidone | Paliperidone Related Compound - B | USP | 6-fluoro-3-(piperidin-4-yl)benzisoxazole hydrochloride | 84163-13-3 |
1123 | Paliperidone | Paliperidone Related Compound - C | USP | 3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one) | 130049-82-0 |
1124 | Paliperidone | Paliperidone Related Compound - D | USP | (3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one N-oxide) | 761460-08-6 |
1125 | Paliperidone | Paliperidone Impurity - D (Debenzyl Imp) | IH | 3-(2-chloro ethyl)-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | 260273-82-3 (Free base) 849727-62-4 |
1126 | Paliperidone | Paliperidone Hydroxy compound | IH | 9-(Benzyloxy)-3-(2-hydroxyethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | 1008796-22-2 |
1127 | Paliperidone | Paliperidone Keto impurity | IH | 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-oxo-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one | 1189516-65-1 |
1128 | Paliperidone | Paliperidone Impurity | IH | 9-(benzyloxy)-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one | 147687-17-0 |
1129 | Paliperidone | Sulfamic acid | IH | Sulfamic acid | 5329-14-6 |
1130 | Paliperidone | Methyl Acetoacetate | IH | Methyl acetoacetate | 105-45-3 |
1131 | Paliperidone | Benzyl Chloride | IH | Benzyl Chloride | 100-44-7 |
1132 | Paliperidone | Furfural | IH | Furfural | 98-01-1 |
1133 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Sodium Sesquihydrate | EP | Sodium 5-(difluoromethoxy)-2-[(RS)-(((3,4-dimethoxy pyridin-2-yl)methyl)sulfinyl) benzimidazol-1-ide sesquihydrate | 164579-32-2 & 102625-70-7 |
1134 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Impurity - A | EP | 5-(difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl] sulfonyl]-1H-benzimidazole (Sulfone) | 127780-16-9 |
1135 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Impurity - B | EP | 5-(difluoromethoxy)-2-[[(3,4-dimethoxypyridin-2-yl)methyl]sulfanyl]-1H- benzimidazole (Sulfide) | 10265-64-9 |
1136 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Impurity - C | EP | 5-(difluoromethoxy)-1H-benzimidazole-2-thiol (Thiol Imp) | 97963-62-7 |
1137 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Related Compound - A | USP | 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl) methyl]sulfonyl]-1H-benzimidazole | 127780-16-9 |
1138 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Related Compound - B | USP | 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-1H-benzimidazole | 102625-64-9 |
1139 | Pantoprazole Sodium Sesquihydrate | Pantoprazole Related Compound - C | USP | 5-(difluoromethoxy)-1H-benzimidazole-2-thiol | 97963-62-7 |
1140 | Pantoprazole Sodium Sesquihydrate | Pantoprazole N-Oxide Impurity | IH | 5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-1-oxido-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; | 953787-60-5 |
1141 | Paracetamol | Paracetamol | EP | N-(4-Hydroxyphenyl)acetamide | 103-90-2 |
1142 | Paracetamol | Paracetamol Impurity - A | EP | N-(2-hydroxyphenyl)acetamide | 614-80-2 |
1143 | Paracetamol | Paracetamol Impurity - D | EP | N-phenylacetamide | 103-84-4 |
1144 | Paracetamol | Paracetamol Impurity - E | EP | 1-(4-hydroxyphenyl)ethanone | 99-93-4 |
1145 | Paracetamol | Paracetamol Impurity - F | EP | 4-nitrophenol | 100-02-7 |
1146 | Paracetamol | Paracetamol Impurity - H | EP | 4-(acetylaminophenylacetate) | 2623-33-8 |
1147 | Paracetamol | Paracetamol Impurity - I | EP | 1-(2-hydroxyphenyl)ethanone | 118-93-4 |
1148 | Paracetamol | Paracetamol Impurity - J | EP | N-(4-chlorophenyl)acetamide (Chloroacetamide) | 539-03-7 |
1149 | Paracetamol | Paracetamol Impurity - K | EP | 4-aminophenol | 123-30-8 |
1150 | Paroxetine Hydrochloride | Paroxetine Hydrochloride | EP | (3S,4R)-3-[1,3-benzodioxol-5-yloxymethyl]-4-(4-fluorophenyl)piperidine hydrochloride anhydrous | 78246-49-8 & 61869-08-7 (Free base) 324024-00-26 (Free base) 1322626-23-2 (HCl salt) |
1151 | Paroxetine Hydrochloride | Paroxetine Impurity - A | EP | (3S,4R)-3-[1,3-benzodioxol-5-yloxymethyl]-4-(4-phenyl)piperidine (desfluoroparoxetine) | 108813-14-7 |
1152 | Paroxetine Hydrochloride | Paroxetine Impurity - C | EP | (3S,4R)-3-[1,3-benzodioxol-5-yloxymethyl]-4-(4-fluorophenyl)piperidine (N-benzylparoxetine) | 108813-14-7 |
1153 | Paroxetine Hydrochloride | Paroxetine Impurity - E | EP | (3RS,4RS)-3-[1,3-benzodioxol-5-yloxymethyl]-4-(4-fluorophenyl)piperidine (cis-paroxetine) | 78246-49-8 & 61869-08-7 (Free base) 69675-10-1 |
1154 | Paroxetine Hydrochloride | Paroxetine Impurity - G | EP | 4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine | 201855-60-9 |
1155 | Paroxetine Hydrochloride | Paroxetine Impurity - H | EP | (3S,4R)-1-benzyl-4-(4-fluorophenyl)piperidin-3-yl)methanol | 201855-60-9 |
1156 | Paroxetine Hydrochloride | Paroxetine Related Compound - E | IN | 4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine | 69675-10-1 |
1157 | Paroxetine Hydrochloride | Paroxetine Related Compound - D | USP | (3RS,4RS)-3-[(benzodioxol-5-yloxymethyl]-4-(4-fluorophenyl)piperidine hydrochloride (cis-paroxetine) | NA |
1158 | Phenytoin | Phenytoin | EP | 5,5-Diphenylimidazolidine-2,4-dione | 57-41-0 |
1159 | Phenytoin | Phenytoin Impurity - A | EP | diphenylmethanone (Benzophenone) | 119-61-9 |
1160 | Phenytoin | Phenytoin Impurity - B | EP | diphenylethanedione (Benzil) | 134-81-6 |
1161 | Phenytoin | Phenytoin Impurity - C | EP | amino(diphenyl)acetic acid (2,2-diphenyl glycine) | 3060-50-2 |
1162 | Phenytoin | Phenytoin Impurity - F | EP | 5-(4-methylphenyl)-5-phenylimidazolidine-2,4-dione | 51169-17-6 |
1163 | Phenytoin | Phenytoin Related Compound - A | USP | (2,2-Diphenylglycine) | 3060-50-2 |
1164 | Phenoxymethylpenicillin | Phenoxymethylpenicillin | EP | (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid | 87-08-1 |
1165 | Phenoxymethylpenicillin | Phenoxymethylpenicillin Impurity - A | EP | (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (Benzylpenicillin) | 61-33-6 |
1166 | Phenoxymethylpenicillin | Phenoxymethylpenicillin Impurity - B | EP | Phenoxyacetic acid | 122-59-8 |
1167 | Pioglitazone Hydrochloride | Pioglitazone Hydrochloride | IN | (RS)-5-(4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl)thiazolidine-2,4-dione | 112529-15-4 & 111025-46-8 (Free base) |
1168 | Pioglitazone Hydrochloride | Pioglitazone N-Oxide Impurity | IN | 5-[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl-2,4-thiazolidinedione N-Oxide | 145350-09-0 |
1169 | Pioglitazone Hydrochloride | Pioglitazone Imino Analog Impurity | IN | 5-[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]benzyl]-2-imino-4-thiazolidinedione ("EPEB") | 105355-26-8 |
1170 | Pioglitazone Hydrochloride | Pioglitazone Impurity - B | IN | 5-[4-[2-(5-Ethyl-2-pyridinylethoxy]benzylidene)-2,4-thiazolidinedione | 144809-28-9 627502-58-3 |
1171 | Pioglitazone Hydrochloride | Pioglitazone Impurity - C | IN | 5-[4-[2-(5-Ethyl-2-pyridinylethoxy]phenylmethyl-N-[2-(5-ethylpyridin-2-yl)ethyl]-2,4-thiazolidinedione | 952188-00-0 |
1172 | Piracetam | Piracetam | EP | 2-(2-Oxopyrrolidin-1-yl)acetamide | 7491-74-9 |
1173 | Piracetam | Piracetam Impurity - A | EP | pyrrolidin-2-one | 616-45-5 |
1174 | Piracetam | Piracetam Impurity - B | EP | methyl (2-oxopyrrolidin-1-yl)acetate | 59776-88-4 |
1175 | Piracetam | Piracetam Impurity - C | EP | ethyl (2-oxopyrrolidin-1-yl)acetate | 61516-73-2 |
1176 | Piracetam | Piracetam Impurity - D | EP | (2-oxopyrrolidin-1-yl)acetic acid | 53934-76-2 |
1177 | Potassium Clavulanate | Potassium Clavulanate | EP | Potassium (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylate | 61177-45-5 |
1178 | Potassium Clavulanate | Clavulanate Impurity - G | EP | 4-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-4-oxobutanoic acid (N-hydrogensucinyltyrosine) | 374816-32-7 |
1179 | Povidone | Povidone | EP | 1-ethenylpyrrolidin-2-one polymers | 9003-39-8 |
1180 | Povidone | Povidone Impurity - A | EP | 1-ethenylpyrrolidin-2-one | 88-12-0 |
1181 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Dihydrochloride Monohydrate | EP | (6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine Dihydrochloride Monohydrate | 191217-81-9 |
1182 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - A | EP | (6S)-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, | 106092-09-5 |
1183 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - B | EP | (6S)-N,N4-dipropyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine, | 1246815-83-7 |
1184 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - C | EP | (6S)-6-N-[3-[(6S)-2-Amino-4,5,6,7-tetrahydro-1,3-benzothiazol-6-yl]amino]-1-ethyl-2-methylpropyl]-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine (C-C Dimer) | 1973461-14-1 |
1185 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - D | EP | (R )-2-Amino-4,5,6,7-tetrahydro-6-(propylamino) benzothiazole (R-isomer) (Des pramipexole) | 104632-27-1 (HCl salt) 104632-28-2 |
1186 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - E | EP | (S)-2-Amino-4,5,6,7-tetrahydro-6-(1-oxo-propylamino)benzothiazole | 106006-84-2 |
1187 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Related Compound - A | USP | (6S)-4,5,6,7-Tetrahydrobenzothiazole-2,6-diamine) | 106092-09-5 |
1188 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Related Compound - D | USP | (R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino) benzothiazole dihydrochloride) | 104632-27-1 |
1189 | Pramipexole Dihydrochloride Monohydrate | R - Isomer Of Pramipexole Impurity | IH | (R)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine dihydrochloride | 104632-27-1 |
1190 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity RRT @ 0.63 | IH | S-1-propyl-2-pyrrolidone-5-acetic acid thiourea amide | 936751-11-0 |
1191 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity RRT @ 0.93 | IH | (S)-2-(methyl) amino-4,5,6,7-tetrahydro - (6 - propyl, 6-hydroxyl methyl) amino benzothiazole | NA |
1192 | Pramipexole Dihydrochloride Monohydrate | Pramipexole Impurity - F | IH | (S)-N6,N6-dipropyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine hydrochloride | 1147937-31-2 |
1193 | Prasugrel Hydrochloride | Prasugrel Hydrochloride | IH | (RS)-5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridin-2-yl-acetate hydrochloride | 389574-19-0 |
1194 | Prasugrel Hydrochloride | Prasugrel Impurity | IH | 1-cyclopropyl-2-(3-fluorophenyl) ethanone | 952722-64-4 |
1195 | Prasugrel Hydrochloride | Des Fluoro Impurity of Prasugrel | IH | 5-(2-cyclopropyl-2-oxo-1-phenyl ethyl)-4,5,6,7-tetrahydrothieno[3,2-c] pyridin-2-yl acetate | 1391053-53-4 (HCl salt) |
1196 | Prasugrel Hydrochloride | 3-Fluoro Impurity of Prasugrel | IH | 5-[2-cyclopropyl-1-(3-fluorophenyl)-2-oxoethyl]-4,5,6,7-tetrahydrothieno[3,2-c] pyridin-2-yl acetate | 1391194-39-0(free base) 1391052-75-7(HCl salt) |
1197 | Pregabalin | Pregabalin | IH | (S)-3-(aminomethyl)-5-methyl hexanoic acid | 148553-50-8 |
1198 | pregabalin | Pregabalin Impurity | IH | 3-(2-Methylpropyl)pentanedioic Acid) | 75143-89-4 |
1199 | Pregabalin | Pregabalin R-isomer Impurity | IH | (3R)-3-aminomethyl)-5-methylhexanoic acid | 148553-51-9 |
1200 | pregabalin | Pregabalin Cyclicamide Impurity | IH | 4-(2-methylpropyl)piperidine-2,6-dione | 916982-10-0 |
1201 | Pregabalin | Pregabalin Racemic Mixture | IH | 3-(2-amino-2-oxo ethyl)-5-methylhexanoic acid | 181289-15-6 |
1202 | Pregabalin | Pregabalin Lactam Impurity | IH | 4-(2-methylpropyl)pyrrolidin-2-one | 61312-87-6 |
1203 | Pregabalin | Pregabalin Impurity | IH | (R)-(+)-α-Methylbenzylamine) | 3886-69-9 |
1204 | Pregabalin | Pregabalin Impurity | IH | (R-)-(-)-3-(Carbamoylmethyl)-5-methylhexanoic acid) | 181289-33-8 |
1205 | Pregabalin | Pregabalin Racemate | IH | 3-(Amino-5-methyl hexanoic acid) | 128013-69-4 |
1206 | Pregabalin | Pregabalin Related Compound - A | USP | (3R)-3-aminomethyl)-5-methylhexanoic acid | 148553-51-9 |
1207 | Primidone | Primidone | EP | 5-Ethyl-5-phenyldihydropyrimidine-4,6(1H,5H)-dione | 125-33-7 |
1208 | Primidone | Primidone Impurity - A | EP | 2-ethyl-2-phenylpropanediamide | 7206-76-0 |
1209 | Primidone | Primidone Impurity - B | EP | 5-ethyl-5-phenylpyrimidine-2,4,6(1H,3H,5H)-trione (phenobarbital) | 50-06-6 |
1210 | Primidone | Primidone Impurity - C | EP | (2RS)-2-phenylbutanamide | 90-26-6 |
1211 | Primidone | Primidone Impurity - E | EP | (2RS)-2-phenylbutanoic acid | 90-27-7 |
1212 | Primidone | Primidone Impurity - F | EP | 5-ethyl-5-phenyl-2-[(1RS)-1-phenylpropyl]dihydropyrimidine-4,6(1H,5H)-dione | 189504-46-8 |
1213 | Primidone | Primidone Related Compound - A | USP | 2-ethyl-2-phenylmalonamide | 7206-76-0 |
1214 | Primidone | Primidone Related Compound - C | USP | 2-phenylbutanamide | 90-26-6 |
1215 | Prochlorperazine Dimaleate | Prochlorperazine Dimaleate | IH | Prochlorperazine Dimaleate | 84-02-6 |
1216 | Prochlorperazine Dimaleate | Prochlorperazine Deschloro Impurity | IH | 10-[3-(4-methyl-1-piperazinyl) propyl]-10H-phenothiazine dihydrochloride | 5317-37-3 & 84-97-9 (Free base) |
1217 | Prochlorperazine Dimaleate | Prochlorperazine Sulfoxide Impurity | IH | 2-Chloro-10-[3-(4-methyl-1-piperazinyl) propyl]-10H-phenothiazine | 10078-27-0 |
1218 | Prochlorperazine Dimaleate | Prochlorperazine 1-isomer Impurity | IH | 1-chloro-10-[3-(4-methylpiperazin-1-yl) propyl]-10H-phenothiazine | 58-38-8 |
1219 | Prochlorperazine Dimaleate | 4-CHLORO-10-H-PHENOTHIAZINE | IH | 4-chloro-10H-phenothiazine | 7369-69-9 |
1220 | Prochlorperazine Dimaleate | Prochlorperazine 4-isomer Impurity | IH | 4-chloro-10-[3-(4-methylpiperazin-1-yl) propyl]-10H-phenothiazine | 1346602-34-3 |
1221 | Prochlorperazine Dimaleate | Prochlorperazine Related Compound - A | USP | 4-chloro-10-[3-(4-methylpiperazin-1-yl) propyl]-10H-phenothiazine dihydrochloride | 1346602-34-3 |
1222 | Propyl Hydroxybenzoate | Propyl Hydroxybenzoate | EP | Propyl 4-hydroxybenzoate | 94-13-3 |
1223 | Propyl Hydroxybenzoate | Propyl Hydroxybenzoate Impurity - A | EP | 4-hydroxybenzoic acid | 99-96-7 |
1224 | Propyl Hydroxybenzoate | Propyl Hydroxybenzoate Impurity - B | EP | methyl 4-hydroxybenzoate (methyl parahydroxybenzoate) | 99-76-3 |
1225 | Propyl Hydroxybenzoate | Propyl Hydroxybenzoate Impurity - C | EP | ethyl 4-hydroxybenzoate (ethyl parahydroxybenzoate) | 120-47-8 |
1226 | Propyl Hydroxybenzoate | Propyl Hydroxybenzoate Impurity - D | EP | butyl 4-hydroxybenzoate (butyl parahydroxybenzoate) | 94-26-8 |
1227 | Prothionamide | Prothionamide | IH | 2-propyl-4-pyridinecarbothioamide | 14222-60-7 |
1228 | Pyrantel Embonate | Pyrantel Embonate | EP | 1-Methyl-2-[(E)-2-(thiophen-2-yl)ethenyl]-1,4,5,6-tetrahydropyrimidine hydrogen 4,4'- methylenebis(3-hydroxynaphthalene-2-carboxylate) | 22204-24-6 |
1229 | Pyrantel Embonate | Pyrantel Impurity - B | EP | (E)-N-[3-(methylamino)propyl]-3-(thiophen-2-yl)prop-2-enamide | 1449108-90-0 (HCl salt) |
1230 | Pyrazinamide | Pyrazinamide | EP | pyrazine-2-carboxamide | 98-96-4 |
1231 | Pyrazinamide | Pyrazinamide Impurity - A | EP | pyrazine-2-carboxylic acid | 98-97-5 |
1232 | Pyrazinamide | Pyrazinamide Impurity - B | IH | Pyrazinecarbonitrile | 19847-12-2 |
1233 | Pyridoxine Hydrochloride | Pyridoxine Hydrochloride | EP | (5-hydroxy-6-methylpyridine-3,4-diyl)dimethanol hydrochloride | 58-56-0 & 65-23-6 |
1234 | Pyridoxine Hydrochloride | Pyridoxine Impurity - A | EP | 6-methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol | 1006-21-9(HCl salt) & 5196-20-3 |
1235 | Pyridoxine Hydrochloride | Pyridoxine Impurity - B | EP | 5-(hydroxymethyl)-2,4-dimethylpyridin-3-ol | 148-51-6 (HCl salt) & 61-67-6 |
1236 | Piroxicam | Piroxicam | EP | 4-hydroxy-2-methyl-N-(pyridin-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide | 36322-90-4 |
1237 | Piroxicam | Piroxicam | IH | 1,1-Dioxide-4-Methoxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-Carboxamide | 76780-03-5 |
1238 | Propafenone Hydrochloride | Propafenone Hydrochloride | EP | 1-[2-[(2RS)-2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one hydrochloride | 34183-22-7 |
1239 | Propafenone Hydrochloride | Propafenone Impurity - C | EP | 1-[2-[[(2RS)-oxiranyl]methoxy]phenyl]-3-phenylpropan-1-one | 22525-95-7 |
1240 | Propafenone Hydrochloride | Propafenone Impurity - F | EP | 1,1'-[2-hydroxypropane-1,3-diylbis(oxy-2,1-phenylene)]bis(3-phenylpropan-1-one) | 1329643-40-4 |
1241 | Propafenone Hydrochloride | Propafenone Impurity - E | EP | 1-[2-[(2RS)-3-Chloro-2-hydroxypropoxy]phenyl]-3-phenylpropan-1-one | 165279-79-8 |
1242 | Propafenone Hydrochloride | Propafenone Impurity - G | EP | 1,1'-[Propyliminobis[(2-hydroxypropane-3,1-diyl)oxy-2,1-phenylene]]bis(3-phenylpropan-1-one | 1346603-80-2 |
1243 | Propafenone Hydrochloride | Propafenone Impurity - D | EP | 1-[2-[(2RS)-2,3-dihydroxypropoxy]phenyl]-3-phenylpropan-1-one | 91401-73-9 |
1244 | Propafenone Hydrochloride | Propafenone Impurity - B | EP | (2E)-1-[2-(2RS)-2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one | 88308-22-9 & 1331636-87-3 (HCl) |
1245 | Propafenone Hydrochloride | Propafenone Related Compound - B | USP | (2E)-1-[2-(2RS)-2-Hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylprop-2-en-1-one | 88308-22-9 |
1246 | Piperonal | Piperonal | IH | 1,3-benzodioxole-5-carbaldehyde | 120-57-0 |
1247 | Piribedil | Piribedil | IH | 2-[4-(1,3-Benzodioxol-5-ylmethyl)-1-piperazinyl]pyrimidine | 3605-01-4 |
1248 | Piribedil | Piribedil Dihydroxy Impurity | IH | 4-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]benzene-1,2-diol | 19971-73-4 50602-50-1 |
1249 | Quetiapine Hemifumarate | Quetiapine Hemifumarate | EP | 2-2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy]ethanol hemifumarate | 111974-72-2 |
1250 | Quetiapine Hemifumarate | Quetiapine Impurity - A | EP | 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy]ethyl acetate | 844639-07-2 |
1251 | Quetiapine Hemifumarate | Quetiapine Impurity - B | EP | 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepine | 111974-74-4(HCl salt) 5747-48-8(Free base) |
1252 | Quetiapine Hemifumarate | Quetiapine Impurity - C | EP | 2-(2-(4-dibenzo[b,f][1,4]thiazepine-11-yl)piperazin-1-yl) ethoxyethyl 2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)acetate | 1798840-31-9 |
1253 | Quetiapine Hemifumarate | Quetiapine Impurity - D | EP | 11,4-bis(dibenzo[b,f][1,4]thiazepin-11-yl)piperazine | 945668-94-0 |
1254 | Quetiapine Hemifumarate | Quetiapine Impurity - E | EP | 1,2-bis(2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl)piperazin-1-yl)ethoxy]ethane | 1371638-05-9 |
1255 | Quetiapine Hemifumarate | Quetiapine Impurity - G | EP | dibenzo[b,f][1,4]thiazepin-11(10H)-one | 460029 |
1256 | Quetiapine Hemifumarate | Quetiapine Impurity - H | EP | 4-(dibenzo[b,f][1,4]thiazepin-11-yl)-1-(2-(2-hydroxyethoxy)ethyl)piperazine-1-oxide | 1076199-40-0 |
1257 | Quetiapine Hemifumarate | Quetiapine Impurity - I | EP | 2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol | 329216-67-3 (Free base) 329218-14-6 |
1258 | Quetiapine Hemifumarate | Quetiapine Impurity - J | EP | 2-(2-(2-(2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy)ethanol | 1356905-17-6 |
1259 | Quetiapine Hemifumarate | Quetiapine Impurity - N | EP | 2-(2-(4-(2-(2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethyl)piperazin-1-yl)ethoxy)ethanol | 1800291-86-4 |
1260 | Quetiapine Hemifumarate | Quetiapine Impurity - O | EP | 11-(4-(2-(2-(triyloxy)ethoxy)ethyl)piperazin-1-yl)dibenzo[b,f][1,4]thiazepine | 844639-06-1 |
1261 | Quetiapine Hemifumarate | Quetiapine Impurity - P | EP | 11-(4-ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine | 1011758-03-4 (HCl salt) |
1262 | Quetiapine Hemifumarate | Quetiapine Impurity - Q | EP | 4-(dibenzo[b,f][1,4]thiazepin-11-yl)-1,1-bis(2-(2-hydroxyethoxy) ethyl) piperazin-1-ium | NA |
1263 | Quetiapine Hemifumarate | Quetiapine Impurity - R | EP | (E)-4-ethoxy-4-oxobut-2-enoic acid | 2459-05-4 |
1264 | Quetiapine Hemifumarate | Quetiapine Impurity - S | EP | 11-(4-(2-(2-hydroxyethoxy)ethyl)piperazin-1-yl)dibenzo [b,f][1,4] thiazepine 5-oxide (S-OXIDE) | 329216-63-9 (HCl salt) |
1265 | Quetiapine Hemifumarate | Quetiapine Impurity - T | EP | 4-(dibenzo[b,f][1,4]thiazepin-11-yl)morpholine | 5747-46-6 |
1266 | Quetiapine Hemifumarate | Quetiapine Impurity - U | EP | dibenzo[b,f][1,4]thiazepin-11-amine | 5786-26-5 |
1267 | Quetiapine Hemifumarate | Quetiapine Impurity - V | EP | 2-(2-(4-phenanthridin-6-yl)piperazin-1-yl)ethoxy)ethanol | NA |
1268 | Quetiapine Hemifumerate | Quetiapine Impurity - W | EP | 11-(2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethoxy)dibenzo[b,f][1,4]thiazepine | 1800608-95-0 & 2204369-14-0 |
1269 | Quetiapine Hemifumerate | Quetiapine Related Compound - B | USP | 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride | NA |
1270 | Quetiapine Hemifumerate | Quetiapine Related Compound - G | USP | dibenzo[b,f][1,4]thiazepin-11(10H)-one | 5747-48-8 & 3159-07-7 |
1271 | Quetiapine Hemifumerate | Quetiapine N-Oxide (R-H) | USP | 4-(dibenzo[b,f][1,4]thiazepin-11-yl)-1-(2-(2-hydroxyethoxy) ethyl) piperazine-1-oxide | 1076199-40-0 |
1272 | Quetiapine Hemifumerate | Quetiapine Desethoxy Impurity | USP | 2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethanol | 329218-14-6 & 329216-67-3(Free base) |
1273 | Quetiapine Hemifumerate | Quetiapine Bis(dibenzothiazepine)piperazine | USP | [1,4 Bis(dibenzo[b,f][1,4]thiazine-11-yl)piperazine | 945668-94-0 |
1274 | Quetiapine Hemifumerate | Quetiapine Impurity - A | IH | 11-(piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride | 111974-74-4 (HCl Salt) |
1275 | Quetiapine Hemifumerate | Quetiapine Impurity - D | IH | (2-(2-(4- dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy)ethoxy] ethanol) | NA |
1276 | Quetiapine Hemifumerate | Quetiapine Bisether Impurity (Triethoxy) | IH | 1,2-bis(2-(4-Dibenzo[b,f][1,4]thiazepine-11-yl)piperazin-1-yl)ethoxy)ethane | 1371638-05-9 |
1277 | Quetiapine Hemifumerate | Quetiapine Impurity - C (Des Ethoxy) | IH | 11-(4-(2-hydroxyethyl)-1-piperazinyl)dibenzo[b,f][1,4]thiazepine | 329216-67-3 |
1278 | Quetiapine Hemifumerate | Quetiapine Impurity - E (N-Methyl) | IH | 11-(4-methylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine) | 1977-09-9 |
1279 | Quetiapine Hemifumerate | Quetiapine Impurity - F (Dimer) | IH | [1,4 Bis(dibenzo[b,f][1,4]thiazine-11-yl)piperazine | 945668-94-0 |
1280 | Quetiapine Hemifumerate | Quetiapine Impurity | IH | 2-(2-(piperazin-1-yl)ethoxy)ethanol | 13349-82-1 |
1281 | Quinine Sulfate | Quinine Sulfate | EP | bis( ( R )-(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]oct-2-yl)(6-methoxyquinolin-4-yl)methanolsulfate(dried substance) | 6119-70-6 |
1282 | Quinine Sulfate | Quinine Sulfate Impurity - A | EP | (S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo (2.2.2]oct-2-yl)(6-methoxyquinolin-4-yl) methanol | 572-60-1 |
1283 | Rabeprazole Sodium | Rabeprazole Sodium | USP | (2-((4-(3-Methoxypropoxy)-3-methyl-2-pyridyl) methyl) sulfinyl) benzimidazole sodium salt) | 881191-56-3 (hydrate) 117976-90-6 |
1284 | Rabeprazole Sodium | Rabeprazole Related Compound - B | USP | 2-{[[1H-benzo[d]imidazol-2-yl)sulfinyl]methyl}-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide) (N-Oxide) | 924663-38-7 |
1285 | Rabeprazole Sodium | Rabeprazole Related Compound - C | USP | 1H-Benzimidazole-2-thiol | 583-39-1 |
1286 | Rabeprazole Sodium | Rabeprazole Related Compound - D | USP | (2-{[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl]sulfonyl}benzimidazole) (Sulfone) | 117976-47-3 |
1287 | Rabeprazole Sodium | Rabeprazole Related Compound - E | USP | (2-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridyl]methyl thio]benzimidazole) (Sulfide) | 117977-21-6 |
1288 | Rabeprazole Sodium | Rabeprazole Related Compound - F | USP | (2-((4-Chloro-3-methyl-2-pyridyl)methyl)sulfinyl) benzimidazole) | 168167-42-8 |
1289 | Rabeprazole Sodium | Rabeprazole Impurity - A | IH | 2-[(4-(3-methoxypropoxy)-3-methyl-2-pyridinyl-1-oxide) methyl sulfinyl]-1H-benzimidazole (N-Oxide) | 924663-38-7 |
1290 | Rabeprazole Sodium | Rabeprazole Impurity - B | IH | 2-{[[4-(3-methoxypropoxy)-3-methyl-1-oxidopyridin-2-yl]methylsulfonyl}-1H-benzimidazole (Sulfone N-Oxide) | 924663-37-6 |
1291 | Rabeprazole Sodium | Rabeprazole Impurity - C | IH | 2-[[[4-chloro-3-methyl-2-pyridinyl]methyl] sulphinyl]-1H-benzimadazole | 168167-42-8 |
1292 | Rabeprazole Sodium | Rabeprazole Impurity - D | IH | 2-[[4-chloro-3-methyl pyridinyl -1-oxide]methyl sulfinyl]-1H-benzimidazole | NA |
1293 | Rabeprazole Sodium | Rabeprazole Impurity - E | IH | 2-{[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfanyl}-1H-benzimidazole | 117977-21-6 |
1294 | Rabeprazole Sodium | Rabeprazole Impurity - F | IH | 2-{[[4-(3-Methoxypropoxy)-3-Methyl-2-Pyridinyl]Methylsulfonyl}benzimidazole | 117976-47-3 |
1295 | Rabeprazole Sodium | Rabeprazole Impurity - G | IH | 2-[(4-3-methoxypropoxy-3-methyl pyridinyl]methyl]sulfinyl)-1-[(4-(3-methoxypropoxy)-3-methylpyridinyl)methyl]-1H-benzimidazole | 935260-92-7 |
1296 | Rabeprazole Sodium | Rabeprazole Chloro Compound | IH | 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine hydrochloride | 153259-31-5 |
1297 | Rabeprazole Sodium | Rabeprazole Stage-II Impurity | IH | 2-{[[4-(3-methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl}-1H-benzimidazole | NA |
1298 | Rabeprazole Sodium | Rabeprazole 4-Methoxy analog | IH | 2-[(4-Methoxy-3-methylpyridin-2-yl)methanesulfinyl]-1H-benzimidazole | 102804-77-3 |
1299 | Rabeprazole Sodium | Rabeprazole Impurity - G | IH | 2-[[(4-Methoxy-3-methylpyridine-2-yl)methyl]sulfinyl]-1H-benzimidazole | 102804-82-0 |
1300 | Ramipril | Ramipril | EP | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoyl]octahydrocyclopenta[b]pyrrol-2-carboxylic acid | 108731-95-9 |
1301 | Ramipril | Ramipril Impurity - D | EP | Ethyl (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxodecahydro-2H-cyclopenta[4,5]pyrrolo[ 1,2-a] pyrazin-2-yl]-4-phenylbutanoate ( Ramipril diketo piperazine) | NA |
1302 | Ramipril | Ramipril Impurity - E | EP | (2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl] octahydro cyclopenta[b]pyrrole-2-carboxylic acid (ramipril diacid) | NA |
1303 | Ramipril | Ramipril Impurity - F | EP | (2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-propanoic acid | 108-88-3 |
1304 | Ramipril | Ramipril Impurity - G | EP | Methylbenzene (toluene) | 108736-10-3 |
1305 | Ramipril | Ramipril Impurity - K | EP | (2S)-2-[(3S,5aS,8aS,9aS)-3-methyl-1,4-dioxo decahydro-2H-cyclopenta (4,5)pyrrolo[1,2-a]pyrazin-2-yl]-4-phenylbutanoicacid (ramipril diketopiperazine acid) | NA |
1306 | Ramipril | Ramipril Impurity - M | EP | (2R,3R)-2,3-bis(benzyloxybutanedioic acid(dibenzoyltartaric acid) | 151387-05-2 |
1307 | Ramipril | Ramipril Impurity - O | EP | Diethyl 2,2'-(2,5-dimethyl-3,6-dioxopiperazine-1,4-diyl)bis( 4-phenylbutanoate) | 108731-95-9 |
1308 | Ramipril | Ramipril Related Compound - D | USP | Ramipril Diketopiperazine | 95635-55-5 142387-99-3 95635-56-6(2HCl) |
1309 | Ranolazine | Ranolazine | IH | N-(2,6-Dimethylphenyl)-4-[2-hydroxy-3-(2-methoxyphenoxy) propyl]-1-piperazineacetamide | 5294-61-1 |
1310 | Ranolazine | Ranolazine Related Compound - C | USP | 1-[(2,6-dimethylphenyl)amine carbonylmethyl]piperazine | 5294-61-1 |
1311 | Ranolazine | Ranolazine Impurity | IH | 1-[(2,6-dimethylphenyl)amine carbonylmethyl]piperazine | 66357-59-3 |
1312 | Ranitidine Hydrochloride | Ranitidine Hydrochloride | EP | N-[2-[[[5-(Dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethyl]-N'-methyl-2-nitrothene-1,1-diamine hydrochloride | 72126-78-4 |
1313 | Ranitidine Hydrochloride | Ranitidine Impurity - A | EP | N,N'-bis[2-[[[5-(dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethyl]-2-nitroethene-1,1-diamine | 66356-53-4 |
1314 | Ranitidine Hydrochloride | Ranitidine Impurity - B | EP | 2-[[[5-[(dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethanamine | 73851-70-4 |
1315 | Ranitidine Hydrochloride | Ranitidine Impurity - C | EP | N-[2-[[[5-(dimethylamino)methyl]furan-2-yl]methyl]sulfanyl]ethyl]-N'-methyl-2-nitrothene-1,1-diamine (Ranitidine S-Oxide) | 112251-56-6 |
1316 | Ranitidine Hydrochloride | Ranitidine Impurity - D | EP | N-[2-[[[5-(dimethylamino)methyl]furan-2-yl] methylsulfanyl]ethyl]-2-nitroacetamide | 73857-20-2 |
1317 | Ranitidine Hydrochloride | Ranitidine Impurity - E | EP | N-[2-[[[5-(dimethyloxoamino)methyl]furan-2-yl]methyl] sulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine (Ranitidine N-Oxide) | 81074-81-9 HCl salt 15433-79-1 |
1318 | Ranitidine Hydrochloride | Ranitidine Impurity - F | EP | [5-(dimethylamino)methyl]furan-2-yl]methanol | 112233-23-5 |
1319 | Ranitidine Hydrochloride | Ranitidine Impurity - G | EP | 3-(methylamino)-5,6-dihydro-2H-1,4-thiazin-2-one oxime | 72078-82-1 |
1320 | Ranitidine Hydrochloride | Ranitidine Impurity - H | EP | N-methyl-2-nitroacetamide | 61832-41-5 |
1321 | Ranitidine Hydrochloride | Ranitidine Impurity - K | EP | N-methyl-1-methylthio-2-nitrothenamine | 91224-69-0 |
1322 | Ranitidine Hydrochloride | Ranitidine Related Compound - A | USP | [5-[[2-aminoethyl)thio]methyl]-N,N-dimethyl-2-furanmethanamine hemifumaratesalt | 72126-78-4 |
1323 | Ranitidine Hydrochloride | Ranitidine Related Compound - B | USP | [N,N'-bis[2-[[[5-(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine | 73851-70-4 |
1324 | Ranitidine Hydrochloride | Ranitidine Related Compound - C | USP | N-2-[[[5-(Dimethylamino)methyl]-2-furanyl]methyl)sulfiny]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine | 72115-14-1 |
1325 | Ranitidine Hydrochloride | Ranitidine Impurity | IH | 1-[2-(5-Dimethylaminomethyl)-2-furanylmethylthio)ethylamino]-1-methylthio-2-nitroethene | 54252-45-8 |
1326 | Ranitidine Hydrochloride | Ranitidine Impurity | IH | 1,1-Bis(methylamino)-2-nitrothene | 136236-51-6 |
1327 | Rasagiline | Rasagiline | IH | (1R)-2,3-dihydro-N-2-propyn-1-yl-1H-inden-1-amine | 117903-1-47-0 |
1328 | Rasagiline | Rasagiline Impurity | IH | N-(2-chloroprop-2-en-1-yl)-2,3-dihydro-1H-inden-1-amine | NA |
1329 | Rasagiline | Rasagiline Impurity - A | IH | N,N-di(prop-2yn-1-yl)-2,3-dihydro-1H-inden-1-amine | 135062-02-1 |
1330 | Repaglinide | Repaglinide | EP | 2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid | 99469-99-5 |
1331 | Repaglinide | Repaglinide Impurity - B | EP | [3-ethoxy-4-(ethoxycarbonyl)phenyl]acetic acid | 219921-94-5 |
1332 | Repaglinide | Repaglinide Related Compound - A | USP | (S)-3-Methyl-1-[2-(1-piperidinyl)phenyl]butyl amine, N-acetyl-L-glutamate Salt | 99469-99-5 |
1333 | Repaglinide | Repaglinide Related Compound - B | USP | (3-ethoxy-4-ethoxycarbonylphenyl acetic acid) | 106266-06-2 |
1334 | Risperidone | Risperidone | EP | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 691007-09-7 |
1335 | Risperidone | Risperidone Impurity - A | EP | 3-[2-[4-[(E)-(2,4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone E-Oxime) | 132961-05-8 |
1336 | Risperidone | Risperidone Impurity - B | EP | 3-[2-[4-[(Z)-(2,4-difluorophenyl)(hydroxyimino)methyl]piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone Z-Oxime) | 144598-75-4 |
1337 | Risperidone | Risperidone Impurity - C | EP | (9RS)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (9-Hydroxy Risperidone) | 1199589-74-6 |
1338 | Risperidone | Risperidone Impurity - D | EP | 3-[2-[4-(5-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 1346602-28-5 |
1339 | Risperidone | Risperidone Impurity - E | EP | (6RS)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2,6-dimethyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (6-methyl Risperidone) | 158691-67-7 |
1340 | Risperidone | Risperidone Impurity - H | EP | 3-[2-[4-(2,4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one | 63234-80-0 (Free base) |
1341 | Risperidone | Risperidone Chloro Impurity | IH | 3-(2-Chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one Hydrochloride (Chloro Compound) | 832747-55-4 |
1342 | Risperidone | Risperidone N-Oxide Impurity | IH | 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-oxido-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone N-Oxide) | NA |
1343 | Risperidone | Risperidone Quarternary Salt | IH | 6-Fluoro-3-[1-bis-[2-(methyl-6,7,8,9-tetrahydropyrido[1,2,a]pyrimidin-4-one-3-yl)ethyl]piperidinium]benzisoxazole | 84163-77-9 (Free base) 84163-13-3 (HCl salt) |
1344 | Risperidone | Risperidone Impurity | IH | 6-Fluoro-3-(piperidin-4-yl)-1,2-benzisoxazole hydrochloride | 70381-58-7 |
1345 | Risperidone | Risperidone Ethyl Impurity | IH | 3-Ethyl-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-4-one | 152542-00-2 |
1346 | Risperidone | Risperidone Related Compound - G | IH | 3-[2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido-[1,2-a]pyrimidine-4-one | 84163-77-9 (Free base) 84163-13-3 (HCl salt) |
1347 | Risperidone | Risperidone Related Compound - B | USP | 6-Fluoro-3-(piperidin-4-yl)-1,2-benzisoxazole hydrochloride | 129101-54-8 |
1348 | Rivastigmine | Rivastigmine Impurity | IH | N-Ethyl-N-methylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenylester (2R,3R)-2,3-Dihydroxybutanedioate | NA |
1349 | Rivastigmine | Rivastigmine Impurity | IH | 3-[1-Dimethylaminoethyl]phenol hydrochloride | 162401-32-3 |
1350 | Roflumilast | Roflumilast | IH | 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide | 162401-62-9 |
1351 | Roflumilast | Roflumilast Impurity - 1 | IH | 3-Cyclopropylmethoxy-4-difluoromethoxy benzoic acid | 22889-78-7 |
1352 | Roflumilast | Roflumilast Impurity - 2 | IH | 3,5-Dichloro-4-aminopyridine | 292135-78-5 |
1353 | Roflumilast | Roflumilast Impurity - 3 | IH | N-(3,5-Dichloropyridin-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide N-Oxide | NA |
1354 | Roflumilast | Roflumilast Impurity - 4 | IH | N-(pyridin-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide | 1391053-75-0 |
1355 | Roflumilast | Roflumilast Impurity - 5 | IH | N-(3-chloropyridin-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide | NA |
1356 | Roflumilast | Roflumilast Impurity - 6 | IH | N-(3-chloropyridin-4-yl)-3-methoxy-4-difluoromethoxybenzamide | 159782-26-0 |
1357 | Roflumilast | Roflumilast Impurity - 7 | IH | N-(3,5-dichloropyridin-4-yl)-3-cyclopropylmethoxy-4-methoxybenzamide | NA |
1358 | Roflumilast | Roflumilast Impurity - C03 | IH | N-(3,5-Dichloropyridin-4-yl)-3,4-bis(difluoromethoxy)benzamide | 162401-43-6 |
1359 | Roflumilast | Roflumilast Impurity - C05 | IH | (4-Cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-3-(difluoromethoxy)benzamide | 1391052-24-6 |
1360 | Roflumilast | Roflumilast Impurity - C06 | IH | 3,4-bis(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)benzamide | NA |
1361 | Roflumilast | Roflumilast Impurity- C07 | IH | 3-(but-3-en-1-yloxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide | 84449-90-1 |
1362 | Rolaxifene | Rolaxifene | IH | [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone | 84541-38-8 |
1363 | Rolaxifene | Rolaxifene dimethoxy Impurity | IH | 6-Methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone | 91374-20-8 |
1364 | Ropinirole Hydrochloride | Ropinirole Hydrochloride | USP | 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one monohydrochloride | 139122-19-3 |
1365 | Ropinirole Hydrochloride | Ropinirole Related Compound - A | USP | 4-(2-hydroxyethyl)indolin-2-one | NA |
1366 | Ropinirole Hydrochloride | Ropinirole Styrene Impurity | IH | 2-(2-bromoethyl)-Beta-Nitro styrene | 80214-83-1 |
1367 | Roxithromycin | Roxithromycin | EP | (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-10-[(E)-[(2-methoxyethoxy)methoxy]imino]- | 114-07-8 |
1368 | Roxithromycin | Roxithromycin Impurity - A | EP | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy- | 69-72-7 |
1369 | Salicylic Acid | Salicylic Acid | EP | 2-Hydroxybenzenecarboxylic acid | 69-72-7 |
1370 | Salicylic Acid | Salicylic acid Impurity - C | EP | Phenol | 108-95-2 |
1371 | Sertraline Hydrochloride | Sertraline HCl | EP | (1S,4S)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | 79559-97-0 |
1372 | Sertraline Hydrochloride | Sertraline Impurity - A | EP | (1RS,4SR)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 79836-45-6 (Free base) 79617-99-5 (HCl salt) |
1373 | Sertraline Hydrochloride | Sertraline Impurity - B | EP | (1RS,4RS)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine | 52758-05-1 (HCl salt) |
1374 | Sertraline Hydrochloride | Sertraline Impurity - C | EP | (1RS,4RS)-4-(4-chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 91797-63-6 (Free Base) 79559-98-1 (HCl) 79646-00-7 |
1375 | Sertraline Hydrochloride | Sertraline Impurity - D | EP | (1RS,4RS)-4-(3-chlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine | 871838-58-3 |
1376 | Sertraline Hydrochloride | Sertraline Impurity - E | EP | (2R)-hydroxyphenylacetic acid ((R)-mandelic acid) | 611-71-2 |
1377 | Sertraline Hydrochloride | Sertraline Impurity - F | EP | (4R)-4-(3,4-dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one | 155748-61-1 |
1378 | Sertraline Hydrochloride | Sertraline Impurity - G | EP | (1R,4R)-4-(3,4-Dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine Hydrochloride | 79617-95-1 |
1379 | Sertraline Hydrochloride | Sertraline Related Compound - A | USP | (1S,4R)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydro-1-naphthalamine hydrochloride | 79836-45-6 |
1380 | Sertraline Hydrochloride | 2,3-Dichloro Isomer Sertraline | IH | 4-(2,3-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine hydrochloride | 1198084-29-5 (HCl Salt) 1198115-10-4 (Free) |
1381 | Sertraline Hydrochloride | 2,3-Dichloro Isomer Tetralone | IH | 4-(2,3-dichlorophenyl)-3,4-dihydronaphthalen-1(2H)-one | 152448-80-1 |
1382 | Sildenafil Citrate | Sildenafil Citrate Impurity - A | USP | 5-[2-ethoxy-5-[(4-methyl piperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methyl propyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one (Iso butylanalog) | 1391053-95-4 |
1383 | Sertraline Hydrochloride | Sertraline Impurity | IH | 4-(3,4-Dichlorophenyl)-3,4-dihydro-1(2H)-naphthalenone | 79560-19-3 |
1384 | Sildenafil Citrate | Sildenafil Citrate | IH | 5-[2-ethoxy-5-[(4-methyl piperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one dihydrogen 2-hydroxypropane-1,2,3-tricarboxylate | 171599-83-0 |
1385 | Sildenafil | Sildenafil Impurity-D | EP | 4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonic acid | 1357931-555 |
1386 | Sildenafil Citrate | Sildenafil Citrate Impurity - A | IH | 5-[2-ethoxy-5-[(4-methyl piperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-(2-methyl propyl)-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one (Iso butylanalog) | 1391053-95-4 |
1387 | Sildenafil Citrate | Sildenafil Citrate Impurity - B | IH | 5-[2-ethoxy-5-[(4-methyl-4-oxidopiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one (N-Oxide) | 1094598-75-0 |
1388 | Sildenafil Citrate | Sildenafil Citrate Impurity - C | IH | 5-[2-Hydroxy-5-[(4-methyl piperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-n-propyl-1,6-dihydro-1H-pyrazolo[4,3-d]pyrimidin-7-one (O-Des ethyl Sildenafil) | 139755-91-2 |
1389 | Sildenafil Citrate | Sildenafil Citrate Impurity - D | IH | 4-ethoxy-3-(1-methyl-7-oxo-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-5-yl)benzene sulphonic acid (Des methyl piperazinyl sulfonic acid) | 1357931-55-5 |
1390 | Sildenafil Citrate | Sildenafil Citrate Impurity - E | IH | 1H-imidazole | 288-32-4 |
1391 | Sildenafil Citrate | Sildenafil Citrate Impurity - G | IH | 1,4-Bis[5-(5-sulfonyl-2-ethoxyphenyl)-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidine-7-one]piperazin | 1346602-67-2 |
1392 | Sildenafil Citrate | Sildenafil Amine Impurity | IH | 4-Amino-1-methyl-3-n-propyl-5-pyrazolecarboxamide | 139756-02-8 |
1393 | Sildenafil Citrate | Sildenafil Cyclized Impurity | IH | 5-(2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidine-7-one | 139756-21-1 |
1394 | Sildenafil Citrate | Sildenafil Methyl Sulfonate Ester | IH | Methyl-4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidine-5-yl)benzenesulfonate | NA |
1395 | Sildenafil Citrate | Sildenafil Piperazine Impurity | IH | 5-[2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one | 139755-82-1 |
1396 | Sildenafil Citrate | Sildenafil Coupled Impurity | IH | 4-(2-ethoxybenzamido)-1-methyl-3-n-propylpyrazole-5-carboxamide | 139756-03-9 |
1397 | Sildenafil Citrate | Sildenafil Chloro Sulfonyl Impurity | IH | 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one | 139756-22-2 |
1398 | Sildenafil Citrate | Sildenafil Acid impurity | IH | 1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxylic acid | 139756-00-6 |
1399 | Sildenafil Citrate | Sildenafil Amide Impurity | IH | 1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide | 139756-01-7 |
1400 | Simvastatin | Simvastatin | EP | (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate | 79902-63-9 |
1401 | Simvastatin | Simvastatin Impurity - A | EP | (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid (tenivastatin) | 101314-97-0 |
1402 | Simvastatin | Simvastatin Impurity - B | EP | (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-(acetyloxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate | 145576-25-6 |
1403 | Simvastatin | Simvastatin Impurity - C | EP | (1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate (Anhydro) | 210980-68-0 |
1404 | Simvastatin | Simvastatin Impurity - E | EP | (1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate | 75330-75-5 |
1405 | Simvastatin | Anhydro Simvastatin | USP | ((1S,3R,7S,8S,8aR)-3,7-Dimethyl-8-[2-[(2R)-6-oxo-3,6-dihydro-2H-pyran-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | 210980-68-0 |
1406 | Simvastatin | Acetyl Simvastatin | USP | ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) | 145576-25-6 |
1407 | Simvastatin | Simvastatin Methyl Ester | IH | Methyl (3R,5R)-7-[(1S,2S,6R,8S,8aR)-8-[(2,2-Dimethylbutanoyl)oxy]-2,6-dimethyl-1,2,6,7,8,8a-Hexahydronaphthalen-1-yl]-3,5-Dihydroxyheptanoate | 145576-26-7 |
1408 | Simvastatin | Simvastatin 2-methyl Impurity | IH | 2,2-Dimethyl-(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-5-methyl-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester Butanoic Acid | 774611-54-0 |
1409 | Sitagliptin | Sitagliptin | IH | (R)-3-Amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one | 486460-32-6 |
1410 | Sitagliptin | Sitagliptin Impurity - E | IH | (3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid | 936630-57-8 |
1411 | Sitagliptin | Sitagliptin Impurity - A | IH | (S)-4-oxo-4[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine phosphate | 823817-58-9 |
1412 | Sitagliptin | Sitagliptin Impurity - B | IH | (R)-4-oxo-4[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,5-difluorophenyl)butan-2-amine | 1345822-87-8 |
1413 | Sitagliptin | Sitagliptin Impurity HOBT | IH | 1-Hydroxy benzotriazole | 2592-95-2 |
1414 | Sitagliptin | Sitagliptin Impurity EDC.HCl | IH | N-(3-(dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride | 25952-53-8 |
1415 | Sitagliptin | Sitagliptin Impurity KSM - II | IH | 3-(trifluoromethyl)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazine Hydrochloride | 762240-92-6 |
1416 | Sitagliptin | Sitagliptin Impurity KSM - I | IH | (3R)-3-[(tert-butoxycarbonyl)amino]-4-(2,4,5-trifluorophenyl)butanoic acid | 486460-00-8 |
1417 | Sitagliptin | Sitagliptin Impurity BOC | IH | N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamic acid 1,1-dimethylethyl ester | 486460-23-5 |
1418 | Sitagliptin | Sitagliptin Impurity EDC.UREA | IH | 1-[3-(dimethylamino)propyl]-3-ethylurea | 32897-26-0 |
1419 | Sitagliptin | Sitagliptin 2-Desfluoro Impurity | IH | (3R)-3-amino-4-(3,4-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one | 486459-88-5 |
1420 | Sitagliptin | Sitagliptin Phenyl Crotonyl Analog | IH | (E)-1-(3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | 1253056-18-6 |
1421 | Sitagliptin | Sitagliptin Impurity | IH | (3E)-1-[3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-c]pyrimidin-6(5H)-yl]-4-(3,4,5-trifluorophenyl)but-3-en-1-one | 1675201-14-5 |
1422 | Sitagliptin | Sitagliptin Impurity-C | EP | (3R)-3-amino-4-(2,4-difluorophenyl)-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]butan-1-one | 1345822-86-7 |
1423 | Sitagliptin | Sitagliptin Phenyl Crotonyl Analog | USP | (E)-1-(3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one | 1253056-18-6 |
1424 | Sodium Cromoglicate | Sodium Cromoglicate | EP | Disodium 5,5'-(2-hydroxypropane-1,3-diyl(oxy))bis(4-oxo-4H-1-benzopyran-2-carboxylate) | 15826-37-6 |
1425 | Sodium Cromoglicate | Sodium Cromoglicate Impurity | IH | 2,6'-Dihydroxyacetophenone | 699-83-2 |
1426 | Sodium Cromoglicate | Sodium Cromoglicate Impurity -2 | IH | 1,3-bis(2-acetyl-3-hydroxy phenoxy)-2-propanal | 16150-44-0 |
1427 | Sodium Cromoglicate | Sodium Cromoglicate Impurity -3 | IH | Diethyl 5,5'-{(2-hydroxypropane-1,3-diyl)dioxy}bis(4-oxo-4H-1-benzopyran-2-carboxylate) (Diethyl cromoglicate) | 16150-45-1 242478-38-2 |
1428 | Solifenacin | Solifenacin | IH | (1S)-3,4-dihydro-1-phenyl-2(1H)-isoquinoline carboxylicacid (3R)-1-azabicyclo [2.2.2]oct-3-yl ester succinate salt | 242478-38-2 242478-37-1 (Free base) |
1429 | Solifenacin | Solifenacin N-Oxide Impurity | IH | (1S)-3,4-dihydro-1-phenyl-2-(1H) -iso-quinoline carboxylic acid (3R)-1-azabicyclo [2.2.2]oct-3-yl ester N-oxide | 180277-28-0 |
1430 | Solifenacin | Solifenacin Impurity - (SOS-IV) | IH | (S)-1-phenyl-1,2,3,4-tetrahydro isoquinoline | 118864-75-8 |
1431 | Solifenacin | Solifenacin Impurity - (SOS-V) | IH | Ethyl(S)-1-phenyl-1,2,3,4-tetrahydro-2-isoquinoline carboxylate | NA |
1432 | Solifenacin | Solifenacin Impurity | IH | N-(2-phenylethyl)benzamide | 3278-14-6 |
1433 | Solifenacin | Solifenacin Impurity | IH | 1-phenyl-3,4-dihydroisoquinoline | 52250-50-7 |
1434 | Solifenacin | Solifenacin Nitrophenyl Ester Impurity | IH | 4-nitrophenyl (1S)-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate | 1229227-22-8 |
1435 | Spironolactone | Spironolactone | EP | (7R)-7α-(acetylsulfanyl-3'-4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione | 52-01-7 |
1436 | Spironolactone | Spironolactone Impurity - F | EP | (2'R)-3',4'-dihydro-5'H-spiro[androst-4,6-diene-17,2'-furan]-3,5'-dione(canrenone) | 976-71-6 |
1437 | Sulfamethoxazole | Sulfamethoxazole | EP | 4-Amino-N-(5-methylisoxazol-3-yl)benzenesulfonamide | 723-46-6 |
1438 | Sulfamethoxazole | Sulfamethoxazole Impurity - A | EP | N-[4-[(5-methylisoxazol-3-yl)sulfamoyl]phenyl]acetamide | 21312-10-7 |
1439 | Sulfamethoxazole | Sulfamethoxazole Impurity - B | EP | 4-[[(4-aminophenyl)sulphonyl]amino]-N-(5-methylisoxazol-3-yl)benzene sulfonamide | 135529-16-7 |
1440 | Sulfamethoxazole | Sulfamethoxazole Impurity - C | EP | 5-methylisoxazol-3-amine | 1072-67-9 |
1441 | Sulfamethoxazole | Sulfamethoxazole Impurity - D | EP | 4-aminobenzenesulfonic acid (sulfanilic acid) | 121-57-3 |
1442 | Sulfamethoxazole | Sulfamethoxazole Impurity - E | EP | 4-aminobenzenesulfonamide (sulfanilamide) | 63-74-1 |
1443 | Sulfamethoxazole | Sulfamethoxazole Impurity - F | BP | 4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide | 17103-52-5 |
1444 | Sulfamethoxazole | Sulfamethoxazole Related Compound - A | USP | N-[4-[(5-methylisoxazol-3-yl)sulfamoyl]phenyl]acetamide | 21312-10-7 |
1445 | Sulfamethoxazole | Sulfamethoxazole Related Compound - B | USP | 4-[[(4-aminophenyl)sulphonyl]amino]-N-(5-methylisoxazol-3-yl)benzene sulfonamide | 135529-16-7 |
1446 | Sulfamethoxazole | Sulfamethoxazole Related Compound - C | USP | 5-methylisoxazol-3-amine | 1072-67-9 |
1447 | Sulfamethoxazole | Sulfamethoxazole Related Compound - F | USP | 4-amino-N-(3-methylisoxazol-5-yl)benzenesulfonamide | 17103-52-5 |
1448 | Silodosin | Silodosin | IH | 2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide | 160970-54-7 |
1449 | Silodosin | Silodosin methane Sulfonate Impurity | IH | 2-(2-Ethoxyphenoxy)ethyl methanesulfonate | 169506-15-4 |
1450 | Silodosin | Silodosin Nitro Impurity | IH | 3-[7-Cyano-5-(2-nitropropyl)indolin-1-yl]propyl benzoate | 350797-56-7 |
1451 | Silodosin | Silodosin racemic KSM - I | IH | 3-[5-(2-Aminopropyl)-7-cyano-2,3-dihydro-1H-indol-1-yl]propyl benzoate | NA |
1452 | Silodosin | Silodosin Racemic Stage - I | IH | 1-(3-(Benzyloxy) propyl]-2,3-dihydro-5[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carbonitrile | 885340-11-4 (Free base) |
1453 | Silodosin | Silodosin KSM - II | IH | 2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethanol | 160969-02-8 |
1454 | Silodosin | Racemic silodosin | IH | 1-(3-hydroxypropyl)-5-(2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl-1H-indole-7-carboxamide | 16097064-9 |
1455 | Silodosin | DehydroKSM - I | IH | 3-[5-(2R)-2-aminopropyl-7-gano-1H-indol-1-yl]propyl benzoate (2R,3R)-2,3-dihydroxysuccinate | 23946885-5 |
1456 | Silodosin | Silodosin - Dehydro Impurity | IH | (R)-1-(3-hydroxypropyl)-5-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl-1H-indole-7-carboxamide | 17887021-0 |
1457 | Silodosin | Silodosin Keto Impurity | IH | 3-[7-Cyano-5-(2-oxopropyl)-2,3-dihydro-1H-indol-1-yl]propyl benzoate | 35079757-8 |
1458 | Silodosin | Benzyl silodosin | IH | (R)-1-(3-(benzyloxypropyl)-5-(2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propylindoline-7-carboxamide | 17887040-3 |
1459 | Silodosin | Silodosin S-isomer Impurity | IH | (S)-1-(3-hydroxypropyl)-5-(2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propylindoline-7-carboxamide | 16097054-7 |
1460 | Salbutamol | Salbutamol | EP | (1RS)-2-[1,1-Dimethylenylamino]-1-(4-hydroxy-3-(hydroxymethyl)phenyl)ethanol. | 18589494-9 |
1461 | Teimisartan | Teimisartan | EP | 4'-[(4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl] biphenyl-2-carboxylic acid | 14470148-4 |
1462 | Teimisartan | Teimisartan Impurity - A | EP | 4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazole | 15262802-9 |
1463 | Teimisartan | Teimisartan Impurity - C | EP | 1,1-dimethylenyl-4'-[4-methyl-6-(1-methyl-1Hbenzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic acid | 14470226-1 |
1464 | Teimisartan | Teimisartan Impurity - E | EP | 1-[2'-carboxylic]phenyl-4-yl-methyl-4-methyl-2-propyl-1H-benzimidazol-6-carboxylic acid | 88433012-5 |
1465 | Teimisartan | Teimisartan Impurity - G | EP | 4'-[(4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl] methyl]biphenyl-2-carboxylic acid | 14470227-2 |
1466 | Teimisartan | Teimisartan Impurity - H | EP | 1,1-dimethylenyl-4'-(bromomethyl)biphenyl-2-carboxylate | 11477240-6 |
1467 | Teimisartan | Teimisartan Impurity - F | EP | 4'-[(4-methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxamide | 91512486-6 |
1468 | Teimisartan | Teimisartan Related Compond - A | USP | (1,7'-dimethyl-2-propyl-1H,3H-2,5-bibenzofilimidazole monohydrate) | 12825545-1 |
1469 | Teimisartan | Teimisartan dimer Impurity | IH | 4'-4''-[(4'-Methyl-2-propyl)(2,6'-bH-1H-benzimidazole]-1,1'-dipylbis(methylene)[bis[1,1'-biphenyl]-2-carboxylic acid | 88433014-7 |
1470 | Teimisartan | Teimisartan Biphenyl amide impurity | IH | 4'-methyl(1,1'-biphenyl)-2-carboxamide | 39627247-7 |
1471 | Teimisartan | Teimisartan | IH | methyl-4'-methyl(1,1'-biphenyl)-2-carboxylate | 11477234-8 |
1472 | Teimisartan | Teimisartan Bromo biphenyl impurity | IH | 4'-(bromomethyl)(1,1'-biphenyl)-2-carboxylic acid | 15076686-2 |
1473 | Teimisartan | Teimisartan Bromo biphenyl nitrole impurity | IH | 4'-(bromomethyl)(1,1'-biphenyl)-2-carboxylic acid | 114772 |
1474 | Teimisartan | Teimisartan | IH | 4'-methyl(1,1'-biphenyl)-2-carboxylic acid | 71486330-0 |
1475 | Teimisartan | Teimisartan | IH | 2-propyl-1H-benzimidazole | 5465292-2 |
1476 | Tenofovir | Tenofovir | IH | ((II/2R)-1-(6-amino-9H-purin-6-yl)propan-2-yl)oxy(methyl)phosphoric acid | 14712719-3 |
1477 | Tenofovir | Tenofovir Disoproxil Related Compound - A | USP | (S)-5-[2-(6-Amino-9H-purin-6-yl)-1-methylethoxy]methyl-2,4,6,8-tetraoxa-5-phosphanonaneelic acid, bis(1-methylethyl) ester, 5-oxide, (E)-2-butenedicate (1:1)) | 14326306-6 |
1478 | Tenofovir | Tenofovir Disoproxil Related Compound - B | USP | ((E)-9-(Prop-1-enyl)-9H-purin-6-amine) | 14464863-4 |
1479 | Tenofovir | Tenofovir Disoproxil Related Compound - E | USP | ((IIIR)-1-(6-Amino-9H-purin-6-yl)propan-2-yloxy(methyl)phytoxy)phosphoryloxy(methyl isopropyl carbonate) | 21136469-1 |
1480 | Tenofovir | Tenofovir Disoproxil Related Compound - G | USP | (O-(Isopropoxycarbonyloxymethyl)-O-isopropyl-[R]-I-(6-amino-9H-purin-6-yl) propan-2-yloxy(methyl)phosphorate) | 14222845-8 |
1481 | Tenofovir | NPOC-POC TENOFOVIR (Mixture of Diastereomers) | IH | 5-[(11R)-2-(6-Amino-9H-purin-6-yl)-1-methylethoxy]methyl-2,4,6,8-tetraoxa-5-phosphanonaneelic acid (1-methyl ethyl)propylene; 5-Oxide; fumarate salt | NA |
1482 | Tenofovir | MOC-POC - TENOFOVIR (Mixture of Diastereomers) | IH | 5-[(11R)-2-(6-Amino-9H-purin-6-yl)-1-methyl ethoxy]methyl-2,4,6,8-tetraoxa-5-phosphanonaneelic acid (1-methyl ethyl)propylene; 5-Oxide; fumarate salt | 12468124-9 |
1483 | Tenofovir | TENOFOVIR DISOPROXIL DIMER | IH | 5-[(11R)-2-(6-Amino-9H-purin-6-yl)-1-methylethoxy]methylethoxy(carbonyl) oxymethoxy); 5-oxide-9-oxo-3,6,8,10-tetraoxa-5-phosphadioide-1-yl; 9H-purin-6-yl)amino] | 10932776-5 |
1484 | Tenofovir | IPR-POC-PMPA IMPURITY STANADARD | IH | (R)-[(2-(6-Amino-9H-purin-6-yl)-1-methylethoxy]methylphosphoric acid isopropyl carbonyl oxymethyl ester isopropyl ester | 14222845-8 |
1485 | Tenofovir | MONO-POC-PMPA TENOFOVIR | IH | [[2-(6-amino-purin-9-yl)-1-methylethoxymethyl]-phosphonic acid mono isopropoxy carbonyloxymethyl ester | 211364-69-1 |
1486 | Tenofovir | TENOFOVIR S-ISOMER | IH | (S)-5-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl]-2,4,6,8-tetraoxa-5-phosphanonandioic acid, bis(1-methylethyl) ester, 5-oxide, (E)-2-butenedioate (1:1) | 1432630-26-6 |
1487 | Tenofovir | TENOFOVIR 9-PROPENYLADENINE IMPURITY | IH | (E)-9-(Prop-1-enyl)-9H-purin-6-amine | 4121-40-8 1446486-33-4 63590-64-7 (Free |
1488 | Tenofovir | Tenofovir 9-Allyl Impurity | IH | 9-(prop-2-en-1-yl)-9H-purin-6-amine | 4121-39-5 |
1489 | Terazosin Hydrochloride Dihydrate | Terazosin Hydrochloride Dihydrate | EP | 1-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-4-[[(2RS)-tetrahydrofuran-2-yl] carbonyl]piperazine hydrochloridedihydrate | 70024-40-7 |
1490 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - A | EP | 2-chloro-6,7-dimethoxyquinazolin-4-amine | 23680-84-4 |
1491 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - C | EP | 6,7-dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine | 60547-97-9 |
1492 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - D | EP | 1-(4-amino-6,7-dimethoxyquinazolin-2-yl)-4-formylpiperazine | 84050-21-5 102714-74-9 (Free base) |
1493 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - E | EP | 2,2'-(piperazine-1,4-diyl)bis(6,7-dimethoxyquinazolin-4-amine) | 102839-00-9 |
1494 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - G | EP | 1-(4-amino-6-hydroxy-7-methoxyquinazolin-2-yl)-4-[[(2RS)-tetrahydrofuran-2-yl] carbonyl]piperazine | 105356-89-6 |
1495 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - H | EP | 1-(4-amino-7-hydroxy-6-methoxyquinazolin-2-yl)-4-[[(2RS)-tetrahydrofuran-2-yl] carbonyl]piperazine | 105356-90-9 |
1496 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - K | EP | 1-(4-amino-6,7-dimethoxyquinazolin-2-yl)-4-furan-2-ylcarbonylpiperazine (Prazosin) | 19237-84-4 (HCl salt) |
1497 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - L | EP | 1-(furan-2-ylcarbonyl)piperazine | 40172-95-0 |
1498 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - M | EP | 1,4-bis(furan-2-ylcarbonyl)piperazine | 31350-27-3 |
1499 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - N | EP | 1-[[(2RS)-tetrahydrofuran-2-yl]carbonyl]piperazine | 63074-07-7 |
1500 | Terazosin Hydrochloride Dihydrate | Terazosin Impurity - O | EP | 1,4-bis[(tetrahydrofuran-2-yl)carbonyl]piperazine | 547730-06-3 |
1501 | Terazosin Hydrochloride Dihydrate | Terazosin Related Compound - A | USP | 6,7-dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine | 60547-97-9 (Free base) |
1502 | Terazosin Hydrochloride Dihydrate | Terazosin Related Compound - C | USP | 1,4-bis(4-amino-6,7-dimethoxy-2-quinazolinyl)piperazine dihydrochloride | 1458612-41-8 102839-00-9 (Free base) |
1503 | Terazosin | Terazosin impurity- | IH | 6,7-dimethoxyquinazoline-2,4-diamine | 60547-96-8 |
1504 | Thiamine Hydrochloride | Thiamine Hydrochloride | IH | 3-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-5-(2-hydroxyethyl)-4-methyl-chloridethiazolium Hydrochloride | 67-03-8 |
1505 | Thiamine Hydrochloride | Thiamine Impurity | IH | 5-(2hydroxyethyl)-4-methylthiazole | 137-00-8 |
1506 | Ticagrelor | Ticagrelor | IH | (1S,2S,3R,5S)-3-{7-{[(1R,2S)-2-(3,4-D1,2-cyclopentanediol)fluorophenyl)cyclopropy]amino}-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl}-5-(2- | 274693-27-5 |
1507 | Ticagrelor | Impurity A | IH | 2-(propylsulfanyl)pyrimidine-4,6-diol | 145783-12-6 |
1508 | Ticagrelor | Ticagrelor TIC-S2 Impurity-G | IH | 5-amino-6-chloro-2-(propylsulfanyl)pyrimidin-4-ol | NA |
1509 | Ticagrelor | Ticagrelor TIC-S2 Impurity-H | IH | 4,6-dichloro-N-hydroxy-2-(propylsulfanyl)pyrimidin-5-amine | NA |
1510 | Ticagrelor | Ticagrelor impurity-C | IH | 4,6-dichloro-5-nitro-2-(propylsulfanyl)pyrimidine | 145783-14-8 |
1511 | Ticagrelor | Ticagrelor Impurity B | IH | 5-nitro-2-(propylsulfanyl)pyrimidine-4,6-diol | 145783-13-7 |
1512 | Tinidazole | Tinidazol e | EP | 1-[2-(Ethylsulfonyl)ethyl]-2-methyl-5-nitro-1H-imidazole | 19387-91-8 |
1513 | Tinidazole | Tinidazole Impurity - A | EP | 2-methyl-5-nitro-1H-imidazole | 696-23-1 |
1514 | Tinidazole | Tinidazole Impurity - B | EP | 1-[2-(ethylsulfonyl)ethyl]-2-methyl-4-nitro-1H-imidazole | 25459-12-5 |
1515 | Tinidazole | Tinidazole Related Compound - A | USP | 2-methyl-5-nitro-1H-imidazole | 696-23-1 |
1516 | Tinidazole | Tinidazole Related Compound - B | USP | 1-[2-(ethylsulfonyl)ethyl]-2-methyl-4-nitro-1H-imidazole | 25459-12-5 |
1517 | Topiramate | Topiramate | USP | Beta-D-fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-sulfamate | 97240-79-4 |
1518 | Topiramate | Topiramate Related Compound - A | USP | (2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose | 20880-92-6 |
1519 | Topiramate | Topiramate Impurity - C | IH | (2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d] pyran-3a-yl)methyl sulfurochloridoate | 150609-95-3 |
1520 | Topiramate | Topiramate Impurity - D | IH | 1,2:4,5-di-O-isopropylidene Beta-D-fructopyranose | 25018-67-1 |
1521 | Torsemide | Torsemide | USP | N-[(1-methylethyl)amino] carbonyl]-4-[(3-methylphenyl)-amino]-3-pyridine sulfonamide | 56211-40-6 |
1522 | Torsemide | Torsemide Related Compound - A | USP | 4-[(3-Methylphenyl)amino]-3-pyridinesulfonamide | 72811-73-5 |
1523 | Torsemide | Torsemide Related Compound - B | USP | N-[(n-butylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridine sulfonamide | 160972-33-8 |
1524 | Torsemide | Torsemide Related Compound - C | USP | N-[(ethylamino)carbonyl]-4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) | 57155-35-4 |
1525 | Torsemide | Torsemide impurity | IH | ethyl [(3-[(3-methylphenyl)amino]pyridin-2-yl)sulfonyl]carbamate | 72810-57-2 |
1526 | Tramadol Hydrochloride | Tramadol Hydrochloride | EP | (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl) cyclohexanol hydrochloride | 36282-47-0 |
1527 | Tramadol Hydrochloride | Tramadol Impurity - D | EP | (1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-hydroxyphenyl)cyclohexanol (O-Desmethyl) | 185453-02-5 |
1528 | Tramadol Hydrochloride | Tramadol Impurity - E | EP | (2RS)-2-[(dimethylamino)methyl] cyclohexanone | 15409-60-6 |
1529 | Tramadol Hydrochloride | Tramadol Related Compound - B | USP | (2-(dimethylaminomethyl)-1-cyclohexanone hydrochloride) | 42036-65-7 |
1530 | Tranexamic Acid | Tranexamic Acid | EP | trans-4-(Aminomethyl)cyclohexanecarboxylic acid | 1197-18-8 |
1531 | Tranexamic Acid | Tranexamic Acid Impurity - D | EP | 4-aminomethylbenzoic acid | 56-91-7 |
1532 | Trihexyphenidyl Hydrochloride | Trihexyphenidyl HCl | EP | (1RS)-1-Cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride | 52-49-3 |
1533 | Trimetazidine Hydrochloride | Trimetazidine Hydrochloride | BP | 1-(2,3,4-Trimethoxybenzyl)piperazine dihydrochloride | 13171-25-0 |
1534 | Trimetazidine Hydrochloride | Trimetazidine Impurity - A | BP | 1-(3,4,5-trimethoxybenzyl)piperazine | 52146-35-7 |
1535 | Trimetazidine Hydrochloride | Trimetazidine Impurity - B | BP | 1,4-bis(2,3,4-trimethoxybenzyl)piperazine | 1257-19-8 |
1536 | Trimetazidine Hydrochloride | Trimetazidine Impurity - C | BP | 2,3,4-trimethoxybenzaldehyde | 2103-57-3 |
1537 | Trimetazidine Hydrochloride | Trimetazidine Impurity - D | BP | (2,3,4-trimethoxyphenyl)methanol | 71989-96-3 |
1538 | Trimetazidine Hydrochloride | Trimetazidine Impurity - E | BP | 1-(2,4,5-trimethoxybenzyl)piperazine | 356083-64-2 |
1539 | Trimetazidine Hydrochloride | Trimetazidine Impurity - F | BP | 1-(2,4,6-trimethoxybenzyl)piperazine | 113698-83-2 |
1540 | Trimetazidine Hydrochloride | Trimetazidine Impurity - G | BP | piperazine | 110-85-0 |
1541 | Trimetazidine Hydrochloride | Trimetazidine Impurity - H | BP | ethyl 4-(2,3,4-trimethoxybenzyl)piperazine-1-carboxylate | 53531-01-4 |
1542 | Trimetazidine Hydrochloride | Trimetazidine Impurity - I | BP | 1-methyl-4-(2,3,4-trimethoxybenzyl)piperazine(N-methyl trimetazidine) | 93152-26-2 |
1543 | Trimetazidine | Trimetazidine Impurity-J | IH | 4-[(2,3,4-trimethoxyphenyl)methyl]piperazine-1-carbaldehyde | 879646-17-0 |
1544 | Trimetazidine | Trimetazidine N-oxide impurity | IH | 1-oxo-1-(2,3,4-trimethoxyphenyl)methyl]-1¹- piperazine | NA |
1545 | Tropicamide | Tropicamide | BP | (2RS)-N-ethyl-3-hydroxy-2-phenyl-N-(pyridin-4-ylmethyl)propanamide | 1508-75-4 |
1546 | Tropicamide | Tropicamide Impurity - A | BP | N-(pyridin-4-ylmethyl)ethanamine | 33403-97-3 |
1547 | Tropicamide | Tropicamide Impurity - B | BP | N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)propenamide | 57322-50-6 |
1548 | Tropicamide | Tropicamide Impurity - C | BP | (2RS)-3-hydroxy-2-phenylpropanoic acid(Tropic acid) | 529-64-6 |
1549 | Tropicamide | Tropicamide Related Compound - A | USP | N-(pyridin-4-ylmethyl)ethanamine | 33403-97-3 |
1550 | Tropicamide | Tropicamide Related Compound - B | USP | N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)propenamide | 57322-50-6 |
1551 | Tropicamide | Tropicamide Related Compound - C | USP | (2RS)-3-hydroxy-2-phenylpropanoic acid(Tropic acid) | 529-64-6 |
1552 | Tropicamide | Tropicamide Related Compound - D | USP | Phenylacetic acid | 103-82-2 |
1553 | Tropicamide | Tropicamide Impurity - D | IH | Phenylacetic acid | 103-82-2 |
1554 | Tolterodine | Tolterodine | IH | (R)-(+)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine | 124937-51-5 |
1555 | Tolterodine | Tolterodine Lactol Impurity | IH | 6-methyl-4-phenyl-2-chromanino[9(or)3,4-Dihydro-6-methyl-4-phenyl-2H-1-benzopyran-2-ol | 209747-04-6 |
1556 | Tolterodine | Tolterodine Monoisopropyl Impurity | IH | [R]-2-[3-(Isopropylamino)-1-phenylpropyl]-4-methylphenol | 194482-41-2 |
1557 | Tolterodine | Tolterodine Diolacetate Impurity | IH | 3-(2-hydroxy-5-methylphenyl)-3-phenyl propyl acetate | NA |
1558 | Tolterodine | Tolterodine Tartrate S-Isomer | IH | (S)-2-[3-Bis-(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol | 124937-54-8(tartrate salt) |
1559 | Tolterodine | Tolterodine Degradation Product - A | IH | 2-[1(R)-3-amino-1-phenylpropyl]-4-methylphenol | 1203453-90-0 |
1560 | Trazodone Hydrochloride | Trazodone Hydrochloride | EP | 2-[3-(4-(3-chlorophenyl)piperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one hydrochloride | 25332-39-2 |
1561 | Trazodone Hydrochloride | Trazodone Related Compound - C | USP | 2-[3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl]-1[2,4]triazolo[4,3-a]pyridine-3(2H)-one hydrochloride | 1263278-77-8 |
1562 | Trazodone Hydrochloride | Trazodone Related Compound - D | USP | 2-[3-[4-(3-Bromophenyl)piperazin-1-yl]propyl]-1[2,4]triazolo[4,3-a]pyridin-3(2H)-one | 1263278-80-3 (HCl salt) |
1563 | Trazodone Hydrochloride | Trazodone | IH | 3-[4-(3-Chlorophenyl)piperazin-1-yl]propan-1-ol | 32229-98-4 |
1564 | Trazodone Hydrochloride | Trazodone | IH | 1-(3-Chlorophenyl)piperazine Hydrochloride | 65369-76-8 |
1565 | Trazodone Hydrochloride | Trazodone Impurity - B | IH | 2-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one | 62337-66-0 |
1566 | Trazodone Hydrochloride | Trazodone Impurity - C | IH | 2-[3-[4-(4-Chlorophenyl)piperazin-1-yl]propyl]-1[2,4]triazolo[4,3-a]pyridine-3(2H)-one hydrochloride | 1263278-77-8 |
1567 | Trazodone Hydrochloride | Trazodone N-Oxide Impurity | IH | 2-[3-[4-(3-chlorophenyl)-1-oxido-1-piperazinyl]propyl]-1,2,4-triazolo[4,3-a]pyridine-3(2H)-one | 55290-68-1 |
1568 | Trazodone Hydrochloride | Trazodone Impurity - D | IH | 2-[3-[4-(3-Bromophenyl)piperazin-1-yl]propyl]-1[2,4]triazolo[4,3-a]pyridin-3(2H)-one | 1263278-80-3 (HCl salt) |
1569 | Trazodone Hydrochloride | Trazodone Bispiperazine Impurity | IH | 1,3-bis-[4-(3-Chlorophenyl)piperazin-1-yl]propane dihydrochloride | 63223-09-7 (Free base) |
1570 | Trazodone Hydrochloride | Trazodone Impurity - G | IH | 3-[4-(3-Chlorophenyl)piperazin-1-yl]propyl isobutyl ether | NA |
1571 | Trazodone Hydrochloride | 4-Ethyl Trazodone Impurity | IH | 2-3-[4-(3-Chloro-4-ethylphenyl)piperazin-1-yl]propyl-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one | 1346599-35-6 |
1572 | Trazodone | Trazodone Impurity | IH | 3-chloro-4-ethylaniline | 50775-72-9 |
1573 | Ursodeoxycholicacid | Ursodeoxycholicacid | EP | 3α,7β-dihydroxy-5β-cholan-24-oic acid | 128-13-2 |
1574 | Ursodeoxycholicacid | Ursodeoxycholicacid Impurity - A | EP | chenodeoxycholic acid | 474-25-9 |
1575 | Ursodeoxycholicacid | Ursodeoxycholicacid Impurity - C | EP | 3α-hydroxy-5β-cholan-24-oic acid (lithocholic acid) | 434-13-9 |
1576 | Ursodeoxycholicacid | Ursodeoxycholicacid Impurity - E | EP | 3α,12α-dihydroxy-5β-cholan-24-oic acid (deoxycholic acid) | 83-44-3 |
1577 | Ursodeoxycholic | Ursodeoxycholic impurity-G | IH | methyl 3α,7β-dihydroxy-5β-cholan-24-oate | 10538-55-3 |
1578 | Valaciclovir Hydrochloride | Valaciclovir Hydrochloride | EP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-valinate hydrochloride | 124832-27-5 124832-26-4 (Free base) |
1579 | Valaciclovir Hydrochloride | Valaciclovir Impurity - E | EP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxy carbonyl)-L-valinate | 124832-31-1 |
1580 | Valaciclovir Hydrochloride | Valaciclovir Impurity - C | EP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride | 1346617-39-7 |
1581 | Valaciclovir Hydrochloride | Valaciclovir Impurity - D | EP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate | 1346747-69-0 |
1582 | Valaciclovir Hydrochloride | Valaciclovir Impurity - F | EP | 2-Hydroxyethyl l-valinate tosylate | 86150-61-0 142863-66-8 (Free base) |
1583 | Valaciclovir Hydrochloride | D-Valaciclovir impurity-R | EP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl D-valinate hydrochloride | 124832-28-6 |
1584 | Valaciclovir Hydrochloride | Valaciclovir Related Compound - C | USP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-methyl-L-valinate hydrochloride | 1346617-39-7 |
1585 | Valaciclovir Hydrochloride | Valaciclovir Related Compound - E | USP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxy carbonyl)-L-valinate | 124832-31-1 |
1586 | Valaciclovir Hydrochloride | Valaciclovir Related Compound - D | USP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-ethyl-L-valinate | 1346747-69-0 |
1587 | Valaciclovir Hydrochloride | Valaciclovir Related Compound - F | USP | 2-Hydroxyethyl l-valinate tosylate | 86150-61-0 |
1588 | Valaciclovir Hydrochloride | D-Valaciclovir impurity | USP | 2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl D-valinate hydrochloride | 124832-28-6 |
1589 | Valproic Acid | Valproic Acid | EP | 2-Propylpentanoic acid | 99-66-1 |
1590 | Valproic Acid | Valproic Acid Impurity - A | EP | Pentanoic Acid (Valeric acid) | 109-52-4 |
1591 | Valproic Acid | Valproic acid Impurity - B | EP | (2RS)-2-ethylpentanoic acid, | 20225-24-5 |
1592 | Valproic Acid | Valproic acid Impurity - C | EP | (2RS)-2-(1-methylethyl)pentanoic acid | 62391-99-5 |
1593 | Valproic Acid | Valproic acid Impurity - E | EP | pentanamide (valeramide) | 626-97-1 |
1594 | Valproic Acid | Valproic acid Impurity - H | EP | pentanenitrile (valeronitrile) | 110-59-8 |
1595 | Valproic Acid | Valproic acid Impurity - I | EP | 2-propylpentanenitrile | 13310-75-3 |
1596 | Valproic Acid | Valproic Acid Butyl Impurity | IH | 2-Propylhexanoic acid | 3274-28-0 |
1597 | Valproic Acid | Valproic Acid Methylester Impurity | IH | Methyl 2-propylpentanoate | 22632-59-3 |
1598 | Valproic Acid | Valproicacid Related Compound - B | USP | (2RS)-2-(1-methylethyl)pentanoic acid | 62391-99-5 |
1599 | Valsartan | Valsartan | USP | (S)-3-methyl-2-(N-{[2'-(1H-1,2,3,4-tetrazol-5-yl)biphenyl-4-yl]methyl}pentanamido)butanoic acid | 137862-53-4 |
1600 | Valsartan | Valsartan Related Compound - A | USP | ((R)-N-Valeryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine) | 137862-87-4 |
1601 | Valsartan | Valsartan Related Compound - B | USP | (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine) | 952652-79-8 |
1602 | Valsartan | Valsartan Related Compound - C | USP | (N-valeryl-N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine benzyl ester) | 137863-20-8 |
1603 | Valsartan | Valsartan impurity-C | EP | (2S)-2-[butanoyl{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}amino]-3-methylbutanoic acid | 952652-79-8 |
1604 | Valsartan | Valsartan Devaleryl Impurity | IH | (N-{[2'-(1H-tetrazole-5-yl)biphenyl-4-yl]methyl}-L-valine) | 676129-92-3 |
1605 | Valsartan | Valsartan Ethyl Ester Impurity | IH | (S)-N-Valeryl-N-{[2'-(1H-tetrazole-5-yl) biphenyl-6-yl]methyl}-L-valine ethyl ester | 1111177-30-0 |
1606 | Valsartan | Valsartan Nitrile Impurity (Methyl Ester) | IH | Methyl N-valeryl-N-{[2'-cyanobiphenyl-4-yl]methyl}-L-valinate | 137863-90-2 |
1607 | Venlafaxine Hydrochloride | Venlafaxine Hydrochloride | EP | 1-[(1RS)-2-(Dimethylamino)-1-(4-methoxyphenyl) ethyl] cyclohexanolhydrochloride | 99300-78-4 |
1608 | Venlafaxine Hydrochloride | Venlafaxine Impurity -A | EP | 2-(4-methoxyphenyl)-N,N-dimethylethanamine | 775-33-5 |
1609 | Venlafaxine Hydrochloride | Venlafaxine Impurity -B | EP | ethyl (2RS)-3-(dimethylamino)-2-(4-methoxyphenyl) propanoate | 323176-93-8 |
1610 | Venlafaxine Hydrochloride | Venlafaxine Impurity -C | EP | 1-[(1RS)-2-amino-1-(4-methoxy phenyl)ethyl]cyclohexanol | 130198-05-9 (HCl salt) |
1611 | Venlafaxine Hydrochloride | Venlafaxine Impurity -D | EP | 1-[(1RS)-1-(4-methoxyphenyl)-2-(methylamino) ethyl] cyclohexanol | 93413-90-2 (HCl salt) |
1612 | Venlafaxine Hydrochloride | Venlafaxine Impurity -E | EP | (5RS)-5-(4-methoxyphenyl)-3-methyl-1-oxa-3-azaspiro[5.5] undecane | 93413-56-0 (HCl salt) |
1613 | Venlafaxine Hydrochloride | Venlafaxine Impurity -F | EP | (2RS)-2-(cyclohex-1-enyl)-2-(4-methoxyphenyl)-N,N-dimethylethanamine | 93413-79-7 (HCl salt) 93413-57-1 (Free base) |
1614 | Venlafaxine Hydrochloride | Venlafaxine Impurity -G | EP | (2RS)-2-cyclohexyl-2-(4-methoxy phenyl)-N,N-dimethyl ethanamine | 1076199-92-2 (HCl salt) |
1615 | Venlafaxine Hydrochloride | Venlafaxine Impurity -H | EP | 1-[(1RS)-1-(4-methoxyphenyl)-2-[[2-(4-methoxy phenyl) ethyl]amino] ethyl]cyclohexanol | 1329795-88-1 |
1616 | Venlafaxine Hydrochloride | Venlafaxine Related Compound - A | USP | 1-[1-(4-Methoxyphenyl)-2-(methylamino)ethyl] cyclo hexanol hydrochloride | 93413-90-2 |
1617 | Venlafaxine | Venlafaxine N-Oxide | IH | 1-[2-(dimethylnitroxy)-1-(4-methoxyphenyl)ethyl]cyclohexanol | 1094598-37-4 |
1618 | Voriconazole | Voriconazole | EP | (2R,3S)-2-(2,4-Difluorophenyl-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 137234-62-9 |
1619 | Voriconazole | Voriconazole Impurity - A | BP | 1-(2,4-difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone | 86404-63-9 |
1620 | Voriconazole | Voriconazole Impurity - C | BP | 4-ethyl-5-fluoropyrimidine | 137234-88-9 |
1621 | Vortioxetine | Vortioxetine | IH | 1-[2-[(2,4-Dimethylphenyl)thio]phenyl]-piperazine hydrobromide | 960203-27-4 |
1622 | Vortioxetine | Votioxetine Impurity - 1 | IH | 1-[2-[(2-Methylphenyl)sulfanyl]phenyl]piperazine | 1293489-71-0 |
1623 | Vortioxetine | Vortioxetine Impurity - 2 | IH | 1-[2-[(3-Methylphenyl)sulfanyl]phenyl]piperazine | 1293489-69-6 |
1624 | Vildagliptin | Vildagliptin Dimer Impurity | IH | (2S)-1-[(2-{(2S)-2-[(pyrrolidine-1-yl){(3-hydroxypyrrolidino[3,3,1,1,{3,7}dec-1-yl)amino]acetyl]}-pyrrolidine-2-carbonitrile | 1036959-23-5 |
1625 | Verapamil | Verapamil impurity-A | EP | N,N'-bis[2-(3,4-dimethoxyphenyl)ethyl]-N,N'-dimethylpropane-1,3-diamine | 63434-11-7 |
1626 | Verapamil | Verapamil impurity-C | IH | 2-(3,4-dimethoxyphenyl)-N,N'-dimethylethan-1-amine—hydrogen chloride (1/1) | 51012-67-0 |
1627 | Verapamil | Verapamil impurity-D | IH | 3-chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methylpropan-1-amine—hydrogen chloride (1/1) | 36770-74-8 |
1628 | Zolpidem Tartrate | Zolpidem Tartrate | EP | Bis{N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl] acetamide} (2R,3R)-2,3-dihydroxybutanedioate | 99294-93-6 |
1629 | Zolpidem Tartrate | Tolyloyl propionic acid | USP | p-methylbenzoyl propionic acid | 4619-20-9 |
1630 | Zolpidem Tartrate | Zolpidem Acid | USP | 2(6-methyl-2-p-tolylimidazo[1,2-a] pyridin-3-yl)acetic acid | 189005-44-5 |
1631 | Zolpidem Tartrate | Tolyloyl propionamide | USP | N,N-Dimethyl-4-oxo-4-(p-tolyl) butanamide | 402470-91-1 |
1632 | Zolpidem | Zolpidem Related Compound-B | USP | N,N'-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]-2-oxoacetamide | 400038-68-8 |
1633 | Zolpidem Tartrate | Zolpidem Related Compound - A | USP | N,N-dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl] acetamide | 1346600-85-8 |
1634 | Zolpidem Tartrate | Zolpidem Carbaldehyde | USP | 6-methyl-2-p-tolylimidazo[1,2-a] pyridine-3-carbaldehyde | 400777-11-9 |
1635 | Zolpidem Tartrate | Zolpidem Tolyloyl bromopropionamide | USP | 3-bromo-N,N-dimethyl-4-(4-methylphenyl)benzamide | 836627-56-6 |
1636 | Zolpidem Tartrate | Zolpidem Related Compound - C | USP | 4-methyl-N-(5-methylpyridin-2-yl) benzamide | 349122-64-1 |
1637 | Zolmitriptan | Zolmitriptan | IH | (4S)-4-[[3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone | 139264-17-8 |
1638 | Zolmitriptan | Zolmitriptan Related Compound-A | USP | 4-[[3-(ethylamino)methyl]-3H-indol-5-yl]methyl]-1,3-oxazolidin-2-one | 139264-35-0 |
1639 | Zolmitriptan | Zolmitriptan Related Compound - E | USP | (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone | 251451-30-6 |
1640 | Zolmitriptan | Zolmitriptan Related Compound - B | USP | (S)-2-Amino-3-[3-[2-(dimethylamino)ethyl]-1H-indol-5yl]propan-1-ol | 139264-69-0 |
1641 | Zolmitriptan | Zolmitriptan N-oxide Impurity | IH | (4S)-4-[[3-[2-(Dimethyloxidoamino)ethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone | 251451-30-6 |
1642 | Zolmitriptan | Zolmitriptan Impurity - B | IH | (S)-2-Amino-3-[3-[2-(dimethylamino)ethyl]-1H-indol-5yl]propan-1-ol | 139264-69-0 |
1643 | Zolmitriptan | Zolmitriptan Aminopropanol Impurity | IH | (2S )-2-amino-3-(4-aminophenyl)propan-1-ol | 726134-79-8 |